<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001918.pub3" GROUP_ID="CF" ID="956899082314374091" MERGED_FROM="" MODIFIED="2014-05-22 12:23:22 +0100" MODIFIED_BY="Tracey Remmington" REVIEW_NO="0018" REVMAN_SUB_VERSION="5.2.11 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2014-05-22 12:09:29 +0100" MODIFIED_BY="Tracey Remmington">
<TITLE MODIFIED="2013-09-19 15:02:53 +0100" MODIFIED_BY="Tracey Remmington">Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia</TITLE>
<CONTACT>
<PERSON ID="DABBCE4282E26AA2001A7553B0565C46" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Nusrat</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shafiq</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>nusrat_shafiq@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pharmacology</DEPARTMENT>
<ORGANISATION>Postgraduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1>+91 172 2747585 ext 5240</PHONE_1>
<PHONE_2/>
<FAX_1>+91 172 2744401</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2014-05-22 12:09:29 +0100" MODIFIED_BY="Tracey Remmington">
<PERSON ID="16720953552990114351120112101226" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Anita</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Malhotra</LAST_NAME>
<SUFFIX/>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>anitamalhotra345@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Physiology</DEPARTMENT>
<ORGANISATION>Government Medical College</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="DABBCE4282E26AA2001A7553B0565C46" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Nusrat</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shafiq</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>nusrat_shafiq@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pharmacology</DEPARTMENT>
<ORGANISATION>Postgraduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1>+91 172 2747585 ext 5240</PHONE_1>
<PHONE_2/>
<FAX_1>+91 172 2744401</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="43819943772877907589120404163706" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Anjuman</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Arora</LAST_NAME>
<SUFFIX/>
<POSITION>PhD Scholar</POSITION>
<EMAIL_1>iqgal_an@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pharmacology</DEPARTMENT>
<ORGANISATION>Post Graduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1>Sector-12</ADDRESS_1>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>PIN-160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4986" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Meenu</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Singh</LAST_NAME>
<SUFFIX>MD</SUFFIX>
<POSITION>Professor of Pediatrics</POSITION>
<EMAIL_1>meenusingh4@gmail.com</EMAIL_1>
<EMAIL_2>meenusingh@rediffmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pediatrics</DEPARTMENT>
<ORGANISATION>Post Graduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1>Sector 12</ADDRESS_1>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1>+91 172 2755620</PHONE_1>
<PHONE_2/>
<FAX_1>+91 172 2744401</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14115993829773365489120404164005" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Rajendra</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Kumar</LAST_NAME>
<SUFFIX/>
<POSITION>PhD Scholar</POSITION>
<EMAIL_1>rajendra.bits@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Immunopathology</DEPARTMENT>
<ORGANISATION>Post graduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1>Sector-12</ADDRESS_1>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>PIN-160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="DAB6EC5282E26AA2001A7553BF8EF949" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Samir</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Malhotra</LAST_NAME>
<SUFFIX/>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>samirmalhotra345@yahoo.com</EMAIL_1>
<EMAIL_2>smal.pgi@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pharmacology</DEPARTMENT>
<ORGANISATION>Postgraduate Institute of Medical Education and Research</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Chandigarh</CITY>
<ZIP>160012</ZIP>
<REGION/>
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1>+91 172 272 1293</PHONE_1>
<PHONE_2/>
<FAX_1>+91 172 274 4401</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2014-05-02 00:51:36 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="2" MONTH="5" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="22" MONTH="8" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="2" MONTH="5" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-05-22 12:02:48 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-05-02 00:49:00 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Four new trials have been included in the update (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>). Additional interventions (e.g. dietary fibers) have been added separately. No major changes have been made to the conclusions of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-05-22 12:02:48 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>A search of the Group's Inborn Errors of Metabolism Trials Regitser and PubMed identified four eligible trials for inclusion (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>) which showed that the addition of plant sterols to the diet significantly reduced the total cholesterol, serum LDL and serum total triglycerides for patients with FH.</P>
<P>The title has been changed from: Dietary treatment for familial hypercholesterolaemia.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-09-20 10:54:33 +0100" MODIFIED_BY="Tracey Remmington">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-08-16 15:46:21 +0100" MODIFIED_BY="Tracey Remmington">
<DATE DAY="20" MONTH="9" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated. Three trials have been added to the previous update (
<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>
, 
<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>
 and 
<LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>
). 
The scientific statement from the American Heart Association (AHA) for the treatment of high-risklipid abnormalities in childr
en and adolescents, which advocated the use of dietary treatment as adjuvant to pharmacolog
ical treatment, was published in 2007. No revision of this statement has been published subsequently. F
ollowing our updated review (2010), we are updating this review with additional information.
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-09-20 10:54:33 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="19" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Four additional trials have been included in the current update (<LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>); and three trials are listed as 'Awaiting classification' (<LINK REF="STD-Fuentes-2008" TYPE="STUDY">Fuentes 2008</LINK>; Retterstol 2009; <LINK REF="STD-Stein-2007" TYPE="STUDY">Stein 2007</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2010-09-20 10:15:38 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="19" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>The team of review authors has changed. Vanessa Poustie and Patricia Rutherford are no longer active authors on this review.</P>
<P>New comparisons between groups have been added. A previous comparison of cholesterol lowering diet and all other dietary interventions has been removed in the current update. Instead a new outcome for the evaluation of the effect of adding dietary intervention to drug therapy has been added in the present review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-16 13:42:54 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="31" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="23" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-05-22 12:08:38 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-05-22 00:11:10 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-10-31 11:08:08 +0000" MODIFIED_BY="Tracey Remmington">Dietary modifications for managing familial hypercholesterolaemia</TITLE>
<SUMMARY_BODY MODIFIED="2014-05-22 00:11:10 +0100" MODIFIED_BY="[Empty name]">
<P>Familial hypercholesterolaemia is an inherited disorder characterised by a raised blood cholesterol, and premature ischaemic heart disease. Changing diet is an important management option to reduce low-density lipoprotein cholesterol (the bad cholesterol) levels. Recently, certain lipid-lowering drugs have shown to be safe and effective for the treatment of children with familial hypercholesterolaemia. However, dietary management remains important either on its own or combined with drug therapy. Several strategies are used to modify diet. This review aimed to compare cholesterol-lowering dietary interventions either in combination with each other or alone. These interventions included adding omega-3 fatty acids or plant sterols or plant stanols or soya proteins to diet. Fifteen trials were included in this updated review. The included trials had either a low or unclear risk of bias for most of the domains used for risk assessment. All the trials were short term and the majority were cross-over in design. For most of the comparisons there was no significant difference in the various intervention strategies when compared to cholesterol-lowering diet. However, for total cholesterol levels, serum low density lipoprotein (LDL) concentrations, a significant benefit was obtained with plant sterols. However, before drawing any conclusions, methodological problems with pooling results from cross-over trials should be considered. There is a need for long-term trials with parallel group design to assess the potential benefits and harms of a cholesterol-lowering diet.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-05-22 09:43:15 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-05-21 23:27:37 +0100" MODIFIED_BY="[Empty name]">
<P>A cholesterol-lowering diet and several other dietary interventions have been suggested as a management approach either independently or as an adjuvant to drug therapy in children and adults with familial hypercholesterolaemia (FH). However, a consensus has yet to be reached on the most appropriate dietary treatment. Plant sterols are commonly used in FH although patients may know them by other names like phytosterols or stanols.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-12-01 04:30:07 +0000" MODIFIED_BY="Nikki Jahnke">
<P>To examine whether a cholesterol-lowering diet is more effective in reducing ischaemic heart disease and lowering cholesterol than no dietary intervention in children and adults with familial hypercholesterolaemia. Further, to compare the efficacy of supplementing a cholesterol-lowering diet with either omega-3 fatty acids, soya proteins, plant sterols or plant stanols.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-05-21 23:27:52 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Inborn Errors of Metabolism Trials Register, which is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated with each new issue of <I>The Cochrane Library</I>), quarterly searches of MEDLINE and the prospective handsearching of one journal - <I>Journal of Inherited Metabolic Disease. </I>Most recent search of the Group's Inborn Errors of Metabolism Trials Register: 22 August 2013. We also searched PubMed to 05 February 2012.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised controlled trials, both published and unpublished, where a cholesterol-lowering diet in children and adults with familial hypercholesterolaemia has been compared to other forms of dietary treatment or to no dietary intervention were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-08-18 13:16:00 +0100" MODIFIED_BY="Tracey Remmington">
<P>Two authors independently assessed the trial eligibility and risk of bias and one extracted the data, with independent verification of data extraction by a colleague.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-05-22 09:43:15 +0100" MODIFIED_BY="[Empty name]">
<P>In the 2014 update of the review, 15 trials have been included, with a total of 453 participants across seven comparison groups. The included trials had either a low or unclear risk of bias for most of the parameters used for risk assessment. Only short-term outcomes could be assessed due to the short duration of follow up in the included trials. None of the primary outcomes, (incidence of ischaemic heart disease, number of deaths and age at death) were evaluated in any of the included trials. No significant differences were noted for the majority of secondary outcomes for any of the planned comparisons. However, a significant difference was found for the following comparisons and outcomes: for the comparison between plant sterols and cholesterol-lowering diet (in favour of plant sterols), total cholesterol levels, mean difference 0.30 mmol/l (95% confidence interval 0.12 to 0.48); decreased serum LDL cholesterol, mean difference -0.60 mmol/l (95% CI -0.89 to -0.31). Fasting serum HDL cholesterol levels were elevated, mean difference -0.04 mmol/l (95% CI -0.11 to 0.03) and serum triglyceride concentration was reduced, mean difference -0.03 mmol/l (95% CI -0.15 to -0.09), although these changes were not statistically significant. Similarly, guar gum when given as an add on therapy to bezafibrate reduced total cholesterol and LDL levels as compared to bezafibrate alone.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-05-02 01:33:09 +0100" MODIFIED_BY="[Empty name]">
<P>No conclusions can be made about the effectiveness of a cholesterol-lowering diet, or any of the other dietary interventions suggested for familial hypercholesterolaemia, for the primary outcomes: evidence and incidence of ischaemic heart disease, number of deaths and age at death,due to the lack of data on these. Large, parallel, randomised controlled trials are needed to investigate the effectiveness of a cholesterol-lowering diet and the addition of omega-3 fatty acids, plant sterols or stanols, soya protein, dietary fibers to a cholesterol-lowering diet.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-05-22 12:08:38 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-05-21 23:40:47 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-05-21 23:39:40 +0100" MODIFIED_BY="[Empty name]">
<P>Familial hypercholesterolaemias are a group of genetic disorders causing severe elevations of blood cholesterol levels. Total cholesterol concentrations in heterozygous familial hypercholesterolemia (FH) patients are in the range of 9 to 14.2 mmol/l (350 to 550 mg/dL) and in homozygotes range from 16.8 to 25.9 mmol/l (650 to 1000 mg/dL) (<LINK REF="REF-Goldberg-2011" TYPE="REFERENCE">Goldberg 2011</LINK>; <LINK REF="REF-SBRG-1991" TYPE="REFERENCE">SBRG 1991</LINK>). This disorder is one of the most common congenital metabolic disorders; the prevalence of heterozygous FH is approximately 1 in 300 to 500 with much higher incidence in certain populations, such as the Afrikaners, Christian Lebanese, Finns, and French-Canadians (<LINK REF="REF-Marais-2004" TYPE="REFERENCE">Marais 2004</LINK>). The characteristic features of FH include elevated levels of low density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in the circulation, deposits of cholesterol in peripheral tissues, presence of tendon xanthomas and accelerated atherosclerosis, leading to premature cardiovascular events (<LINK REF="REF-Goldstein-1995" TYPE="REFERENCE">Goldstein 1995</LINK>). Primary mutations causing FH are either due to defects in the low density lipoprotein-receptor gene (LDLR), apolipoprotein B-100 gene (APOB), or proprotein convertase subtilisin/kexin type 9 gene (PCSK9), singly or in combination (<LINK REF="REF-Rader-2003" TYPE="REFERENCE">Rader 2003</LINK>). The most prevalent of these genetic defects are defects in the LDLR gene with approximately 1600 known (till date) mutations in the LDLR gene causing almost 85% to 90% cases of FH. Defects in the APOB gene account for 5% to 10% of FH in northern European population (less in other populations). The PCSK9 gene defects account for about 5% of cases of FH (<LINK REF="REF-Hopkins-2011" TYPE="REFERENCE">Hopkins 2011</LINK>).The most severe form is related to total lack of receptors (receptor-negative mutations), while &#8216;receptor-defective&#8217; mutations that comprise most of the mutations are usually accompanied by lesser symptoms (<LINK REF="REF-Austin-2004" TYPE="REFERENCE">Austin 2004</LINK>).</P>
<P>It is recommended that in children under 16 years of age, diagnosis of FH is based on a total cholesterol level of above 6.7 mmol/l (260 mg/dl) and a LDL cholesterol of above 4.0 mmol/l (155 mg/dl) on two measurements taken one month apart (<LINK REF="REF-Wray-1996" TYPE="REFERENCE">Wray 1996</LINK>). In the 1994 revision of the Simon Broome Register Group definition, cases are categorised as 'definite' or 'possible' (<LINK REF="REF-Marks-2003" TYPE="REFERENCE">Marks 2003</LINK>). According to the revision, 'DNA based evidence of an LDL-receptor mutation or familial defective apoB-100' was added as a sufficient criteria for 'definite' familial hypercholesterolaemia diagnosis. The aim of treatment in children and adults is the reduction of blood LDL cholesterol concentrations in order to reduce the risk of ischaemic heart disease.</P>
<P>Management of FH aims at lowering LDL by &#8805; 50% or to &lt; 3.36 mmol/l (130mg/dL). Statins are the most preferred pharmacological agents recommended for the treatment of FH along with diet and physical activity management in all age groups (<LINK REF="REF-Avis-2007" TYPE="REFERENCE">Avis 2007</LINK>; <LINK REF="REF-Shafiq-2007" TYPE="REFERENCE">Shafiq 2007</LINK>). Four statins (lovastatin, simvastatin, pravastatin and atorvastatin) have also been approved by U.S. Food and Drug Administration (US FDA) for use in children with familial hypercholesterolaemia. Children who do not achieve the LDL cholesterol goal after prescribed initial statin dosing need higher dose of statin or addition of another lipid lowering agent. Ezetimibe, a cholesterol absorption inhibitor, is recommended as a monotherapy or in combination with statins in children and adolescents (<LINK REF="REF-Yeste-2009" TYPE="REFERENCE">Yeste 2009</LINK>). Bile acid sequestrants cholestyramine and cholestipol are not recommended for use in pediatric age group due to severe gastrointestinal side effects and poor palatability. Colesvelam, another bile acid sequastrant, can be used in boys aged 7 to 10 years and in postmenarchal girls as monotherapy or as adjuvant to statins. Niacin and fibrates are not recommended in the pediatric age group due to their adverse effects (<LINK REF="REF-O_x0027_Connor-1990" TYPE="REFERENCE">O'Connor 1990</LINK>; <LINK REF="REF-Tonstad-1997a" TYPE="REFERENCE">Tonstad 1997a</LINK>).<BR/>
<BR/>
</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-05-21 23:34:28 +0100" MODIFIED_BY="[Empty name]">
<P>A cholesterol-lowering diet based on the following principles is recommended in the United Kingdom, the USA and elsewhere for the dietary treatment of FH (<LINK REF="REF-Maclean-1994" TYPE="REFERENCE">Maclean 1994</LINK>; <LINK REF="REF-Goldstein-1995" TYPE="REFERENCE">Goldstein 1995</LINK>; <LINK REF="REF-AHA-Statement-2007" TYPE="REFERENCE">AHA Statement 2007</LINK>):</P>
<OL>
<LI>reduction in the intake of saturated fatty acids (fatty acids are components of fats);</LI>
<LI>reduction in dietary cholesterol intake;</LI>
<LI>reduction in total fat intake;</LI>
<LI>manipulation of carbohydrate intake to replace the energy deficit of the low fat diet;</LI>
<LI>increasing the intake of certain dietary components, e.g. garlic, onions, soy protein, plant sterols and stanols and omega-3 (&#969;-3) fatty acids, barley, psyllium, oat bran and rice bran.</LI>
</OL>
</INTERVENTION>
<THEORY MODIFIED="2014-05-21 23:40:47 +0100" MODIFIED_BY="[Empty name]">
<P>The currently prescribed diet is sometimes considered to be monotonous and can lead to problems with compliance. The reduction in fat intake, if taken to the extreme, could potentially lead to a deficiency of essential fatty acids and fat soluble vitamins and a reduction in the overall energy content of the diet which has implications for satiety and growth in children who have relatively high energy requirements. An increase in the carbohydrate content of the diet may lead to raised blood levels of another type of fat, called triglyceride, which is also a risk factor for ischaemic heart disease. In addition, the aim of the diet is to decrease the total cholesterol concentration in the blood. However this form of dietary treatment may result in not only a reduction of LDL cholesterol but also high density lipoprotein (HDL) levels (<LINK REF="REF-Howell-1997" TYPE="REFERENCE">Howell 1997</LINK>). HDL is thought be involved in the removal of cholesterol from the blood and therefore any intervention which lowers the levels of HDL in the blood could have a detrimental effect. In view of this, a number of other dietary therapies have been considered for the treatment of FH, including:</P>
<OL>
<LI>manipulation of different types of fatty acids whilst maintaining normal total fat intake;</LI>
<LI>increasing dietary intake of soluble fibre;</LI>
<LI>increasing the dietary intake of antioxidants;</LI>
<LI>increasing the intake of certain dietary components, e.g. garlic, onions, soy protein, plant sterols and stanols and omega-3 (&#969;-3) fatty acids (<LINK REF="REF-AHA-Statement-2007" TYPE="REFERENCE">AHA Statement 2007</LINK>).</LI>
</OL>
<P>Several scientific and authoritative bodies recommend the daily consumption of 2 g plant stanols or plant sterols for improving blood lipid levels (<LINK REF="REF-US-FDA-2010" TYPE="REFERENCE">US FDA 2010</LINK>). Phytosterols, found in fat-soluble fractions of plants, chemically resemble cholesterol and inhibit cholesterol absorption in the small intestine. They reduce plasma total and LDL-C levels (<LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
<P>Oral omega-3 ethyl esters improve the lipid profile principally by reducing TG levels. However, changes in TC and HDL-C were generally not found to be clinically significant, with a small net increase in LDL-C associated with a shift toward less atherogenic LDL subfractions (<LINK REF="REF-Levantesi-2010" TYPE="REFERENCE">Levantesi 2010</LINK>)</P>
<P>&#946;-glucan contained in soy protein has been shown to slow gastric emptying, digestion, and absorption (<LINK REF="REF-Schneeman-1998" TYPE="REFERENCE">Schneeman 1998</LINK>). This causes increased excretion of bile acids and neutral sterols, increasing catabolism of cholesterol, and reduced absorption of cholesterol and fat (<LINK REF="REF-Marlett-1997" TYPE="REFERENCE">Marlett 1997</LINK>).</P>
<P>Various soluble fibers reduce total and LDL Cholesterol as has been previously shown (<LINK REF="REF-Brown-1999" TYPE="REFERENCE">Brown 1999</LINK>). However, this effect was only modest. The lipid lowering effects of soluble dietary fibers acts through its ability to increase intraluminal viscosity thereby affecting the entero-hepatic recirculation ob bile acids and lipid metabolism.</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-05-18 16:15:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>The majority of these interventions do not appear to have been adequately assessed and consensus has yet to be reached on the most appropriate dietary treatment for FH. The aim of this review was to assess the effectiveness of the currently recommended cholesterol lowering diet compared to no dietary treatment or to other forms of dietary intervention.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-09-20 10:44:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>The aims of this review were to examine in children and adults with familial hypercholesterolaemia.</P>
<OL>
<LI>Whether manipulating the fat, protein or carbohydrate content of the diet influences serum lipid levels and the risk of ischaemic heart disease;</LI>
<LI>What effect does adding &#969;-3 fatty acids (or their ethyl esters) to the background diet have on serum lipid levels and the risk of ischaemic heart disease?</LI>
<LI>What effect does adding plant sterols or stanols (both usually given in the form of esters) to the background diet have on serum lipid levels and the risk of ischaemic heart disease? Is there any dose response effect?</LI>
<LI>Does adding soy protein to the background diet influence serum lipid levels and the incidence of ischaemic heart disease?</LI>
<LI>Does adding dietary fibers such as barley, oat bran, rice bran , flax seeds or psyllium influence serum lipid levels and the incidence of ischemic heart disease?</LI>
<LI>Does using any of the above dietary strategies in addition to lipid lowering drugs have any added benefit?</LI>
</OL>
<P>
<I>Post hoc </I>change:these comparisons in the current update have been changed from the previous review, in lieu with the growing knowledge about the effects of dietary supplements in altering blood lipid levels.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-05-22 00:11:36 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-09-20 12:01:46 +0100" MODIFIED_BY="Nikki Jahnke">
<CRIT_STUDIES MODIFIED="2009-07-13 04:38:08 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs), both published and unpublished. Trials where quasi-randomisation methods such as alternation were included if there was sufficient evidence that the treatment and comparison groups were comparable in terms of clinical and nutritional status.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-09-20 10:44:26 +0100" MODIFIED_BY="anita  s malhotra">
<P>Children and adults with familial hypercholesterolaemia. Trials which included people with familial hypercholesterolaemia alongside those with non-familial hypercholesterolaemia were only included if the group of familial individuals was well defined and the results for this group were available.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-10-19 15:31:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Cholesterol-lowering diet or any other dietary intervention intended to lower serum total and LDL cholesterol, for a period of at least six months. When dietary treatment had been used as a control in a trial of cholesterol-lowering drugs, these trials were excluded. However, trials were included in the review when the only difference between the control and treatment groups was the diet, for example, if a drug treatment alone was compared to the same drug treatment in combination with dietary treatment. Trials where one form of modified dietary intake was compared to another form of dietary intake were included if the comparison was done in a head-to-head comparison.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-09-20 12:01:46 +0100" MODIFIED_BY="Nikki Jahnke">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-09-20 10:44:59 +0100" MODIFIED_BY="Nikki Jahnke">
<OL>
<LI>Evidence and incidence of ischaemic heart disease</LI>
<LI>Number of deaths</LI>
<LI>Age at death</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-09-20 12:01:46 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Fasting serum total cholesterol concentration</LI>
<LI>Fasting serum LDL cholesterol</LI>
<LI>Fasting serum HDL cholesterol</LI>
<LI>Fasting serum triglyceride concentration</LI>
<LI>Fasting apolipoprotein A-1concentration,</LI>
<LI>Fasting apolipoprotein B-100 concentration</LI>
<LI>Quality of life</LI>
<LI>Compliance</LI>
<LI>Morbidity</LI>
<LI>Weight, height and other measures of nutritional status</LI>
<LI>Micronutrient intake</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-09-20 10:47:41 +0100" MODIFIED_BY="Tracey Remmington">
<ELECTRONIC_SEARCHES MODIFIED="2013-09-20 10:46:53 +0100" MODIFIED_BY="Tracey Remmington">
<P>Relevant trials were identified by searching the Inborn Errors of Metabolism Trials Register using the term: diet*.</P>
<P>The Inborn Errors of Metabolism Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of <I>The Cochrane Library</I>), quarterly searches of MEDLINE and the prospective handsearching of one journal - <I>Journal of Inherited Metabolic Disease. </I>Unpublished work is identified by searching through the abstract books of the Society for the Study of Inborn Errors of Metabolism conference and the SHS Inborn Error Review Series. For full details of all searching activities for the register, please see the relevant section of the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/cf/frame.html">Cystic Fibrosis and Genetic Disorders Group Module</A>.</P>
<P>Date of the most recent search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Inborn Errors of Metabolism Register: 22 August 2013.</P>
<P>An additional search of of the Cochrane Central Register of Controlled Trials (CENTRAL) was undertaken (05 March 2012) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-09-20 10:47:41 +0100" MODIFIED_BY="Tracey Remmington">
<P>Clinicaltrials.gov (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>) was also searched. Five trials were identified, none of them was completed and the recruitment status was unknown .</P>
<P>Additional trials were identified from handsearching the <I>Journal of Inherited Metabolic Disease</I> (from inception (1978) to 5 March 2012).</P>
<P>Additional trials were identified from the reference lists of identified trials. Unpublished work was identified through the searching of the abstract books of the major conference on inborn errors of metabolism and metabolic disease.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-05-22 00:11:36 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-05-25 14:13:07 +0100" MODIFIED_BY="Tracey Remmington">
<P>At initial review stage and for each update, two authors independently selected the trials to be included in the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-05-02 01:33:14 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (AR and AM) independently extracted data using a pre-designed data extraction form that contained publication details, patient population, randomisation, allocation concealment, details of blinding measures, description of interventions and results (<LINK REF="REF-Zavala-2006" TYPE="REFERENCE">Zavala 2006</LINK>). They resolved any differences in the extracted data by consulting the other review authors (NS, SM and MS). The data entered into Review Manager software (RevMan 5.1) for was rechecked for accuracy (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>).</P>
<P>Due to the diverse range of dietary interventions suggested for FH, the authors divided the trials into the following comparisons - cholesterol lowering diet with no intervention; &#969;-3 fatty acids added to cholesterol lowering diet with cholesterol lowering diet alone; plant sterols added to cholesterol lowering diet with cholesterol lowering diet alone; plant stanols added to cholesterol lowering diet with cholesterol lowering diet alone; soya protein added to cholesterol lowering diet with cholesterol lowering diet alone; barley added to cholesterol lowering diet with cholesterol lowering diet alone; and dietary modification with lipid lowering drugs; and lipid lowering drugs alone.</P>
<P>The authors planned to group outcome data into those measured at up to one, three, six and twelve months and annually thereafter. However, as was the case, if outcome data were recorded at other time periods (e.g. one- to two-month data) then the authors planned to consider examining these as well. Between a fortnight and one month is generally the time when the treatment effects of dietary intervention on lipids become visible. In order to see how the effects are maintained, analyses at longer periods are desirable. For the primary outcomes, analysing the results of longer follow-up is necessary. For outcomes relating to weight, it may not be apparent in the trials whether an increase or decrease in weight would be desirable. For example, in a group of overweight adults with FH, a reduction in body weight may be desirable. However, for adults of normal body weight, such a reduction may not be desirable. Therefore, unless a judgement can be made on whether it is desirable for weight to increase, decrease or remain static during a trial, the authors planned to discuss data on body weight and related outcomes in the results section of the review, but not include these in the meta-analysis.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-05-25 14:13:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>The authors independently assessed the following domains as either low, unclear or high risk of bias:</P>
<OL>
<LI>sequence generation;</LI>
<LI>allocation concealment;</LI>
<LI>blinding (of participants, personnel and outcome assessors);</LI>
<LI>incomplete outcome data addressed;</LI>
<LI>free of selective outcome reporting;</LI>
<LI>free of other bias.</LI>
</OL>
<P>Overall, trials were considered at high-risk of bias if we could only assess the majority of domains as having a high or unclear risk. The authors resolved any differences by consultation.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-02-27 12:07:15 +0000" MODIFIED_BY="[Empty name]">
<P>For future updates of the review, if we have data for the two primary outcomes of incidence of ischaemic heart disease and death, the number of events and the total number randomised in each group will be taken to calculate the odds ratio and 95% confidence intervals (CIs).</P>
<P>We analysed continuous outcomes using the mean difference (MD) and associated 95% CIs. For future updates, we will calculate the standardised mean difference (SMD) if different scales of measurement have been used. When only the standard error (SE) was provided, we converted this to the SD by multiplying the SE by the square root of the number of participants.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-09-20 11:05:25 +0100" MODIFIED_BY="Tracey Remmington">
<P>Where we obtained data from cross-over trials, we would have undertaken a paired analysis if possible, to allow a within-individual comparison of the treatment intervention. This is the preferred method of analysis of data from cross-over trials (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). As these data were not available from any of the trials included in the review, we used data from the first arm of two of the trials in the analysis (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). For the remaining trials, data presented in the original papers were combined from both treatments and control arms of the trials, thereby ignoring the cross-over design. We included such data in the meta-analysis, which may be considered to be justified but unsatisfactory. This should be taken into account when considering the results of this review. We attempted to contact the authors but no response was obtained.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-05-22 00:11:22 +0100" MODIFIED_BY="[Empty name]">
<P>In order to allow an intention-to-treat analysis, the authors would have sought data on the number of participants with each outcome event, by allocated treatment group, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow up.</P>
<P>Data for the Guardamagna trial have not been included in the present analysis since the authors have not reported the results of subgroup of patients with familial hypercholesterolaemia (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). The authors were requested to supply these data through electronic communication. At the time of writing this review, these data have not been received.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-05-02 01:33:16 +0100" MODIFIED_BY="[Empty name]">
<P>We tested for heterogeneity between trial results using a standard chi-square test, P &lt; 0.1 was considered statistically significant.</P>
<P>We also used the I<SUP>2</SUP> statistic as a measure of heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). This describes the percentage of the variability in effect estimates that is due to heterogeneity rather than chance. We used the following ranges and descriptions:</P>
<UL>
<LI>0% to 40%: might not be important;</LI>
<LI>30% to 60%: may represent moderate heterogeneity;</LI>
<LI>50% to 90%: may represent substantial heterogeneity;</LI>
<LI>75% to 100%: considerable heterogeneity.</LI>
</UL>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-05-22 00:11:36 +0100" MODIFIED_BY="[Empty name]">
<P>The authors planned to assess publication bias with the means of a funnel plot. The primary outcome measure was to be the main outcome for generation of the funnel plot. In the absence of an adequate number of trials reporting the primary outcome, any secondary outcome for which three or more trials were available, would have been used for funnel plot construction.</P>
<P>The authors intended to assess outcome reporting bias ideally by comparing the original trial protocols with the final published papers. If the protocols were not available the authors planned to compare the outcomes that were described as being measured in the 'Methods' section of the final papers with the 'Results' section to identify any outcomes that were not reported. In addition, the authors clinical knowledge would help them identify any outcomes they would normally expect to be measured, but which were not reported.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2009-10-28 09:16:25 +0000" MODIFIED_BY="Nikki Jahnke">
<P>We performed a fixed-effect meta-analysis where we observed no statistically significant heterogeneity. Otherwise, we used a random-effects model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-09-20 11:07:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Where heterogeneity did exist between the trials (P &lt; 0.1 (chi-square test) or substantial to considerable heterogeneity as defined by values of I<SUP>2</SUP> above, was used as evidence of statistical heterogeneity), we investigated this and performed a random-effects meta-analysis.</P>
<P>We planned to undertake a subgroup analysis on those trials carried out in children.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-05-21 23:41:42 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to perform a sensitivity analysis based on the risk of bias of the trials, including and excluding quasi-randomised trials; however, we identified insufficient trials to allow such analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-05-22 12:08:38 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-05-22 11:59:00 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2014-05-22 00:12:09 +0100" MODIFIED_BY="[Empty name]">
<P>In a previous version of this review 377 references were identified from the electronic and manual search strategies. In this updated version of the review, we detected 397 references. We identified and retrieved 17 new and potentially relevant trials, of which 13 were excluded as they did not meet our inclusion criteria (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>), therefore, there are now a total of 375 excluded studies. For this update, four new trials were included (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>), bringing the total number of included trials to 15.</P>
<P>A further two studies are listed as '<LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>' (<LINK REF="STD-Fuentes-2008" TYPE="STUDY">Fuentes 2008</LINK>; <LINK REF="STD-Stein-2007" TYPE="STUDY">Stein 2007</LINK>). We identified one ongoing study (<LINK REF="STD-P_x00e1_rraga-ongoing" TYPE="STUDY">Párraga ongoing</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-05-22 11:59:00 +0100" MODIFIED_BY="[Empty name]">
<P>In total, 15 trials met the criteria for inclusion in the review with a total of 453 participants (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>;<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>). None of the included trials reported data on the primary outcomes of this review. Long-term data were not available for any of the outcomes. After consultation with experts in the field of FH, it was decided to include short-term trials as information on change in serum lipid levels; nutritional status and nutritional intake from such trials could be considered useful.</P>
<P>We report on ten different interventions separately.</P>
<SUBSECTION>
<HEADING LEVEL="5">01 Cholesterol-lowering diet compared with no dietary intervention or nutritional advice</HEADING>
<P>We included two trials in this intervention (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). The first of which was conducted in adults with FH (<A HREF="http://www.archie.cochrane.org/sections/documents/view?version=45764411129084839611091101165704&amp;format=REVMAN#STD-Chisholm-1992">Chisholm 1992</A>). The trial was a short-term randomised controlled cross-over trial in 19 patients with three eight-week treatment periods in each arm (high-fat diet followed by low-fat diet followed by high-fat diet compared to low-fat diet followed by high-fat diet followed by low-fat diet). All participants continued with lipid-lowering medication (simvastatin) throughout the trial. In the second trial 40 children were randomised to receive either cholesterol lowering diet comprising of yeast rice extract, monacolins, policosanaols, folic acid coenzyme Q10, astaxanthin or placebo (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). Patients either had familial hypercholesterolemia (n = 24 ) or combined familial hyperlipidaemia (n = 16). No results from this trial could be included in the review as no subgroup analysis for patients with FH was undertaken separately.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">02 Supplementation with omega-3 fatty acids given with a cholesterol-lowering diet compared to a cholesterol-lowering diet alone</HEADING>
<P>Two trials assessed the effect of adding &#969;-3 fatty acids to a cholesterol-lowering diet (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>). The Balestrieri trial assessed the impact of increasing the intake of fish oils in adults (n = 16) with FH (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>). The Engler trial investigated the effect of docosahexaenoic acid (DHA) supplementation to a cholesterol-lowering diet in children with FH (n = 20) (<LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>). Both trials were of cross-over design, of short duration and provided data which we were able to include in a meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">03 Cholesterol-lowering diet compared with dietary interventions to increase intake of plant stanols</HEADING>
<P>We included two cross-over trials, one of which reported on children with FH (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>) and one on adults (<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>). The Gylling trial (n = 14), which was a short-term trial, evaluated the effect of sitostanol (3 g/day) ester dissolved in rapeseed oil-rich margarine for six weeks in a double-blind cross-over design (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>). The Ketomaki trial (n = 5) studied the effect of both plant stanol and sterol ester spreads on triglyceride-rich lipoprotien (TRL) removal in statin-treated patients with FH using intravenous intralipid-squalene fat tolerance test (<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">04 Cholesterol-lowering diet compared with dietary interventions to increase intake of plant sterols</HEADING>
<P>For this comparison, five trials have been included (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>). Three of the trials were on adults (<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>) and two on children (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). All five trials were cross-over in design. The Neil trial presented data on the trials FH subgroup (n = 30) (type IIa patients were also included (n = 26)) as a parallel group (<LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>). All five trials were short-term with each arm of the trial lasting between one and two months (with variable washout periods).</P>
<P>The Amundsen (n = 41), Neil and Nigon (n = 53) trials compared a plant sterol-enriched fat spread with a control fat spread not enriched with plant sterols (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>). The Ketomaki trial (n = 5) compared low fat plant sterol ester spread or low fat plant stanol ester spread over and above ongoing drug therapy (<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>). The Guardamagna trial (n = 24) compared a dietary supplement containing 200 mg red yeast rice extract, corresponding to 3 mg of monacolins, and 10 mg policosanols once-daily versus placebo (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>).</P>
<P>
<B>05 Soy protein as a form of dietary intervention compared to another form of dietary intervention or drug or no treatment</B>
</P>
<P>No trials were identified.</P>
<P>
<B>06 Dietary fibers as a form of dietary intervention compared to another form of dietary intervention or drug or no treatment</B>
</P>
<P>The dietary fibers which were considered were barley, guar gum, psyllium, oat bran, flax seed and rice bran. Only one trial (n = 12) was found which satisfied inclusion criteria (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>). In this trial guar gum was administered with bezafibrate and this was compared with bezafibrate given alone. The trial included adult patients with familial hypercholesterolemia.</P>
<P>
<B>07 Dietary modification with lipid-lowering drugs</B>
</P>
<P>No trials were identified.</P>
<P>
<B>08 Lipid-lowering drugs alone</B>
</P>
<P>No trials were identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">09 Cholesterol-lowering diet compared to a high-protein diet</HEADING>
<P>We were able to include two cross-over trials for this intervention (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). One trial assessed the effect of soy products in children (n = 10) with FH (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>), while the other assessed the effect of a high-protein diet in adults with FH (n = 5) (<LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). Both were short-term trials with each arm of the trial lasting between one and three months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10 Comparing one form of dietary intervention with another, where cholesterol-lowering diet is not the control group</HEADING>
<P>Three short-term trials of adults with FH were included in this intervention group (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). In the 2005 Ketomaki trial, adults with FH (n = 18) receiving hypolipidaemic drugs were randomised to receive either plant sterols or stanols. The trial was of cross-over design and did not allow the comparison of the addition of plant sterols or stanols supplementation to drug treatment (<LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>). In another trial by Ketomaki, 16 out of 23 children had FH (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>). The data from these children were not reported separately and the authors were contacted for this information. This trial compared plant sterol and sterol ester spreads added to low-fat diet given to all the participants. The third trial was of parallel design with three separate treatment groups: plant sterols versus low-dose plant stanols versus high-dose plant stanols (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). This trial had 69 FH participants who were included alongside unaffected individuals (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). The authors did provide the data for the 69 individuals with FH. However, these data were not in the format which could be used for analysis; percentage change in the lipid levels were given instead of actual values.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-02-27 11:56:47 +0000" MODIFIED_BY="[Empty name]">
<P>There were over 300 studies excluded for the following reasons: not being an RCT; not being trials of dietary interventions; not including participants with FH; and including familial participants alongside non-familial participants but not as a well-defined subgroup. </P>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting classification</HEADING>
<P>In addition two studies were classified as studies awaiting classification for reasons that include non-availability of required data or inadequacy of dietary intervention (<LINK REF="STD-Fuentes-2008" TYPE="STUDY">Fuentes 2008</LINK>; <LINK REF="STD-Stein-2007" TYPE="STUDY">Stein 2007</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-05-22 12:08:38 +0100" MODIFIED_BY="[Empty name]">
<P>Please refer to the additional figure for a summary of the risk of bias (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<ALLOCATION MODIFIED="2014-05-22 00:13:37 +0100" MODIFIED_BY="[Empty name]">
<P>Generation of the randomisation sequence was adequate in one (low risk of bias), where authors have stated that computer-generated random numbers were used to assign the participants to either test or the control group with equal probability (<LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>) and unclear in the remaining 13 trials.</P>
<P>Concealment of allocation was adequate in one trial (low risk of bias) where the trial reports have described the methods adopted for assuring allocation concealment (<LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>). Tamper-proof block randomisation was used and clinic and lab staff remained unaware of the assigned treatment throughout the trial. However, concealment of allocation was unclear for the remainder of the trials (unclear risk of bias) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-05-22 00:13:45 +0100" MODIFIED_BY="[Empty name]">
<P>Twelve trials were reported as being double-blinded (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). Information regarding blinding was not given in the other trials (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>). Assessment bias could therefore not be ruled out for these trials.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-05-22 09:46:34 +0100" MODIFIED_BY="[Empty name]">
<P>It was unclear if an intention-to-treat analysis was carried out in one of the trials, giving an unclear risk of bias (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>). In eight trials intention-to-treat analysis was considered adequate giving a low risk of bias (<LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>); and in three trials participants were withdrawn from the trials and not included in the final analysis, therefore intention-to-treat analysis was not applied (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). Two participants withdrew from one trial due to medical reasons (one suffered a heart attack and one required vascular surgery) (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>). Two participants were withdrawn from another trial for lack of compliance and elevated serum lipid levels (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). Two trials undertook a <I>per protocol </I>analysis (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). In the former, six of them discontinued the trial before visit 1: two had difficulties in drinking the yogurt; two had poor adherence to the diet program; one was unable to attend visits and only one reported recurrent abdominal discomfort. No sample attrition occurred in the Wirth trial (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-05-21 23:15:52 +0100" MODIFIED_BY="[Empty name]">
<P>Selective reporting was not noted in any of the include trials (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>; <LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>; <LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). </P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-05-22 11:57:25 +0100" MODIFIED_BY="[Empty name]">
<P>All the trials from which data were extracted and included in the meta-analysis employed a cross-over design except one which was a parallel trial (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). Only seven of the trials presented data in such a way that the preferred method of analysis could be conducted (<LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). However, such data were not provided for all of the outcomes assessed in these trials. Re-analysis of the data will be undertaken at a future date if we are successful in contacting the authors for individual patient data.</P>
<P>Only those comparison groups for which there are eligible trials are listed below.</P>
<P>Only short-term outcomes are included in this review due to the length of the trials identified from the searches. For primary outcomes, incidence of ischaemic or atheromatous disease and deaths were not reported on in any of the included trials. For secondary outcomes, quality of life, compliance with treatment and morbidity were not assessed in any of the included trials. Therefore we have not listed these outcomes below.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 01: Cholesterol-lowering diet compared with no dietary intervention or nutritional advice</HEADING>
<P>Two trials were identified (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>; <LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). In the first trial which included 19 participants (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>). No significant differences were found between the two interventions for any of the outcomes assessed in which data could be entered into the meta-analysis. None of the results from the second trial could be included in the meta-analysis since no subgroup analysis for patients with familial hypercholesterolemia was undertaken separately from those individuals with combined familial hyperlipidaemia (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The primary outcomes of ischaemic heart disease, number of deaths and or age at death were not reported in the included trial (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Serum total cholesterol concentration (fasting)</HEADING>
<P>There was no significant difference between treatments for this outcome, MD -0.40 (95% CI -0.95 to 0.15) mmol/l (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting)</HEADING>
<P>There was no significant difference between treatments for his outcome,<I> </I>MD -0.27 (95% CI -0.79 to 0.25) mmol/l (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting)</HEADING>
<P>There was no significant difference between treatments for his outcome, MD -0.11 (95% CI -0.34 to 0.12)mmol/l (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting)</HEADING>
<P>There was no significant difference between treatments for his outcome, MD 0.06 (95% CI -0.43 to 0.55) mmol/l (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).<I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting)</HEADING>
<P>There was a significant difference in favouring the cholesterol-lowering diet, MD -0.06 (95% CI -0.12 to -0.01) g/L (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting)</HEADING>
<P>There was no significant difference in favouring the cholesterol-lowering diet, MD -0.01 (95% CI -0.05 to 0.03) g/L (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>This outcome was not reported in the included trial (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>This outcome was not reported in the included trial (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>This outcome was not reported in the included trial (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>Insufficient data (weight, height, body mass index (BMI)) were provided to allow inclusion of these outcomes in the meta-analysis (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>). However, weight and BMI appeared to remain static during the two arms of the trial (mean BMI was 29.2 on the cholesterol-lowering diet and 29.3 on a free diet, although no SDs were provided).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>Not assessed in the included trial (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 02: Supplementation with &#969;-3 fatty acids given with cholesterol-lowering diet compared to cholesterol-lowering diet alone</HEADING>
<P>Two trials including 34 participants were identified (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>). No significant differences were found between the two interventions for any of the outcomes assessed.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The primary outcomes of ischaemic heart disease, number of death and or age at death were not reported in either of the trials (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).The follow-up period was too short to have any effect on primary outcomes (four weeks in the Baestrieri trial and six weeks in the Engler trial).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Serum total cholesterol concentration (fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD -0.06 (95% CI - 0.80 to 0.69) mmol/l (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups,<I> </I>MD -0.12 (95% CI -0.93 to 0.69) mmol/l (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD 0.02 (95% CI -0.10 to 0.13) mmol/l (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD 0.18 (95% CI -0.07 to 0.43) mmol/l (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>) (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting)</HEADING>
<P>This outcome was assessed by one trial (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>). There was no significant difference between treatment groups, MD -0.02 (95% CI -0.35 to 0.31) g/L (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting)</HEADING>
<P>This outcome was assessed by one trial (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>). There was no significant difference between treatment groups, MD 0.01 (95% CI -21.99 to 22.01 g/L (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 03: Cholesterol-lowering diet compared with dietary interventions to increase intake of plant stanols</HEADING>
<P>Two trials were included, one on children (N = 14) (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>) and one on adults (N = 5) (<LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The authors did not evaluate any of the primary outcomes of ischaemic heart disease and number of deaths and or age at death in either of these trials (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Serum total cholesterol concentration (fasting)</HEADING>
<P>There was a significant difference in cholesterol level between the stanol treatment and cholesterol-lowering diet group favouring stanol treatment, MD 0.51 (95% CI 0.07 to 0.96) mmol/l after pooling the two trials (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>) (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting)</HEADING>
<P>There was a significant difference between stanol treatment and the cholesterol-lowering diet group favouring stanol treatment, MD 0.71 (95% CI 0.43 to 0.99) mmol/l after pooling (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>) (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting)</HEADING>
<P>The difference between treatment groups after pooling did not quite reach statistical significance, MD -0.08 (95% CI -0.15 to -0.00) mmol/l (<LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>) (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting)</HEADING>
<P>There was no significant difference between treatment groups after pooling, SMD 0.12 (95% CI -0.52 to 0.76) mmol/l (<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>) (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting)</HEADING>
<P>This was not assessed in the included trials (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting)</HEADING>
<P>This was not assessed in the included trials (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>Neither trial reported on this outcome (<LINK REF="STD-Gylling-1995" TYPE="STUDY">Gylling 1995</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 04: Cholesterol-lowering diet compared with dietary interventions to increase intake of plant sterols</HEADING>
<P>Data from four trials with 129 participants were included in this comparison (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>). A fifth trial was also eligible, but the data from the trial done by Guardamagna have not been included in the present analysis since the authors have not reported the results of subgroup of patients with familial hypercholesterolaemia (<LINK REF="STD-Guardamagna-2011a" TYPE="STUDY">Guardamagna 2011a</LINK>). The authors were requested to supply these data through electronic communication. At the time of writing this review, these data have not been received. However, in their manuscript do mention that the dietary supplementation did favourably alter the lipid profile in patients with familial hypercholesterolaemia similar to that seen in the combined analysis of all the patients.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The authors did not evaluate any of the primary outcomes of ischaemic heart disease and number of deaths and or age at death in any of the trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.Serum total cholesterol concentration (fasting)</HEADING>
<P>All the four trials reported on this outcome. There was a significant difference between sterol treated participants as compared to cholesterol-lowering diet alone favour of sterol, MD 0.30 (95% CI 0.12 to 0.48) mmol/l (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting)</HEADING>
<P>All the four trials reported on this outcome. The LDL was significantly lower with the sterol treatment, MD -0.60 (95% CI -0.89 to -0.31) mmol/l (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting)</HEADING>
<P>All the four trials reported on this outcome. The HDL levels were not significantly different between plant sterol treated and cholesterol-lowering diet alone, MD -0.04 (95% CI -0.11 to 0.03) mmol/l (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting)</HEADING>
<P>All the four trials reported on this outcome. The TG levels were not significantly lower with sterol treatment, MD -0.03 (95% CI -0.15 to 0.09) mmol/l, although there was considerable heterogeneity (<LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>)<I>.</I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting)</HEADING>
<P>This outcome was assessed by two trials (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>). There was no significant difference between treatment groups, MD 0.03 (95% CI -0.08 to 0.14) g/L (<LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>) (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting)</HEADING>
<P>This outcome was assessed by two trials (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>, <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>). There was no significant difference between treatment groups, MD 0.02 (95% CI -0.09 to 0.13) g/L (<LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>None of the trials reported on this outcome (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>None of the trials reported on this outcome (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>None of the trials reported on this outcome (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>None of the trials reported on this outcome (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>None of the trials reported on this outcome (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 06: Dietary fibers as a form of dietary intervention compared to another form of dietary intervention or drug or no treatment</HEADING>
<P>One trial in adults was included (N = 12) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The authors did not evaluate any of the primary outcomes of ischaemic heart disease and number of deaths and or age at death in any of the trials (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.Serum total cholesterol concentration (fasting)</HEADING>
<P>There was no significant difference between guar gum and bezafibrate treated group as compared to group of patients treated with bezafibrate alone, MD -0.57 (95% CI -2.08 to 0.94) mmol (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting)</HEADING>
<P>The LDL was significantly lower when guar gum was combined with bezafibrate compared to bezafibrate alone, MD -1.83 (95% CI -3.32 to -0.34) mmol (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting)</HEADING>
<P>There was no change in the level of HDL in the group receiving guar gum in addition to bezafibrate, MD -0.18 (95% CI -0.46 to 0.10) mmol (<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting)</HEADING>
<P>There was no significant change in this outcome with the use of guar gum, MD -0.41 (95% CI -0.12 to 0.94) mmol (<LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting)</HEADING>
<P>No significant change was noted for this outcome, MD -0.04 (95% CI -6.75 to 6.83) gm/L (<LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting)</HEADING>
<P>There was a significant change noted for this outcome in favour of the use of guar gum with bezafibrate, MD -0.50 (95% CI -0.65 to -0.35) gm/L (<LINK REF="CMP-006.06" TYPE="ANALYSIS">Analysis 6.6</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>This outcome was not reported in the included trial (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>The trial reported that none of the patients were excluded for inadequate compliance (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>This was not reported in the included trial (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>Only weight was reported in the trial. There was no significant difference in the weights in the two groups at the end of the trial period, MD -0.40 (95% CI -5.09 to 5.89) gm/L (<LINK REF="CMP-006.07" TYPE="ANALYSIS">Analysis 6.7</LINK>) (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>This was not evaluated in the included trial (<LINK REF="STD-Wirth-1982" TYPE="STUDY">Wirth 1982</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 09: Cholesterol-lowering diet compared to a high-protein diet</HEADING>
<P>Two trials were included in this comparison (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>). One of a cholesterol-lowering diet compared with a high-protein diet (five participants) (<LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>) and one of a cholesterol-lowering diet compared with a soy-protein diet (10 participants) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). No significant differences were found between the two interventions for any of the outcomes assessed.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The authors did not evaluate any of the primary outcomes of ischaemic heart disease and number of deaths and or age at death (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Serum total cholesterol concentration (fasting and non-fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD 0.08 (95% CI - 0.65 to 0.81) mmol/l (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting and non-fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD 0.12 (95% CI -0.46 to 0.69) mmol/l (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting and non-fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD -0.07 (95% CI -0.23 to 0.08) mmol/l (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting and non-fasting)</HEADING>
<P>Both trials reported on this outcome. There was no significant difference between treatment groups, MD 0.25 (95% CI -0.01 to 0.50) mmol/l (<LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>)<I>.</I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting and non-fasting)</HEADING>
<P>This outcome was assessed by one trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). There was no significant difference between treatment groups, MD 0.04 (95% CI -5.84 to 5.92) g/L (<LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>) (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting and non-fasting)</HEADING>
<P>This outcome was assessed by one trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). There was no significant difference between treatment groups, MD 0.00 (95% CI -3.92 to 3.92) mg/dL (<LINK REF="CMP-005.06" TYPE="ANALYSIS">Analysis 5.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>This outcome was not assessed in either trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>This outcome was not assessed in either trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>This outcome was not assessed in either trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>These outcomes were assessed in one trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>). There was no significant difference between treatment groups for any of these outcomes: weight, MD 0.00 (95% CI -7.58 to 7.58) kg (<LINK REF="CMP-005.07" TYPE="ANALYSIS">Analysis 5.7</LINK>); height, MD 0.00 (95% CI -7.63 to 7.63) cm (<LINK REF="CMP-005.08" TYPE="ANALYSIS">Analysis 5.8</LINK>); and BMI, MD -0.09 (95% CI -2.77 to 2.95) (<LINK REF="CMP-005.09" TYPE="ANALYSIS">Analysis 5.9</LINK>). No pooling of data were possible as the results are from one trial only.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>This outcome was not assessed in either trial (<LINK REF="STD-Laurin-1991" TYPE="STUDY">Laurin 1991</LINK>; <LINK REF="STD-Wolfe-1992" TYPE="STUDY">Wolfe 1992</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 10: One form of dietary intervention compared to another form of dietary intervention</HEADING>
<P>Three short-term trials of adults with FH were included in this intervention group (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). Two trials included participants with and without FH, but data are not presented separately in either trial for the subset of participants with FH (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>The authors did not evaluate any of the primary outcomes of ischaemic heart disease and number of deaths and or age at death (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Serum total cholesterol concentration (fasting and non-fasting)</HEADING>
<P>The results of 134 participants in the O'Neill trial demonstrated a significant reduction in serum total cholesterol (TC) from baseline at the end of two months in both the high-dose (2.6 g) stanol group (HSTA) and the low-dose (1.6 g) stanol group (LSTA) (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). In the HSTA group, serum total cholesterol levels decreased from mean (SD) 6.1 (0.20) mmol/l at baseline to 5.3 (0.15) mmol/l (P &lt; 0.001). This was also the case in the LSTA group after two months; serum total cholesterol levels showed a significant reduction from mean (SD) 5.8 (0.19) mmol/l at baseline to 5.5 (18.00) mmol/l (P &lt; 0.001). In the sterol (STE) group (1.6 g), cholesterol levels were significantly reduced at one month from mean (SD) 5.8 (0.17) mmol (baseline) to 5.4 (0.15) mmol/l (P &lt; 0.001) at one month. A subgroup analysis of the 69 FH participants was not presented.</P>
<P>In the second trial, the authors noted a significant reduction in total cholesterol levels following a five-week intervention period by both stanol and sterol esters (percentage change from baseline (mean (SE of the mean (SEM)) - 9 (3) and -6 (2), respectively) (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>). The data for 16 participants with FH was not presented separately.</P>
<P>In the third trial, in the plant stanol group, the serum total cholesterol values reduced from mean (SD) 6.30 (0.24) at baseline to 5.65 (0.22) mmol/l while in STE group, TC reduced to 5.7 (0.21) mmol/l following two consecutive four-week intervention periods (<LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>). This reduction was significant as compared to baseline values. In both the groups the participants were on statins.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Serum LDL cholesterol (fasting and non-fasting)</HEADING>
<P>O' Neill observed a significant reduction from baseline in LDL cholesterol in all the three groups: HSTA mean (SD) 3.77 (0.18) to 3.30 (0.14) mmol/l (P &lt; 0.001); LSTA mean (SD) 3.83 (0.16) to 3.54 (0.14) (P = 0.03); and STE mean (SD) 3.81 (0.15) to 3.63 (0.15) (P = 0.003) (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). The data for 69 FH participants were not available.</P>
<P>In the earlier Ketomaki trial, a significant percentage reduction from baseline in LDL cholesterol was noted in both stanol and sterol groups, mean (SEM) -12% (3%) and -9% (3%) respectively (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>). The data were expressed only as percentage reduction. Additionally, data for 16 FH participants were not given separately.</P>
<P>In the later Ketomaki trial, when given in addition to statins, a significant reduction from baseline in LDL cholesterol levels was noted in both the stanol group (mean (SD) 4.50 (0.21) to 3.81 (0.18))mmol/l and the sterol group (mean (SD) 4.50 (0.21) to 3.86 (0.19) mmol/l (<LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Serum HDL cholesterol (fasting and non-fasting)</HEADING>
<P>While O&#8217;Neill reported no statistically significant changes in HDL cholesterol levels in the LSTA and STE groups, a significant reduction in HDL cholesterol levels was noted after two months in the HSTA group (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). Again, the data for 69 FH patients were not presented separately.</P>
<P>In the earlier Ketomaki trial, no significant difference in HDL cholesterol level was noted in any of the groups (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>). In the later Ketomaki trial, when given over and above statins, sterols caused a significant increase in HDL cholesterol; from mean (SD) 1.26 (0.05) mmol/l at baseline to 1.37 (0.04) mmol/l (<LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Serum triglyceride concentration (fasting and non-fasting)</HEADING>
<P>O'Neill demonstrated significant decrease in triglyceride levels at two months in the HSTA group (-15.0%) and no changes in the LSTA and the STE groups (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
<P>No significant difference in triglyceride (TG) levels was observed in either the stanol or the sterol groups in the second trial (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>). In the third trial, the authors concluded significant decrease in serum TG only in the sterol group from mean (SD) 1.19 (0.10) at baseline to 1.05 (0.09) following two consecutive four-week intervention periods (<LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Apolipoprotein A1concentration, the protein component of HDL cholesterol (fasting and non-fasting)</HEADING>
<P>None of the three trials evaluated apolipoprotein A1 concentration (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Apolipoprotein B-100 concentration, the protein component of LDL cholesterol (fasting and non-fasting)</HEADING>
<P>O' Neill reported a significant reduction in Apo B-100 levels in the LSTA, HSTA and STE groups at two months; -6.6%, -8.5% and -5.9% respectively) (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). These data were not separately presented for FH participants. The other two trials did not report this outcome (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Quality of life</HEADING>
<P>This outcome was not assessed in any of the trials (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Compliance</HEADING>
<P>This outcome was not assessed in any of the trials (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Morbidity</HEADING>
<P>This outcome was not assessed in any of the trials (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Weight, height and other measures of nutritional status</HEADING>
<P>No significant reduction from baseline was noted for weight in any of the three trials (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">11. Micronutrient intake</HEADING>
<P>This outcome was not evaluated in any of the trials (<LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-05-22 09:44:03 +0100" MODIFIED_BY="[Empty name]">
<P>In the present update of this review, 14 trials have been included with a total of 441 participants across seven comparison groups. The sample size of included trials is a concern as inadequately-powered trials seldom lead to meaningful conclusions. Further, the majority of trials included in this review were cross-over in design. One trial which used a parallel group design included FH participants only as a subgroup (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). For another trial, the authors provided the data of FH subgroup as a parallel group, although the trial had a cross-over design (<LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>). This does make it important that caution be exercised in interpreting the pooled results.</P>
<P>Only one trial was identified which assessed the effect of a cholesterol-lowering diet compared to no dietary intervention (<LINK REF="STD-Chisholm-1992" TYPE="STUDY">Chisholm 1992</LINK>). This is disappointing as a cholesterol-lowering diet is the recommended dietary treatment for FH. Although no significant differences have been found between the comparisons assessed, this does not mean that the diets are not effective, rather that the data available are insufficient to reach any conclusions on the efficacy of the different dietary treatments. There is a wide range of dietary treatment options that have been suggested for FH; however, for each of these options there appear to have been very few or no trials carried out.</P>
<P>The use of plant sterols and stanols has received renewed attention in recent years and seven trials assessing this intervention were included in the analysis (<LINK REF="STD-Amundsen-2002" TYPE="STUDY">Amundsen 2002</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2003" TYPE="STUDY">Ketomäki 2003</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2004a" TYPE="STUDY">Ketomäki 2004a</LINK>; <LINK REF="STD-Ketom_x00e4_ki-2005" TYPE="STUDY">Ketomäki 2005</LINK>; <LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-Nigon-2001" TYPE="STUDY">Nigon 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). The last one of these compared sterol and stanol substitution on the background of lipid lowering drugs, mainly statins. Both the interventions significantly improved the lipid profile. However, the trial design did not allow analysis of the effect of adding plant sterols or stanols to lipid lowering drugs when compared to lipid lowering drugs given alone. There was no effect in other outcomes like apolipoproteins A and B100.</P>
<P>Fish oils containing omega-3 fatty acids have also been evaluated as an option for dietary intervention (<LINK REF="STD-Balestrieri-1996" TYPE="STUDY">Balestrieri 1996</LINK>; <LINK REF="STD-Engler-2004" TYPE="STUDY">Engler 2004</LINK>). However, much needs to be clarified on this issue as regards to the optimal dose and the ratio of docosahexaenoic acid (DHA) and eicosopentanoic acid (EPA) which should be used. More trials are needed to investigate this dietary intervention strategy.</P>
<P>All the trials identified were short term and did not assess long-term outcomes. It is disappointing that no long-term trials were identified as long-term outcomes may be more relevant to people with familial hypercholesterolaemia and their care givers. None of the primary outcomes could be evaluated for the same reason.</P>
<P>Again, there is the problem of combining the results of familial hypercholesterolaemia with hypercholesterolaemia. <I>A priori </I>subgroup analysis was not planned by any of the authors for the trials in which this problem was noted. Two of the authors provided the data for FH participants and these trials have thus been included in the present update (<LINK REF="STD-Neil-2001" TYPE="STUDY">Neil 2001</LINK>; <LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). For one of the trials, however, the data could not be incorporated for meta-analysis as the authors did not provide the data in the required format for evaluation by RevMan (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). Hopefully, in a future version of this review these data may also be included.</P>
<P>Further, in view of evolving approaches in the management of familial hypercholesterolaemia, we had planned to undertake additional analysis. One of the aims of the review was to assess the usefulness of cholesterol-lowering diet over and above the drug therapy (statins, bile acid sequestrants, fenofibrate and anion exchange resins). Trials designed to evaluate various dietary modifications over and above lipid-lowering drugs are needed.</P>
<P>Trials in which head-to-head comparisons of various dietary intervention strategies are carried out were remarkably absent with a few exceptions. In one trial, the effect of low-dose and high-dose stanol was compared to sterol esters in a head-to-head manner (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). The authors noted that, despite a trend, the improvement in serum lipid profile with a high-dose stanol ester was no better than that of low-dose stanol esters. In the other trial, sterol esters were compared with stanol esters (<LINK REF="STD-O_x0027_Neill-2004" TYPE="STUDY">O'Neill 2004</LINK>). The authors analysed the change from baseline in the levels of total cholesterol, LDL, HDL and triglycerides. However, a comparison between sterol and stanol ester groups was not made.</P>
<P>The new comparisons included in this update were soluble fibers such as barley, oat bran, rice bran, guar gum, psyllium or flax seeds and soy protein as form of dietary intervention compared to another form of dietary intervention or drug or no dietary intervention. Only one trial satisfying inclusion criteria was identified. The intervention used was guar gum with bezafibrate. It was in 12 adult familial hypercholesterolemic patients. Though statistically significant reduction in total and LDL cholesterol levels were noted, the utility of this finding in the current era of statins is suspect. A meta-analysis (<LINK REF="REF-Brown-1999" TYPE="REFERENCE">Brown 1999</LINK>) has shown beneficial effect of soluble dietary fibers in hypercholesterolemia and thus there is a case for studying dietary fibers in an adequately powered trial.</P>
<P>People with FH may be more susceptible to potentially detrimental psychological and nutritional consequences of their dietary treatment. For this reason, it is disappointing to note that very few of the trials included in this review assessed measures of nutritional status and none assessed quality of life or nutritional intake.</P>
<P>Publication bias cannot be ruled out. A funnel plot could not be constructed as the data required were not available in sufficient quantities. We hope that with new possibilities opening up for publishing negative trials, more trials will come to the fore and possibly be included in the review.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-08-11 08:46:22 +0100" MODIFIED_BY="Nikki Jahnke">
<IMPLICATIONS_PRACTICE MODIFIED="2009-10-19 16:30:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>No conclusions can be made about the short- or long-term effectiveness of the cholesterol-lowering diet.</P>
<P>Considering the fact that the pooled trials did not conform completely to the requirements for pooling, careful attention should be paid when implementing the conclusions for practice. Sterol treatment did significantly lower total cholesterol; however, more evidence is required in the form of large, good quality controlled trials before sterols are recommended for people with FH.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-08-11 08:46:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>A large, parallel, randomised controlled trial is needed to investigate the effectiveness of the cholesterol-lowering diet and no dietary intervention. Due to the relatively small numbers of people with this condition, it is recommended that a multi-centre approach is adopted and that participants should not be recruited to small scale trials which may preclude them from being involved in larger trials. It is also important that future trials consider the long-term outcomes in addition to short-term ones. Since drug therapy , particularly statins, is the standard of care in FH, dietary intervention would need to be studied as adjuvant. In addition, as the effect of statins on hard outcomes would be large, the effect of dietary interventions on these outcomes would be very difficult to study and effect on surrogate outcomes (LDL) would be important. To assist in ensuring the appropriateness of future trials, it would be useful to involve people with FH and their carers in the design of the trial.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS/>
<CONFLICT_OF_INTEREST MODIFIED="2012-05-25 14:55:09 +0100" MODIFIED_BY="Tracey Remmington">
<P>None declared.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-05-25 14:55:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>
<B>From 1999 to October 2008</B>
</P>
<P>The review authors were Vanessa Poustie and Patricia Rutherford. Each of these review authors participated in the writing of the text, the selection of eligible studies and the assessment of methodological quality. Vanessa Poustie undertook the searching for additional studies and extracted the data.</P>
<P>
<B>From October 2008:</B>
</P>
<P>Designing the review: Dr Nusrat Shafiq, Dr Meenu Singh Dr S. Malhotra<BR/>Data collection for the review: Dr Nusrat Shafiq<BR/>Designing search strategies: Dr Nusrat Shafiq, Natalie Yates (Trials Search Co-ordinator, Cochrane Cystic Fibrosis &amp; Genetic Disorders Group)<BR/>Undertaking searches: Natalie Yates<BR/>Screening search results:Dr Nusrat Shafiq, Dr Pratibha Khosla, Dr Sharonjeet Kaur<BR/>Organising retrieval of papers: Natalie Yates<BR/>Screening retrieved papers against inclusion criteria:Dr Pratibha Khosla, Dr Nusrat Shafiq<BR/>Appraising quality of papers: Dr Pratibha Khosla, Dr Sharonjeet Kaur<BR/>Writing to authors of papers for additional information: Dr Nusrat Shafiq,Dr Meenu Singh<BR/>Obtaining and screening data on unpublished studies: Natalie Yates<BR/>Data management for the review: Dr Nusrat Shafiq, Dr Samir Malhotra, Dr Pratibha Khosla<BR/>Entering data into RevMan:Dr Nusrat Shafiq<BR/>Analysis of data: Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Interpretation of data:Dr Nusrat Shafiq, Dr Samir Malhotra, Dr Meenu Singh<BR/>Providing a methodological perspective:Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Providing a clinical perspective: Dr Nusrat Shafiq, Dr Meenu Singh, Dr Samir Malhotra,<BR/>Providing a policy perspective: Dr Samir Malhotra, Dr Meenu Singh<BR/>Writing the review: Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Providing general advice on the review: Dr Meenu Singh, Dr Samir Malhotra</P>
<P>
<B>From March 2012:</B>
</P>
<P>Designing the review: Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Data collection for the review: Dr. Anita Malhotra, Anjuman Arora and Dr Nusrat Shafiq<BR/>Designing search strategies: Dr Nusrat Shafiq, Natalie Yates and Ms Neelima Chaddha (Trials Search Co-ordinator, Cochrane Cystic Fibrosis &amp; Genetic Disorders Group)<BR/>Undertaking searches: Natalie Yates and Ms Neelima Chaddha<BR/>Screening search results:Dr Nusrat Shafiq and Dr Anita Malhotra<BR/>Organising retrieval of papers: Natalie Yates and Ms. Neelima Chaddha<BR/>Screening retrieved papers against inclusion criteria: Dr Nusrat Shafiq and Dr. Anita Malhotra<BR/>Appraising quality of papers: Dr Nusrat Shafiq, Dr Anita Malhotra, Dr Samir Malhotra, Anjuman Arora, Rajendra Kumar<BR/>Writing to authors of papers for additional information: Dr Nusrat Shafiq, Dr Meenu Singh<BR/>Obtaining and screening data on unpublished studies: Natalie Yates<BR/>Data management for the review: Dr Nusrat Shafiq<BR/>Entering data into RevMan:Dr Anita Malhotra<BR/>Analysis of data: Dr Nusrat Shafiq and Dr, Anita Malhotra<BR/>Interpretation of data:Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Providing a methodological perspective:Dr Nusrat Shafiq<BR/>Providing a clinical perspective: Dr Meenu Singh and Dr Samir Malhotra<BR/>Providing a policy perspective: Dr Nusrat Shafiq, Dr Samir Malhotra<BR/>Writing the review: Dr Anita Malhotra, Anjuman Arora<BR/>Providing general advice on the review: Dr Nusrat Shafiq, Dr Meenu Singh and Dr. Samir Malhotra</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-05-22 12:03:24 +0100" MODIFIED_BY="[Empty name]">
<P>The comparisons listed in <LINK TAG="OBJECTIVES" TYPE="SECTION">Objectives</LINK> in the current update have been changed from the previous review, in line with the growing knowledge about the effects of dietary supplements in altering blood lipid levels.</P>
<P>May 2014: the title has been changed from 'Dietary treatment for familial hypercholesterolaemia'.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2009-10-28 09:13:14 +0000" MODIFIED_BY="Nikki Jahnke">
<P>The review was first published in Issue 2, 2001 by Vanessa Poustie and Patricia Rutherford. The review team changed to the current team from Issue 1, 2010.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-05-22 12:22:09 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-09-20 11:26:06 +0100" MODIFIED_BY="Nikki Jahnke">
<INCLUDED_STUDIES MODIFIED="2013-08-23 10:08:55 +0100" MODIFIED_BY="Nikki Jahnke">
<STUDY DATA_SOURCE="PUB" ID="STD-Amundsen-2002" NAME="Amundsen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amundsen AL, Ose L, Nenseter MS, Ntanios FY</AU>
<TI>Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<NO>2</NO>
<PG>338-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Balestrieri-1996" NAME="Balestrieri 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;31&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balestrieri GP,Maffi V, Sleiman I, Spandrio S, Di Stefano O, Salvi A, et al</AU>
<TI>Fish oil supplementation in patients with heterozygous familial hypercholesterolemia</TI>
<SO>Recenti Progressi in Medicina</SO>
<YR>1996</YR>
<VL>87</VL>
<NO>3</NO>
<PG>102-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chisholm-1992" MODIFIED="2012-04-27 11:49:42 +0100" MODIFIED_BY="Tracey Remmington" NAME="Chisholm 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-04-27 11:49:42 +0100" MODIFIED_BY="Tracey Remmington" NOTES="&lt;p&gt;10&lt;/p&gt;" NOTES_MODIFIED="2012-04-27 11:49:42 +0100" NOTES_MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chisholm A, Mann J, Sutherland W, Williams S, Ball M</AU>
<TI>Dietary management of patients with familial hypercholesterolaemia treated with Simvastatin</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>1992</YR>
<VL>85</VL>
<NO>2-3</NO>
<PG>825-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chisholm A, Sutherland W, Ball M</AU>
<TI>The effects of dietary fat content on plasma noncholesterol sterol concentrations in patients with familial hypercholesterolaemia treated with simvastatin</TI>
<SO>Metabolism</SO>
<YR>1994</YR>
<VL>43</VL>
<NO>3</NO>
<PG>310-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engler-2004" NAME="Engler 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engler MM, Engler MG, Malloy M, Chiu E, Besio D, Paul S, et al</AU>
<TI>Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY Study</TI>
<SO>International Journal of Clinical Pharmacology and Therapeutics</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>12</NO>
<PG>672-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guardamagna-2011a" MODIFIED="2012-04-20 10:45:36 +0100" MODIFIED_BY="anita  s malhotra" NAME="Guardamagna 2011a" YEAR="2011">
<REFERENCE MODIFIED="2012-04-20 10:33:16 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F</AU>
<TI>The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols</TI>
<SO>Nutrition, Metabolism and Cardiovascular Diseases</SO>
<YR>2011</YR>
<VL>21</VL>
<NO>6</NO>
<PG>424-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gylling-1995" NAME="Gylling 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;7&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gylling H, Siimes MA, Miettinen TA</AU>
<TI>Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia</TI>
<SO>Journal of Lipid Research</SO>
<YR>1995</YR>
<VL>36</VL>
<PG>1807-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ketom_x00e4_ki-2003" MODIFIED="2012-04-27 13:19:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ketomäki 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-09-07 10:39:06 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ketomaki AM, Gyllling H, Antikaimen M, Simes MA, Miettinen TA</AU>
<TI>Red cell and plasma plant sterols are related during consumption of plant sterols are related during consumption of plant stanol ester spreads in children with hypercholesterolemia</TI>
<SO>Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>142</VL>
<NO>5</NO>
<PG>524-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ketom_x00e4_ki-2004a" MODIFIED="2012-08-16 15:46:21 +0100" MODIFIED_BY="anita  s malhotra" NAME="Ketomäki 2004a" YEAR="2004">
<REFERENCE MODIFIED="2012-07-19 13:43:29 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ketomäki A, Gylling H, Miettinen TA</AU>
<TI>Removal of intravenous Intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis</TI>
<SO>Clinica Chimica Acta</SO>
<YR>2004</YR>
<VL>344</VL>
<NO>1-2</NO>
<PG>83-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ketom_x00e4_ki-2005" MODIFIED="2012-08-16 15:47:03 +0100" MODIFIED_BY="[Empty name]" NAME="Ketomäki 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-16 15:47:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ketomäki A, Gylling H, Miettinen TA</AU>
<TI>Non-cholesterol sterols in serum, lipoproteins and red cells in statin-treated familial hypercholesterolemia subjects off and on plant stanol and sterol ester spreads</TI>
<SO>Clinica Chimica Acta</SO>
<YR>2005</YR>
<VL>353</VL>
<NO>1-2</NO>
<PG>75-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurin-1991" NAME="Laurin 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jacques H, Laurin D, Moorjani S, Steinke M, Gagne C, Brun D, et al</AU>
<TI>Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolaemia</TI>
<SO>Journal of American College of Nutrition</SO>
<YR>1992</YR>
<VL>11 Suppl</VL>
<PG>69-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;5&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurin D, Jacques H, Moorjani S, Steinke F, Gagne C, Brun D, et al</AU>
<TI>Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>54</VL>
<PG>98-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Neil-2001" NAME="Neil 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neil HA, Meijer GW, Roe LS</AU>
<TI>Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread</TI>
<SO>Atherosclerosis</SO>
<YR>2001</YR>
<VL>156</VL>
<NO>2</NO>
<PG>329-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nigon-2001" MODIFIED="2012-04-20 12:01:21 +0100" MODIFIED_BY="anita  s malhotra" NAME="Nigon 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-04-20 12:01:21 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nigon F, Serfaty-Lacrosnière C, Beucler I, Chauvois D, Neveu C, Giral P, et al</AU>
<TI>Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment</TI>
<SO>Clinical Chemistry and Laboratory Medicine</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>7</NO>
<PG>634-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-O_x0027_Neill-2004" NAME="O'Neill 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>O'Neill FH, Brynes A, Mandeno R, Rendell N, Taylor G, Seed M, et al</AU>
<TI>Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism</TI>
<SO>Nutrition, Metabolism, and Cardiovascular Diseases</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>3</NO>
<PG>133-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wirth-1982" MODIFIED="2013-08-23 10:08:55 +0100" MODIFIED_BY="[Empty name]" NAME="Wirth 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-08-23 10:08:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wirth A, Middelhoff G, Braeuning Ch, Schlierf G</AU>
<TI>Treatment of familial hyperholesterolemia with combination of bezafibrate and guar</TI>
<SO>Atherosclerosis</SO>
<YR>1982</YR>
<VL>45</VL>
<PG>291-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolfe-1992" MODIFIED="2009-10-19 16:55:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wolfe 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 16:55:15 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolfe BM, Giovannetti PM</AU>
<TI>High protein diet complements resin therapy of familial hypercholesterolemia</TI>
<SO>Clinical and Investigative Medicine</SO>
<YR>1992</YR>
<VL>15</VL>
<NO>4</NO>
<PG>349-59</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:55:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolfe BM</AU>
<TI>Potential role of raising dietary protein intake for reducing risk of atherosclerosis</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1995</YR>
<VL>11 Suppl G</VL>
<PG>127G-31G</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-08-23 11:47:36 +0100" MODIFIED_BY="Nikki Jahnke">
<STUDY DATA_SOURCE="PUB" ID="STD-Abbey-1990" MODIFIED="2009-08-05 12:32:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Abbey 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-08-05 12:32:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 ARRIVED 24/2/00" NOTES_MODIFIED="2009-08-05 12:32:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abbey M, Clifton P, Kestin M, Belling B, Nestel P</AU>
<TI>Effect of fish oil on lipoproteins, lecithin: cholesterol acyltransferase and lipid transfer protein activity in humans</TI>
<SO>Arteriosclerosis</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>1</NO>
<PG>85-94</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:30:49 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abbey-1993a" MODIFIED="2009-08-05 12:32:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Abbey 1993a" YEAR="1993">
<REFERENCE MODIFIED="2009-08-05 12:32:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME REJECT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-08-05 12:32:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abbey M, Belling B, Noakes M, Hirata F, Nestel P</AU>
<TI>Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>57</VL>
<NO>3</NO>
<PG>391-8</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:32:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abbey-1993b" MODIFIED="2009-08-05 12:32:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Abbey 1993b" YEAR="1993">
<REFERENCE MODIFIED="2009-08-05 12:32:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME REJECT RCT/NOT FH" NOTES_MODIFIED="2009-08-05 12:32:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abbey M, Nestel P, Baghurst PA</AU>
<TI>Antioxidant vitamins and low-density lipoprotein oxidation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>58</VL>
<NO>4</NO>
<PG>525-32</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:32:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abrahamson-1974" MODIFIED="2009-08-05 12:34:42 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Abrahamson 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-08-05 12:34:42 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-08-05 12:34:42 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abrahamson H, Gustafson A, Ohlson R</AU>
<TI>Polyunsaturated fatty acids in hyperlipoproteinemia</TI>
<SO>Nutrition Metabolism</SO>
<YR>1974</YR>
<VL>17</VL>
<NO>6</NO>
<PG>337-9</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:33:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahmed-1984" MODIFIED="2009-08-05 12:35:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ahmed 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-08-05 12:35:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP751.LIP NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-08-05 12:35:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahmed AA, Holub BJ</AU>
<TI>Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod liver oil</TI>
<SO>Lipids</SO>
<YR>1984</YR>
<VL>19</VL>
<NO>8</NO>
<PG>617-24</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:34:51 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahrens-1954" MODIFIED="2009-08-05 12:35:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ahrens 1954" YEAR="1954">
<REFERENCE MODIFIED="2009-08-05 12:35:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-08-05 12:35:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ahrens EH, Blankenhorn DH, Tsaltas TT</AU>
<TI>Effect on human serum lipids of substituting plant for animal fat in the diet</TI>
<SO>Proceedings of the Society for Experimental Biology and Medicine</SO>
<YR>1954</YR>
<VL>86</VL>
<PG>872</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:35:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahrens-1957" MODIFIED="2009-08-05 12:35:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ahrens 1957" YEAR="1957">
<REFERENCE MODIFIED="2009-08-05 12:35:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT - INCL.FH" NOTES_MODIFIED="2009-08-05 12:35:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahrens EH, Insull W, Blomstrand R, Hirsch J, Tsaltas TT, Peterson ML</AU>
<TI>The influence of dietary fats on serum lipid levels in man</TI>
<SO>Lancet</SO>
<YR>1957</YR>
<VL>86</VL>
<PG>943-53</PG>
<IDENTIFIERS MODIFIED="2009-08-05 12:35:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahrens-1959" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ahrens 1959" YEAR="1959">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahrens EH, Insull W, Hirsch J, Stoffel W, Peterson ML, Farquhur JW, et al</AU>
<TI>The effect on human serum lipids of a dietary fat, highly unsaturated, but poor in essential fatty acids</TI>
<SO>Lancet</SO>
<YR>1959</YR>
<VL>i</VL>
<PG>115</PG>
<IDENTIFIERS MODIFIED="2009-07-20 15:13:23 +0100" MODIFIED_BY="Nikki Jahnke">
<IDENTIFIER TYPE="MEDLINE" VALUE="345"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Am-Acad-Paed-1972" MODIFIED="2009-10-19 16:55:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Am Acad Paed 1972" YEAR="1972">
<REFERENCE MODIFIED="2009-10-19 16:55:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - consensus statement only - not copied" NOTES_MODIFIED="2009-10-19 16:55:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics Committee on Nutrition</AU>
<TI>Childhood diet and coronary heart disease</TI>
<SO>Pediatrics</SO>
<YR>1972</YR>
<VL>49</VL>
<NO>2</NO>
<PG>305-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:55:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amundsen-2004" MODIFIED="2009-10-08 14:10:56 +0100" MODIFIED_BY="[Empty name]" NAME="Amundsen 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-10-08 14:10:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amundsen AL, Ntanios F, Put N, Ose L.</AU>
<TI>Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>58</VL>
<NO>12</NO>
<PG>1612-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1957" MODIFIED="2009-10-19 16:55:53 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Anderson 1957" YEAR="1957">
<REFERENCE MODIFIED="2009-10-19 16:55:53 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RM214.JOU NOT RCT/INSTITUTIONALISED PATIENTS" NOTES_MODIFIED="2009-10-19 16:55:53 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson JT, Keys A, Grande F</AU>
<TI>The effects of different food fats on serum cholesterol concentrations in man</TI>
<SO>Journal of Nutrition</SO>
<YR>1957</YR>
<VL>62</VL>
<NO>3</NO>
<PG>421</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:55:53 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1976" MODIFIED="2009-10-19 16:56:06 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Anderson 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-10-19 16:56:06 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson JT, Grande F, Keys A</AU>
<TI>Independence of the effects of cholesterol and degree of saturation of the fat diet on serum cholesterol in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1976</YR>
<VL>29</VL>
<NO>11</NO>
<PG>1784-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:06 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1980" MODIFIED="2009-10-19 16:56:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Anderson 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 16:56:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/DIABETES" NOTES_MODIFIED="2009-10-19 16:56:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson JT, Chen WL, Sieling B</AU>
<TI>Hypolipidemic effects of high-carbohydrate, high-fibre diets</TI>
<SO>Metabolism</SO>
<YR>1980</YR>
<VL>29</VL>
<PG>551-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1984a" MODIFIED="2009-10-19 16:56:23 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Anderson 1984a" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 16:56:23 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - RCT including FH patients" NOTES_MODIFIED="2009-10-19 16:56:23 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson JW, Story L, Sieling B, Chen W-JL, Petro MS, Story J</AU>
<TI>Hypercholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>40</VL>
<PG>1146-55</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:23 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1984b" MODIFIED="2009-10-19 16:56:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Anderson 1984b" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 16:56:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 16:56:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson JW, Story L, Sieling B, Chen WL</AU>
<TI>Hypocholesterolemic effects of high fibre diets rich in water soluble plant fibres</TI>
<SO>Journal of the Canadian Dietetic Association</SO>
<YR>1984</YR>
<VL>45</VL>
<PG>140-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asherio-1995" MODIFIED="2009-10-19 16:56:38 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Asherio 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 16:56:38 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT-NOT FH" NOTES_MODIFIED="2009-10-19 16:56:38 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willet WC</AU>
<TI>Dietary intake of marine n-3 fatty acids and the risk of coronary disease among men</TI>
<SO>New England Journal of Medicine</SO>
<YR>1995</YR>
<VL>332</VL>
<PG>977-82</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Atkinson-1987" MODIFIED="2009-10-19 16:56:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Atkinson 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 16:56:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:56:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atkinson PM, Wheeler MC, Mendelsohn D, Pienaar N, Chetty N</AU>
<TI>Effects of a four week fresh water fish (trout) diet on platelet aggregation, platelet fatty acids, serum lipids and coagulation factors</TI>
<SO>American Journal of Hematology</SO>
<YR>1987</YR>
<VL>24</VL>
<PG>143-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baggio-1988" MODIFIED="2009-10-19 16:56:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Baggio 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 16:56:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT including some FH patients" NOTES_MODIFIED="2009-10-19 16:56:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baggio G, Pagnan A, Muraca M, Martini S, Opportuno A, Bonanome A, et al</AU>
<TI>Olive oil enriched diet: effect on serum lipoprotein and biliary cholesterol saturation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1988</YR>
<VL>47</VL>
<PG>960-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bartram-1992" MODIFIED="2013-08-23 11:47:36 +0100" MODIFIED_BY="[Empty name]" NAME="Bartram 1992" YEAR="1992">
<REFERENCE MODIFIED="2013-08-23 11:47:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bartram P, Geriarch S, Scheppach W, Keller F, Kasper H.</AU>
<TI>Effect of single oat bran cereal breakfast on serum cholesterol, lipoproteins and apolipoproteins in patients with hyperlipoproteiemia type IIa</TI>
<SO>JPEN J Parenter Enteral Nutr</SO>
<YR>1992</YR>
<VL>16</VL>
<PG>533-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becker-1983" MODIFIED="2009-10-19 16:56:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Becker 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 16:56:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not RCT, healthy subjects only" NOTES_MODIFIED="2009-10-19 16:56:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker N, Illingworth DR, Alaupovic P, Connor WE, Sundberg EE</AU>
<TI>Effects of saturated, monounsaturated and n-6 polyunsaturated fatty acids on plasma lipids, lipoproteins and apolipoproteins in humans</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>37</VL>
<PG>355-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:56:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becker-1993" MODIFIED="2009-10-19 16:57:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Becker 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 16:57:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - FH but not RCT/CCT - not copied" NOTES_MODIFIED="2009-10-19 16:57:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker M, Staab D, von Bergmann K</AU>
<TI>Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol</TI>
<SO>Journal of Pediatrics</SO>
<YR>1993</YR>
<VL>122</VL>
<PG>292-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beil-1991" MODIFIED="2009-10-19 16:57:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beil 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 16:57:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - RCT/FH" NOTES_MODIFIED="2009-10-19 16:57:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beil FU, Terres W, Orgass M, Heimer G</AU>
<TI>Dietary fish oils lower lipoprotein(a) in primary hypertriglyceridemia</TI>
<SO>Atherosclerosis</SO>
<YR>1991</YR>
<VL>90</VL>
<PG>95-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beitz-1981" MODIFIED="2009-10-19 16:57:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beitz 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 16:57:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:57:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beitz J, Mest HJ, Forster W</AU>
<TI>Influence of linseed oil diet on the pattern of serum phospholipids in man</TI>
<SO>Acta Biologica Medica Germanica</SO>
<YR>1981</YR>
<VL>40</VL>
<PG>31-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berg-1991" MODIFIED="2009-10-19 16:57:29 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Berg 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 16:57:29 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RB1.CLI - not RCT but includes FH patients" NOTES_MODIFIED="2009-10-19 16:57:29 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berg Schmidt E, Klausen IC, Kristensen SD, Lervang HH, Faergeman O, Dyerberg J</AU>
<TI>The effect of n-3 polyunsaturated fatty acids on Lp(a)</TI>
<SO>Clinica Chimica Acta</SO>
<YR>1991</YR>
<VL>198</VL>
<PG>271-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berge-1959" MODIFIED="2009-10-19 16:57:34 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Berge 1959" YEAR="1959">
<REFERENCE MODIFIED="2009-10-19 16:57:34 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="MI/JR - NOT CCT/RETROSPECTIVE/FH" NOTES_MODIFIED="2009-10-19 16:57:34 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berge GK, Achor RWP, Barker NW, Power MH</AU>
<TI>Comparison of the treatment of hypercholesterolemia with nicotinic acid, sitosterol and safflower oil</TI>
<SO>American Heart Journal</SO>
<YR>1959</YR>
<VL>58</VL>
<PG>849</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:34 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berry-1991" MODIFIED="2009-10-19 16:57:39 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Berry 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 16:57:39 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - RCT but healthy subjects" NOTES_MODIFIED="2009-10-19 16:57:39 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berry EM, Eisenberg S, Haratz D, Friedlander Y, Norman Y, Kaufmann NA, et al</AU>
<TI>Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - The Jerusalem Nutritional Study: High MUFAs vs high PUFAs</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>53</VL>
<NO>4</NO>
<PG>899-907</PG>
<EN>53</EN>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:39 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Best-1954" MODIFIED="2009-10-19 16:57:45 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Best 1954" YEAR="1954">
<REFERENCE MODIFIED="2009-10-19 16:57:45 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1 RCT/?FH PTS" NOTES_MODIFIED="2009-10-19 16:57:45 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Best MM, Duncan CH, Vanloon EJ, Wathen JD</AU>
<TI>Lowering of serum cholesterol by the administration of a plant sterol</TI>
<SO>Circulation</SO>
<YR>1954</YR>
<VL>10</VL>
<PG>201</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:45 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Best-1955" MODIFIED="2009-10-19 16:57:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Best 1955" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 16:57:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.AME ?RCT/?FH" NOTES_MODIFIED="2009-10-19 16:57:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Best MM, Duncan CH, van Loon EJ, Wathen JD</AU>
<TI>The effects of sitosterol on serum lipids</TI>
<SO>American Journal of Medicine</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>61</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Best-1956" MODIFIED="2009-10-19 16:58:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Best 1956" YEAR="1956">
<REFERENCE MODIFIED="2009-10-19 16:58:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.ANN - ?RCT/CCT, includes FH patients" NOTES_MODIFIED="2009-10-19 16:58:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Best MM, Duncan CH</AU>
<TI>Modification of abnormal serum lipid patterns in atherosclerosis by administration of sitosterol</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1956</YR>
<VL>45</VL>
<PG>614</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:57:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beveridge-1955" MODIFIED="2009-10-19 16:58:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beveridge 1955" YEAR="1955">
<REFERENCE MODIFIED="2009-10-19 16:58:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RM214.JOU NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:58:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beveridge JMR, Connell WF, Mayer GA, Firstbrook JB, DeWolfe MS</AU>
<TI>The effects of certain vegetable and animal fats on the plasma lipids of humans</TI>
<SO>Journal of Nutrition</SO>
<YR>1955</YR>
<VL>56</VL>
<PG>311-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:58:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beveridge-1957" MODIFIED="2009-10-19 16:58:49 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beveridge 1957" YEAR="1957">
<REFERENCE MODIFIED="2009-10-19 16:58:49 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QH301.FED INCORRECT REFERENCE" NOTES_MODIFIED="2009-10-19 16:58:49 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beveridge JMR, Connell WF, Mayer GA</AU>
<TI>Plasma cholesterol depressant factor in corn oil</TI>
<SO>Federation Proceedings</SO>
<YR>1957</YR>
<VL>16</VL>
<PG>11</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:58:49 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beveridge-1959" MODIFIED="2009-10-19 16:58:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beveridge 1959" YEAR="1959">
<REFERENCE MODIFIED="2009-10-19 16:58:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.CAN CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:58:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beveridge JMR, Connell WF, Haust HL, Mayer GA</AU>
<TI>Dietary cholesterol and plasma cholesterol levels in man</TI>
<SO>Canadian Journal of Biochemistry and Physiology</SO>
<YR>1959</YR>
<VL>37</VL>
<PG>575-82</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:58:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beynen-1985" MODIFIED="2009-10-19 16:59:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Beynen 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 16:59:02 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:59:02 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beynen AC, Katan MB</AU>
<TI>Reproducibility of the variations between humans in the response of serum cholesterol to cessation of egg consumption</TI>
<SO>Atherosclerosis</SO>
<YR>1985</YR>
<VL>57</VL>
<PG>19-31</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bierenbaum-1963" MODIFIED="2009-10-19 16:59:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bierenbaum 1963" YEAR="1963">
<REFERENCE MODIFIED="2009-10-19 16:59:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/POST MI" NOTES_MODIFIED="2009-10-19 16:59:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bierenbaum ML, Green DP, German JB, et al</AU>
<TI>The effects of two low fat dietary patterns on the blood cholesterol level of young male coronary patients</TI>
<SO>Journal of Chronic Diseases</SO>
<YR>1963</YR>
<VL>16</VL>
<PG>1073</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bierenbaum-1970" MODIFIED="2009-10-19 16:59:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bierenbaum 1970" YEAR="1970">
<REFERENCE MODIFIED="2009-10-19 16:59:15 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/UNCLEAR IF FH PATIENTS" NOTES_MODIFIED="2009-10-19 16:59:15 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bierenbaum ML, Fleischman AI, Green DP, Raichelson RI, Hayton T, Watson PB, et al</AU>
<TI>The 5-years experience of a modified fat diet on younger men with coronary heart disease</TI>
<SO>Circulation</SO>
<YR>1970</YR>
<VL>42</VL>
<PG>943-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blair-2000" MODIFIED="2012-08-16 15:44:41 +0100" MODIFIED_BY="anita  s malhotra" NAME="Blair 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-08-16 15:44:41 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB</AU>
<TI>Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy</TI>
<SO>American Journal of Cardiology</SO>
<YR>2000</YR>
<VL>86</VL>
<NO>1</NO>
<PG>46-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blankenhorn-1990" MODIFIED="2009-10-19 16:59:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Blankenhorn 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 16:59:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - Only placebo group of diet v drug RCT" NOTES_MODIFIED="2009-10-19 16:59:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blankenhorn DH, Johnson RL, Mack WJ, El Zein HA, Vailas LI</AU>
<TI>The influence of diet on the appearance of new lesions in human coronary arteries</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1990</YR>
<VL>263</VL>
<PG>1646-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blaton-1984" MODIFIED="2009-10-19 16:59:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Blaton 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 16:59:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/?INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 16:59:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blaton V, De Buyzere M, Declercq B, et al</AU>
<TI>Effect on polyunsaturated isocaloric fat diets on plasma lipids, apolipoproteins and fatty acids</TI>
<SO>Atherosclerosis</SO>
<YR>1984</YR>
<VL>53</VL>
<PG>9-20</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boberg-1986" MODIFIED="2009-10-19 16:59:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Boberg 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 16:59:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="13" NOTES_MODIFIED="2009-10-19 16:59:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boberg M, Vessby B, Selinus I</AU>
<TI>Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients</TI>
<SO>Acta Medica Scandinavia</SO>
<YR>1986</YR>
<VL>220</VL>
<PG>153-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonanome-1988" MODIFIED="2009-10-19 16:59:42 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bonanome 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 16:59:42 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT-?INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 16:59:42 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonanome A, Grundy SM</AU>
<TI>Effects of dietary stearic acid on plasma cholesterol and lipoprotein levels</TI>
<SO>New England Journal of Medicine</SO>
<YR>1988</YR>
<VL>318</VL>
<PG>1244-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:42 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonanome-1992" MODIFIED="2009-10-19 16:59:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bonanome 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 16:59:46 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 16:59:46 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, et al</AU>
<TI>Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<PG>529-33</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:46 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bowry-1993" MODIFIED="2009-10-19 16:59:51 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bowry 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 16:59:51 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 16:59:51 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bowry VW, Stocker R</AU>
<TI>Tocopherol-mediated peroxidation: the effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein</TI>
<SO>Journal of the American Chemical Society</SO>
<YR>1993</YR>
<VL>115</VL>
<PG>6029-44</PG>
<IDENTIFIERS MODIFIED="2009-10-19 16:59:51 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boyd-1990" MODIFIED="2009-10-19 17:00:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Boyd 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:00:02 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/BREAST CA" NOTES_MODIFIED="2009-10-19 17:00:02 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boyd NF, Cousins M, Beaton M, Kriukov, Lockwood G, Tritchler D</AU>
<TI>Quantitative changes in dietary fat intake and serum cholesterol on women: results of a randomised controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1990</YR>
<VL>52</VL>
<PG>470-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Braden-1990" MODIFIED="2009-10-19 17:00:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Braden 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:00:07 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR DOGS" NOTES_MODIFIED="2009-10-19 17:00:07 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Braden GA, Knapp HR, Fitzgerald DJ, Fitzgerald GA</AU>
<TI>Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator</TI>
<SO>Circulation</SO>
<YR>1990</YR>
<VL>82</VL>
<PG>178-87</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brensike-1982" MODIFIED="2009-10-19 17:00:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brensike 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:00:10 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="32" NOTES_MODIFIED="2009-10-19 17:00:10 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brensike JF</AU>
<TI>National heart, lung and blood institute type II coronary intervention study</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1982</YR>
<VL>3</VL>
<PG>91-111</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brensike-1984" MODIFIED="2009-10-19 17:00:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brensike 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:00:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="16" NOTES_MODIFIED="2009-10-19 17:00:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brensike JF, Levy RI, Kelsey SF, Passamani ER, Richardson JM, Loh IK, et al</AU>
<TI>Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study</TI>
<SO>Circulation</SO>
<YR>1984</YR>
<VL>69</VL>
<PG>313-24</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brinton-1990" MODIFIED="2013-08-11 12:30:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brinton 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-08-11 12:30:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU INCORRECT REFERENCE" NOTES_MODIFIED="2013-08-11 12:30:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brinton EA, Eisenberg S, Breslow JL</AU>
<TI>A low fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1990</YR>
<VL>85</VL>
<PG>144-51</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:23 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-08-11 12:28:43 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-11 12:28:43 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Briones-1984" MODIFIED="2009-10-19 17:00:19 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Briones 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:00:19 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Briones ER, Steiger D, Palumbo PJ, Kottke BA</AU>
<TI>Primary hypercholesterolaemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation</TI>
<SO>Mayo Clinic Proceedings</SO>
<YR>1984</YR>
<VL>59</VL>
<PG>251-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:19 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brongeest-1979a" MODIFIED="2009-10-19 17:00:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brongeest 1979a" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:00:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:00:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brongeest-Schoute HO, Hautvast JGAJ, Hermus RJJ</AU>
<TI>Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man.I. Effects of dietary cholesterol in a linoleic-acid rich diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<PG>2183-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brongeest-1979b" MODIFIED="2009-10-19 17:00:31 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brongeest 1979b" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:00:31 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:00:31 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brongeest-Schoute HO, Brongeest-Schoute DC, Hermus RJ, Dallinga-Thie GM, Hautvast JG</AU>
<TI>Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man.II. Effects of dietary cholesterol in a linoleic acid-poor diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<PG>2188-92</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:31 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brongeest-1979c" MODIFIED="2009-10-19 17:00:35 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brongeest 1979c" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:00:35 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:00:35 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bronsgeest-Schoute DC, Hermus RJ, Dallinga-Thie GM, et al</AU>
<TI>Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man.III. The effect on serum cholesterol of removal of eggs from the diet of free-living, habitually egg-eating people</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<NO>11</NO>
<PG>2193-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:35 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bronte_x002d_Stewart-1956" MODIFIED="2009-10-19 17:00:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bronte-Stewart 1956" YEAR="1956">
<REFERENCE MODIFIED="2009-10-19 17:00:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/NOT FH" NOTES_MODIFIED="2009-10-19 17:00:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bronte-Stewart B, Antonis A Eales L, Brock JF</AU>
<TI>Effects of feeding different fats on serum cholesterol levels</TI>
<SO>Lancet</SO>
<YR>1956</YR>
<VL>1</VL>
<PG>521-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1991" MODIFIED="2009-10-19 17:00:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brown 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:00:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.JOU CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:00:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown SA, Morrisett J, Patsch JR, Reeves R, Gotto AM, Patsch W</AU>
<TI>Influence of short term dietary cholesterol and fat on human plasma Lp[a] and LDL levels</TI>
<SO>Journal of Lipid Research</SO>
<YR>1991</YR>
<VL>32</VL>
<PG>1281-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brox-1981" MODIFIED="2009-10-19 17:00:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brox 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:00:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR ?RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:00:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brox JH, Killie JE, Gunnes S, Nordoy A</AU>
<TI>The effect of cod liver oil and corn oil on platelets and vessel wall in man</TI>
<SO>Thrombosis and Haemostasis</SO>
<YR>1981</YR>
<VL>46</VL>
<PG>604</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:00:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brox-1983" MODIFIED="2009-07-08 05:50:25 +0100" MODIFIED_BY="[Empty name]" NAME="Brox 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-07-08 05:10:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brox JH, Killie JE, Osterud B, Holme S, Nordoy A</AU>
<TI>Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type A)</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1983</YR>
<VL>213</VL>
<PG>137</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruckner-1987" MODIFIED="2009-10-19 17:01:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bruckner 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:01:10 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/?FH" NOTES_MODIFIED="2009-10-19 17:01:10 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bruckner G, Webb P, Greenwell L, Chow C, Richardson D</AU>
<TI>Fish oil increases peripheral capillary blood cell velocity in humans</TI>
<SO>Atherosclerosis</SO>
<YR>1987</YR>
<VL>66</VL>
<PG>237-45</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brude-1997" MODIFIED="2009-10-19 17:01:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brude 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-10-19 17:01:13 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K, et al</AU>
<TI>Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants</TI>
<SO>Arteriosclerosis, Thrombosis, and Vascualr Biology</SO>
<YR>1997</YR>
<VL>17</VL>
<PG>2576-88</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brussaard-1980" MODIFIED="2009-10-19 17:01:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Brussaard 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:01:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH(JOU) - CCT of healthy volunteers" NOTES_MODIFIED="2009-10-19 17:01:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brussaard JH, Dallinga-Thie G, Grott PH, Katan MB</AU>
<TI>Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man: a controlled 8-week trial</TI>
<SO>Atherosclerosis</SO>
<YR>1980</YR>
<VL>36</VL>
<PG>515-27</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burr-1989" MODIFIED="2009-10-19 17:01:24 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Burr 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:01:24 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/POST MI MALES" NOTES_MODIFIED="2009-10-19 17:01:24 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al</AU>
<TI>Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>2</VL>
<PG>757-61</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:24 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canetti-1995" MODIFIED="2009-10-19 17:01:29 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Canetti 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:01:29 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canetti M, Moreira M, Mas R, Illnait J, Fernandez L, Fernandez J</AU>
<TI>A two year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia</TI>
<SO>International Journal of Clinical Pharmacology Research</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>159-65</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carlson-1971" MODIFIED="2009-10-19 17:01:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carlson 1971" YEAR="1971">
<REFERENCE MODIFIED="2009-10-19 17:01:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH - CCT only" NOTES_MODIFIED="2009-10-19 17:01:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carlson LA, Olsson AG, Oro L, Rossner S</AU>
<TI>Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia</TI>
<SO>Atherosclerosis</SO>
<YR>1971</YR>
<VL>14</VL>
<PG>391-400</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carmen_x002d_Ramon-1998" MODIFIED="2009-10-19 17:01:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carmen-Ramon 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-10-19 17:01:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="26" NOTES_MODIFIED="2009-10-19 17:01:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carmen-Ramon R, Ascaso JF, Real JT, Ordovas JM, Carmen R</AU>
<TI>Genetic variation at the ApoA-IV gene locus and response to diet in familial hypercholesterolemia</TI>
<SO>Arteriosclerosis, Thrombosis, and Vascualr Biology</SO>
<YR>1998</YR>
<VL>18</VL>
<PG>1266-74</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carranza-1997" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carranza 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carranza-Madrigal J, Herrera-Abarca JE, Alvizouri-Munza M, Alvarado-Jimenez MR, Chavez-Carbajal F</AU>
<TI>Effects of a vegetarian diet vs a vegetarian diet enriched with avocado in hypercholesterolemic patients</TI>
<SO>Archives of Medical Research</SO>
<YR>1997</YR>
<VL>28</VL>
<NO>4</NO>
<PG>537-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carroll-1975" MODIFIED="2009-10-19 17:01:53 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carroll 1975" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:01:53 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:01:53 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carroll KK, Hamilton RMG</AU>
<TI>Effects of dietary protein and carbohydrate on plasma cholesterol levels in relation to atherosclerosis</TI>
<SO>Journal of Food Science</SO>
<YR>1975</YR>
<VL>40</VL>
<PG>18</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:01:53 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carroll-1978" MODIFIED="2009-10-19 17:02:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carroll 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:02:00 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP751.LIP RABBITS" NOTES_MODIFIED="2009-10-19 17:02:00 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carroll KK</AU>
<TI>The role of dietary protein in hypercholesterolemia and atherosclerosis</TI>
<SO>Lipids</SO>
<YR>1978</YR>
<VL>13</VL>
<PG>360</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carroll-1982" MODIFIED="2009-10-19 17:02:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carroll 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:02:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QH301.FED INCORRECT REFERENCE" NOTES_MODIFIED="2009-10-19 17:02:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carroll KK</AU>
<TI>Hypercholesterolemia and atherosclerosis: effects of dietary protein</TI>
<SO>Federation Proceedings</SO>
<YR>1982</YR>
<VL>41</VL>
<PG>2792-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carroll-1991" MODIFIED="2009-10-19 17:02:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Carroll 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:02:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - REVIEW" NOTES_MODIFIED="2009-10-19 17:02:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carroll KK</AU>
<TI>Review of clinical studies on cholesterol-lowering response to soy protein</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1991</YR>
<VL>91</VL>
<PG>820-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chait-1974" MODIFIED="2009-10-19 17:02:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Chait 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-10-19 17:02:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH - Hypertriglyceridemia patients (+ healthy controls)" NOTES_MODIFIED="2009-10-19 17:02:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chait A, Onitiri A, Nicoll A, Rabaya E, Davies J, Lewis B</AU>
<TI>Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition</TI>
<SO>Atherosclerosis</SO>
<YR>1974</YR>
<VL>20</VL>
<PG>347-64</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-1990" MODIFIED="2009-10-19 17:02:16 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Chang 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:02:16 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:02:16 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chang NW, Huang PC</AU>
<TI>Effects of dietary monounsaturated fatty acids on plasma lipids in humans</TI>
<SO>Journal of Lipid Research</SO>
<YR>1990</YR>
<VL>31</VL>
<PG>2141-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:16 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-1979" MODIFIED="2009-10-19 17:02:21 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Chen 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:02:21 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RATS" NOTES_MODIFIED="2009-10-19 17:02:21 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen WL, Anderson JT</AU>
<TI>Effects of plant fibre in decreasing plasma total cholesterol and increasing high density lipoprotein cholesterol</TI>
<SO>Proceedings of the Society for Experimental Biology and Medicine</SO>
<YR>1979</YR>
<VL>162</VL>
<PG>310-3</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:21 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chenoweth-1981" MODIFIED="2009-10-19 17:02:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Chenoweth 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:02:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:02:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chenoweth W, Ullmann M, Simpson R, Leveille G</AU>
<TI>Influence of dietary cholesterol and fat on serum lipids in man</TI>
<SO>Journal of Nutrition</SO>
<YR>1981</YR>
<VL>111</VL>
<PG>2069-80</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Childs-1981" MODIFIED="2009-10-19 17:02:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Childs 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:02:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:02:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Childs MT, Bowlin JA, Ogilvie JT, Hazzard WR, Albers JJ</AU>
<TI>The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects</TI>
<SO>Atherosclerosis</SO>
<YR>1981</YR>
<VL>38</VL>
<PG>217-28</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clevidence-1992" MODIFIED="2009-10-19 17:02:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Clevidence 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:02:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:02:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clevidence BA, Judd JT, Schatzkin A, et al</AU>
<TI>Plasma lipid and lipoprotein concentrations of men consuming a low-fat, high fibre diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>55</VL>
<PG>689-94</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clifton-1992" MODIFIED="2009-10-19 17:02:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Clifton 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:02:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - RCT/?FH" NOTES_MODIFIED="2009-10-19 17:02:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clifton PM, Wight MB, Nestel PJ</AU>
<TI>Is fat restriction needed with HMGCoA reductase inhibitor treatment?</TI>
<SO>Atherosclerosis</SO>
<YR>1992</YR>
<VL>93</VL>
<PG>59-70</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cobb-1991" MODIFIED="2009-10-19 17:02:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Cobb 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:02:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - RCT with some FH patients - also assessed drugs" NOTES_MODIFIED="2009-10-19 17:02:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cobb M, Teitelbaum H, Breslow J</AU>
<TI>Lovestatin efficiency in reducing low density lipoprotein cholesterol levels on high vs low fat diets</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1991</YR>
<VL>265</VL>
<PG>997-1001</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cole-1992" MODIFIED="2009-10-19 17:02:59 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Cole 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:02:59 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT ONLY" NOTES_MODIFIED="2009-10-19 17:02:59 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cole TG, Bowen PE, Schmeisser D, Prewitt TE, Aye P, Langenberg P, et al</AU>
<TI>Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexes</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>55</VL>
<NO>22</NO>
<PG>385-94</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:02:59 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colquhoun-1992" MODIFIED="2009-10-19 17:03:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Colquhoun 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:03:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT healthy subjects" NOTES_MODIFIED="2009-10-19 17:03:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colquhoun DM, Moores D, Somerset SM, Humphries JA</AU>
<TI>Comparison of the effects on lipoproteins and apolipoproteins of a diet high in monounsaturated fatty acids enriched with avocado, and a high carbohydrate diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>56</VL>
<PG>671-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connor-1961a" MODIFIED="2009-10-19 17:03:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Connor 1961a" YEAR="1961">
<REFERENCE MODIFIED="2009-10-19 17:03:07 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:03:07 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connor WE, Hodges RE, Blieler RE</AU>
<TI>Effect of dietary cholesterol upon serum lipids in man</TI>
<SO>Journal of Laboratory and Clinical Medicine</SO>
<YR>1961</YR>
<VL>57</VL>
<PG>331-42</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connor-1961b" MODIFIED="2009-10-19 17:03:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Connor 1961b" YEAR="1961">
<REFERENCE MODIFIED="2009-10-19 17:03:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:03:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connor WE, Hodges RE, Blieler RE</AU>
<TI>The serum lipids in men receiving high cholesterol and cholesterol-free diets</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1961</YR>
<VL>40</VL>
<PG>894-901</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connor-1964" MODIFIED="2009-10-19 17:03:16 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Connor 1964" YEAR="1964">
<REFERENCE MODIFIED="2009-10-19 17:03:16 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:03:16 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connor WE, Stone DB, Hodges RE</AU>
<TI>The interrelated effects of dietary cholesterol and fat upon human serum lipid levels</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1964</YR>
<VL>43</VL>
<PG>1691-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:16 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connor-1982" MODIFIED="2009-10-19 17:03:20 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Connor 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:03:20 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.MED NOT RCT/CCT" NOTES_MODIFIED="2009-10-19 17:03:20 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connor WE, Connor SL</AU>
<TI>The dietary treatment of hyperlipidemia. Rationale, technique and efficacy</TI>
<SO>Medical Clinics of North America</SO>
<YR>1982</YR>
<VL>66</VL>
<PG>485-518</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:20 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corder-1989" MODIFIED="2009-10-19 17:03:24 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Corder 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:03:24 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corder CN, Kloer HU, Price MD</AU>
<TI>CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1989</YR>
<VL>37</VL>
<PG>477-81</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:24 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cortese-1983" MODIFIED="2009-10-19 17:03:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Cortese 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:03:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="11" NOTES_MODIFIED="2009-10-19 17:03:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cortese C, Levy Y, Janus ED, Turner PR, Rao SN, Miller NE, et al</AU>
<TI>Modes of action of lipid-lowering diets in man: studies of apolipoprotein B kinetics in relation to fat consumption and dietary fatty acid composition</TI>
<SO>European Journal of Clinical Investigation</SO>
<YR>1983</YR>
<VL>13</VL>
<PG>79-85</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crouse-1979" MODIFIED="2009-10-19 17:03:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Crouse 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:03:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R850.A1.MET NOT RCT/NOT FH" NOTES_MODIFIED="2009-10-19 17:03:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crouse JR, Grundy SM</AU>
<TI>Effects of sucrose polyester on cholesterol metabolism in man</TI>
<SO>Metabolism</SO>
<YR>1979</YR>
<VL>28</VL>
<PG>994-1000</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Da-Col-1984" MODIFIED="2009-10-19 17:03:35 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Da Col 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:03:35 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Da Col PG, Cattin L, Fonda M, Mameli MG, Feruglio FS</AU>
<TI>Pantethine in the treatment of hypercholesterolemia: A randomised double blind trial versus tiadenol</TI>
<SO>Current Therapeutic Research, Clinical and Experimental</SO>
<YR>1984</YR>
<VL>36</VL>
<PG>314-22</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:35 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dattilo-1992" MODIFIED="2009-10-19 17:03:39 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Dattilo 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:03:39 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="REVIEW - COPIED" NOTES_MODIFIED="2009-10-19 17:03:39 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dattilo AM, Kris-Etherton PM</AU>
<TI>effects of weight reduction on blood lipids and lipoproteins: a meta-analysis</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>56</VL>
<PG>320-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:39 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davidson-1991" MODIFIED="2009-10-19 17:03:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Davidson 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:03:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.ARC - RCT - ?included FH patients (cross-over)" NOTES_MODIFIED="2009-10-19 17:03:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davidson MH, Burns JH, Papasani VS, Conn ME, Dremman KB</AU>
<TI>Marine oil capsule therapy for the treatment of hyperlipidemia</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1991</YR>
<VL>151</VL>
<PG>1732-40</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davis-1985" MODIFIED="2009-10-19 17:03:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Davis 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:03:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU DIET AND DRUGS V DIET AND PLACEBO" NOTES_MODIFIED="2009-10-19 17:03:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis TA, Anderson EC, Ginsburg AV, Goldberg AP</AU>
<TI>Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia</TI>
<SO>Journal of Laboratory and Clinical Medicine</SO>
<YR>1985</YR>
<VL>106</VL>
<PG>447-54</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Groot-1963" MODIFIED="2009-10-19 17:04:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="de Groot 1963" YEAR="1963">
<REFERENCE MODIFIED="2009-10-19 17:04:04 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Groot AP, Luyken R, Pikaar NA</AU>
<TI>Cholesterol lowering effect of rolled oats</TI>
<SO>Lancet</SO>
<YR>1963</YR>
<VL>2</VL>
<PG>303-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:03:59 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Jong-2008" MODIFIED="2012-04-20 10:42:44 +0100" MODIFIED_BY="anita  s malhotra" NAME="De Jong 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-04-20 10:42:44 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Jong A, Plat J, Lütjohann D, Mensink RP</AU>
<TI>Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment</TI>
<SO>British Journal of Nutrition</SO>
<YR>2008</YR>
<VL>100</VL>
<NO>5</NO>
<PG>937-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demke-1988" MODIFIED="2009-10-19 17:04:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Demke 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:04:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/?FH" NOTES_MODIFIED="2009-10-19 17:04:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demke DM, Peters GR, Linet OI, Metzler CM, Klott KA</AU>
<TI>Effects of a fish oil concentrate in patients with hypercholesterolemia</TI>
<SO>Atherosclerosis</SO>
<YR>1988</YR>
<VL>70</VL>
<PG>73-80</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:04:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demke-1991" MODIFIED="2009-10-19 17:04:47 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Demke 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:04:47 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demke DM, Grundy SM</AU>
<TI>Lauric acid is hypercholesterolemic in man [abstract]</TI>
<SO>Circulation</SO>
<YR>1991</YR>
<VL>84 (Suppl II)</VL>
<PG>218</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:04:47 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denke-1995" MODIFIED="2009-10-19 17:04:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Denke 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:04:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - Not FH or RCT/CCT - not copied" NOTES_MODIFIED="2009-10-19 17:04:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Denke M</AU>
<TI>Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>392-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:04:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Descovich-1980" MODIFIED="2009-10-19 17:04:56 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Descovich 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:04:56 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - Some FH patients but not RCT/CCT - not copied" NOTES_MODIFIED="2009-10-19 17:04:56 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Descovich GC, Gaddi A, Mannino G</AU>
<TI>Multicentre study of soybean-protein diet for outpatient hypercholesterolemic patients</TI>
<SO>Lancet</SO>
<YR>1980</YR>
<VL>2</VL>
<PG>709-12</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:04:56 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Detre-1985" MODIFIED="2009-10-19 17:05:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Detre 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:05:00 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="30" NOTES_MODIFIED="2009-10-19 17:05:00 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Detre KM, Levy RI, Kelsey SF, Epstein SE, Brensike JF, Passamani ER, et al</AU>
<TI>Secondary prevention and lipid lowering: results and implications</TI>
<SO>American Heart Journal</SO>
<YR>1985</YR>
<VL>110</VL>
<PG>1123-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dieber-1991" MODIFIED="2009-10-19 17:05:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Dieber 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:05:04 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.JOU CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:05:04 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbaur H</AU>
<TI>Effect of oral supplementation with D-alpha-tocopherol on the vitamin e content of human low density lipoproteins and resistance to oxidation</TI>
<SO>Journal of Lipid Research</SO>
<YR>1991</YR>
<VL>32</VL>
<PG>1325-32</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dreon-1990" MODIFIED="2009-10-19 17:05:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Dreon 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:05:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - Not RCT - healthy volunteers" NOTES_MODIFIED="2009-10-19 17:05:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dreon DM, Vranizan KM, Krauss RM, Austin MA, Wood PD</AU>
<TI>The effects of polyunsaturated versus monounsaturated fat on plasma lipoproteins</TI>
<SO>Journal of American Medical Association</SO>
<YR>1990</YR>
<VL>263</VL>
<PG>2462-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dreon-1994" MODIFIED="2009-10-28 09:20:27 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Dreon 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-28 09:20:27 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="QH301.FAS RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-28 09:20:27 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dreon DM, Fernstrom HA, Miller B, Krauss RM</AU>
<TI>Low density subclass patterns and lipoprotein response to a reduced fat diet in man</TI>
<SO>The FASEB journal: official publication of the Fedeation of American Societies for Experimental Bioogy</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>121-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dreon-1997" MODIFIED="2009-10-19 17:05:19 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Dreon 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-10-19 17:05:19 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDERED 14/2/00 - NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:05:19 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dreon DM, Krauss RM</AU>
<TI>Diet-gene interactions in human lipoprotein metabolism</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1997</YR>
<VL>4</VL>
<PG>313-24</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:19 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Durrington-1977" MODIFIED="2009-10-19 17:05:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Durrington 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:05:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:05:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Durrington PN, Bolton CH, Hartog M, Angelinetta R, Emmett P, Furniss S</AU>
<TI>The effect of a low-cholesterol, high-polyunsaturate diet on serum lipid levels, apolipoprotein B levels and triglyceride fatty acid composition</TI>
<SO>Atherosclerosis</SO>
<YR>1977</YR>
<VL>27</VL>
<PG>465-75</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dyerberg-1978" MODIFIED="2009-10-19 17:05:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Dyerberg 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:05:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT" NOTES_MODIFIED="2009-10-19 17:05:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dyerberg J, Bang HO, Stoffersen E</AU>
<TI>Eicosapentanoic acid and prevention of thrombosis and atherosclerosis</TI>
<SO>Lancet</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>117-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-East-1988" MODIFIED="2009-10-19 17:05:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="East 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:05:50 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>East C, Bilheimer DW, Grundy SM</AU>
<TI>Combination drug therapy for familial combined hyperlipidaemia</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1988</YR>
<VL>109</VL>
<PG>25-32</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edington-1989" MODIFIED="2009-10-19 17:05:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Edington 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:05:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/INCLUDED ONE FH PATIENT" NOTES_MODIFIED="2009-10-19 17:05:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edington JD, Geekie M, Carter R, Benfield L, Ball M, Mann J</AU>
<TI>Serum lipid response to dietary cholesterol in subjects fed a low-fat, high fibre diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1989</YR>
<VL>50</VL>
<PG>58-62</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehnholm-1982" MODIFIED="2009-10-19 17:05:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ehnholm 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:05:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/CCT" NOTES_MODIFIED="2009-10-19 17:05:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehnholm C, Huttunen JK, Pietinen P, et al</AU>
<TI>Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>1982</YR>
<VL>307</VL>
<PG>850-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:05:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehnholm-1984" MODIFIED="2013-08-11 12:36:11 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ehnholm 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:06:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="INCORRECT REFERENCE" NOTES_MODIFIED="2009-10-19 17:06:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehnholm C, Huttien JK, Peitinen P, et al</AU>
<TI>Effect of a diet low in saturated fatty acids on plasma lipids, lipoproteins and HDL subfractions</TI>
<SO>Arteriosclerosis</SO>
<YR>1989</YR>
<VL>4</VL>
<PG>265-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elkeles-1988" MODIFIED="2009-10-19 17:06:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Elkeles 1988" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:06:05 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT - FH" NOTES_MODIFIED="2009-10-19 17:06:05 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elkeles RS, Chakrabarti R, Vickers MV, Stirling Y, Meade TW</AU>
<TI>Effect of treatment of hyperlipidaemia on haemostatic variables</TI>
<SO>British Medical Journal</SO>
<YR>1980</YR>
<VL>281</VL>
<PG>973-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erickson-1964" MODIFIED="2009-10-19 17:06:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Erickson 1964" YEAR="1964">
<REFERENCE MODIFIED="2009-10-19 17:06:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU CCT/PRISONERS" NOTES_MODIFIED="2009-10-19 17:06:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erickson BA, Coots RH, Mattson FH, Kligman AM</AU>
<TI>The effect of partial hydrogenation of dietary fats, of the ratio of polyunsaturated to saturated fatty acids, and of dietary cholesterol upon plasma lipids in man</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1964</YR>
<VL>43</VL>
<PG>2017-25</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eritsland-1995" MODIFIED="2009-10-19 17:06:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Eritsland 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:06:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/POST BYPASS PTS" NOTES_MODIFIED="2009-10-19 17:06:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eritsland J, Arnesen H, Seljeflot I, Hostmark AT</AU>
<TI>Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>831-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ernst-1980" MODIFIED="2009-10-19 17:06:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ernst 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:06:15 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT -FH" NOTES_MODIFIED="2009-10-19 17:06:15 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ernst N, Fisher M, Bowen P, Schaefer EJ, Levy RI</AU>
<TI>Changes in plasma lipids and lipoproteins after a fat modified diet</TI>
<SO>Lancet</SO>
<YR>1980</YR>
<VL>2</VL>
<PG>111-3</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Failor-1986" MODIFIED="2009-10-19 17:06:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Failor 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:06:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR ?RCT/FH (ABSTRACT)" NOTES_MODIFIED="2009-10-19 17:06:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Failor RA, Childs MT, Bierman EL</AU>
<TI>The effect of Omega-3 and Omega-6 fatty acid enriched diets upon plasma lipoproteins in subjects with familial combined hyperlipoproteinemia</TI>
<SO>Clinical Research</SO>
<YR>1986</YR>
<VL>34</VL>
<PG>103</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Falko-1980" MODIFIED="2009-10-19 17:06:24 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Falko 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:06:24 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/TYPE III FH" NOTES_MODIFIED="2009-10-19 17:06:24 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falko JM, Schofeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R</AU>
<TI>Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1980</YR>
<VL>50</VL>
<PG>521-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:24 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fallat-1979" MODIFIED="2009-10-28 09:21:03 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Fallat 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-28 09:21:03 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME CCT/SOME FH PATIENTS" NOTES_MODIFIED="2009-10-28 09:21:03 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fallat RW, Glueck CJ, Lutmer FH</AU>
<TI>Short term study of sucrose polyester, a non-absorbable fat-like material as a dietary agent for lowering plasma cholesterol</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>29</VL>
<PG>1204-15</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farquhar-1956" MODIFIED="2009-10-19 17:06:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Farquhar 1956" YEAR="1956">
<REFERENCE MODIFIED="2009-10-19 17:06:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.CIR - CCT - included some FH patients" NOTES_MODIFIED="2009-10-19 17:06:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farquhar JW, Smith RE, Dempsey M</AU>
<TI>The effect of beta-sitosterol on the serum lipids of young men with arteriosclerotic heart disease</TI>
<SO>Circulation</SO>
<YR>1956</YR>
<VL>14</VL>
<PG>77</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farquhar-1958" MODIFIED="2009-10-19 17:06:45 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Farquhar 1958" YEAR="1958">
<REFERENCE MODIFIED="2009-10-19 17:06:45 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.CIR - RCT included FH patients" NOTES_MODIFIED="2009-10-19 17:06:45 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farquhar JW, Sokolow M</AU>
<TI>Response of serum lipids and lipoproteins of man to beta-sitosterol and safflower oil</TI>
<SO>Circulation</SO>
<YR>1958</YR>
<VL>17</VL>
<PG>890</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:45 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fehily-1983" MODIFIED="2009-10-19 17:06:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fehily 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:06:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:06:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fehily AM, Burr ML, Phillips MC, Deadman NM</AU>
<TI>The effect of fatty fish on plasma lipid and lipoprotein concentrations</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>38</VL>
<PG>349-51</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandes-1977" MODIFIED="2009-10-19 17:06:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fernandes 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:06:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="4" NOTES_MODIFIED="2009-10-19 17:06:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandes J, Dijkhuis-Stoffelsma R, Grose WFA</AU>
<TI>The effect of cholestyramine on serum lipids and platelet aggregation of hypercholesterolemic children (Type IIA) while on high linoleic acid diet</TI>
<SO>Acta Paediatric Scandinavia</SO>
<YR>1977</YR>
<VL>66</VL>
<PG>621-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:06:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandes-1981" MODIFIED="2009-10-19 17:07:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fernandes 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:07:02 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - FH patient - CCT or ?RCT" NOTES_MODIFIED="2009-10-19 17:07:02 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandes J, Dijkhuis-Stoffelsma R, Groot PHE, Grose WFA, Ambaptsheer JJ</AU>
<TI>The effect of a virtually cholesterol-free, high linoleic acid vegetarian diet on serum lipoproteins of children with hypercholesterolemia (type IIa)</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1981</YR>
<VL>70</VL>
<PG>677-82</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferro_x002d_Luzzi-1984" MODIFIED="2009-10-19 17:07:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ferro-Luzzi 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:07:10 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:10 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferro-Luzzi A, Strazzullo P, Scaccini PC, Siani A, Sette S, Mariani MA, et al</AU>
<TI>Changing the Mediterranean diet: effects on blood lipids</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>40</VL>
<NO>5</NO>
<PG>1027-37</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fisher-1983" MODIFIED="2009-10-19 17:07:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fisher 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:07:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.JOU CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisher EA, Blum CB, Zanni VI, Breslow JL</AU>
<TI>Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins and apolipoprotein E</TI>
<SO>Journal of Lipid Research</SO>
<YR>1983</YR>
<VL>24</VL>
<PG>1039-48</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flaim-1981" MODIFIED="2009-10-19 17:07:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Flaim 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:07:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flaim E, Ferrei LF, Thye FW, Hill JE, Ritchey SJ</AU>
<TI>Plasma lipid and lipoprotein cholesterol concentrations in adult males consuming normal and high cholesterol diets under controlled conditions</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<PG>1103-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flynn-1981" MODIFIED="2009-10-19 17:07:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Flynn 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:07:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flynn MA, Heine B, Nolph GB, Naumann HD, Parisi E, Ball D, et al</AU>
<TI>Serum lipids in humans fed diets containing beef or fish and poultry</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<NO>12</NO>
<PG>2734-41</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Follick-1984" MODIFIED="2009-10-19 17:07:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Follick 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:07:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.ARC NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Follick MO, Abrams DB, Smith TW, Henderson LO, Herbert PN</AU>
<TI>Contrasting short and long term effects of weight loss on lipoprotein levels</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1984</YR>
<VL>144</VL>
<PG>1571-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forsythe-1986" MODIFIED="2009-10-19 17:07:29 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Forsythe 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:07:29 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forsythe WA, Green MS, Anderson JJB</AU>
<TI>Dietary protein effects on cholesterol and lipoprotein concentrations: A review</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1986</YR>
<VL>5</VL>
<PG>533-49</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frank-1978" MODIFIED="2009-10-19 17:07:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Frank 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:07:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME NOT RCT/CCT" NOTES_MODIFIED="2009-10-19 17:07:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frank GC, Berenson GS, Webber LS</AU>
<TI>Dietary studies and the relationship of diet to cardiovascular disease risk factor variables in 10yr old children (The Bogalusa Heart Study)</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1978</YR>
<VL>31</VL>
<PG>328-40</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frankel-1994" MODIFIED="2009-10-19 17:07:49 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Frankel 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:07:49 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP751.LIP RCT/HYPERTRIGLYCERIDEMICS" NOTES_MODIFIED="2009-10-19 17:07:49 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frankel EN, Parks EJ, Xu R, Schneeman BO, Davis PA, German JB</AU>
<TI>Effect of n-3 fatty acid rich fish oil supplementation on the oxidation of low density lipoproteins</TI>
<SO>Lipids</SO>
<YR>1994</YR>
<VL>29</VL>
<PG>233-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:49 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frantz-1975" MODIFIED="2009-10-19 17:07:53 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Frantz 1975" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:07:53 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR INSTITUTIONAL TRIAL" NOTES_MODIFIED="2009-10-19 17:07:53 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frantz ID, Dawson EA, Kuba K, Brewer ER, Gatewood LC, Bartch GE</AU>
<TI>The Minnesota Coronary Survey: Effect of diet on cardiovascular events and deaths [abstract]</TI>
<SO>Circulation</SO>
<YR>1975</YR>
<VL>51-52</VL>
<PG>ii-4-</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:53 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frantz-1989" MODIFIED="2009-10-19 17:07:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Frantz 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:07:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/INSTITUTIONALISED SUBJECTS" NOTES_MODIFIED="2009-10-19 17:07:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frantz ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K. et al</AU>
<TI>Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey</TI>
<SO>Arteriosclerosis</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>1</NO>
<PG>129-35</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:07:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friday-1991" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Friday 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friday KE, Failor RA, Childs MT,Bierman EL</AU>
<TI>Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apoliproteins in heterozygous familial hypercholesterolaemia</TI>
<SO>Arteriosclerosis &amp; Thrombosis</SO>
<YR>1991</YR>
<VL>11</VL>
<PG>47-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fumagalli-1978" MODIFIED="2009-10-19 17:08:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fumagalli 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:08:04 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QH301.LIF RABBITS" NOTES_MODIFIED="2009-10-19 17:08:04 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fumagalli R, Paoletti R, Howard AN</AU>
<TI>Hypocholesterolemic effect of soya</TI>
<SO>Life Sciences</SO>
<YR>1978</YR>
<VL>22</VL>
<PG>947</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fumagalli-1982" MODIFIED="2009-10-19 17:08:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fumagalli 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:08:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH(JOU) - ?CCT/RCT - included FH patients" NOTES_MODIFIED="2009-10-19 17:08:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fumagalli R, Soleri L, Farina R, Musanti R, Mantero O, Noseda G, et al</AU>
<TI>Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet</TI>
<SO>Atherosclerosis</SO>
<YR>1982</YR>
<VL>43</VL>
<NO>2-3</NO>
<PG>341-53</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gaddi-1987" MODIFIED="2009-10-19 17:08:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gaddi 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:08:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AHNOT RCT/CCT - FH" NOTES_MODIFIED="2009-10-19 17:08:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gaddi A, Descovich GC, Noseda G, Fragiacomo C, Nicolini A, Montanari G, et al</AU>
<TI>Hypercholesterolemia treated by soybean protein diet</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1987</YR>
<VL>62</VL>
<PG>274-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galvan-1996" MODIFIED="2009-10-19 17:08:16 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Galvan 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:08:16 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galvan AQ, Natali A, Baldi S, Frascerra S, Sampietro T, Galetta F, et al</AU>
<TI>Effect of a reduced fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1996</YR>
<VL>28</VL>
<NO>4</NO>
<PG>595-602</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:16 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gardner-1995" MODIFIED="2009-10-19 17:08:19 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gardner 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:08:19 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR META-ANALYSIS" NOTES_MODIFIED="2009-10-19 17:08:19 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gardner CD, Kraemar HC</AU>
<TI>Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis</TI>
<SO>Arteriosclerosis, Thrombosis, and Vascular Biology</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>1917-27</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:19 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gardner-2005" MODIFIED="2012-08-16 15:59:36 +0100" MODIFIED_BY="anita  s malhotra" NAME="Gardner 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-16 15:59:36 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW</AU>
<TI>The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2005</YR>
<VL>142</VL>
<NO>9</NO>
<PG>725-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1972" MODIFIED="2009-10-19 17:08:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1972" YEAR="1972">
<REFERENCE MODIFIED="2009-10-19 17:08:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - FH patients and ?CCT but Diet Alone vs Diet &amp;amp; Drug - not copied" NOTES_MODIFIED="2009-10-19 17:08:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, Fallat R, Tsang R</AU>
<TI>Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin</TI>
<SO>Pediatrics</SO>
<YR>1972</YR>
<VL>52</VL>
<PG>669-79</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1977" MODIFIED="2009-10-19 17:08:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:08:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - FH patients and ?CCT" NOTES_MODIFIED="2009-10-19 17:08:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, Reginald C, Tsang R, Ronald W, Fallat R, Mellies MJ</AU>
<TI>Diet in children heterozygous for familial hypercholesterolemia</TI>
<SO>American Journal in Diseases in Children</SO>
<YR>1977</YR>
<VL>131</VL>
<PG>162-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1978" MODIFIED="2009-10-19 17:08:30 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:08:30 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.CIR - Consensus statement only" NOTES_MODIFIED="2009-10-19 17:08:30 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, McGill HC Jr, Shank RE, Lauer RN</AU>
<TI>Value and safety of diet modification to control hyperlipidemia in childhood and adolescence. A statement for physicians</TI>
<SO>Circulation</SO>
<YR>1978</YR>
<VL>58</VL>
<PG>381A-5A</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:30 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1979" MODIFIED="2009-10-19 17:08:34 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:08:34 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:08:34 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, Mattson FH, Jandacek RJ</AU>
<TI>The lowering of plasma cholesterol by sucrose polyester in subjects consuming diets with 800, 300 or less than 50mg of cholesterol per day</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<PG>1636-44</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:34 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1983" MODIFIED="2009-10-19 17:08:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:08:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME NOT RCT/FH" NOTES_MODIFIED="2009-10-19 17:08:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, Jandacek RJ, Hogg E, Allen C, Baehler L, Tewksbury MB</AU>
<TI>Sucrose polyester: substitution for dietary fats in hypocaloric diets in the treatment of familial hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>37</VL>
<PG>347-54</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glueck-1991" MODIFIED="2009-10-19 17:08:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Glueck 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:08:46 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R850.A1.MED NOT TRIAL" NOTES_MODIFIED="2009-10-19 17:08:46 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J</AU>
<TI>Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol and premature coronary heart disease in hypercholesterolemic probands and their first degree relatives</TI>
<SO>Metabolism</SO>
<YR>1991</YR>
<VL>40</VL>
<PG>842-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:46 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldberg-1982" MODIFIED="2009-10-19 17:08:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Goldberg 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:08:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH - RCT - ?included FH patients" NOTES_MODIFIED="2009-10-19 17:08:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg AP, Lim A, Kolar JB, Grundhauser JJ, Steinke FH, Schonfeld G</AU>
<TI>Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia</TI>
<SO>Atherosclerosis</SO>
<YR>1982</YR>
<VL>43</VL>
<PG>355-68</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodnight-1981" MODIFIED="2009-10-19 17:08:53 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Goodnight 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:08:53 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC633.A1.BLO - RCT - healthy volunteers" NOTES_MODIFIED="2009-10-19 17:08:53 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodnight SH Jr, Harris WS, Connor WE</AU>
<TI>The effects of dietary omega-3 fatty acids on platelet composition and function in man: a prospective, controlled study</TI>
<SO>Blood</SO>
<YR>1981</YR>
<VL>58</VL>
<PG>880-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:53 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gordon-1977" MODIFIED="2009-10-19 17:08:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gordon 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:08:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.AME NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:08:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR</AU>
<TI>High density lipoprotein as a protective factor against coronary heart disease</TI>
<SO>American Journal of Medicine</SO>
<YR>1977</YR>
<VL>62</VL>
<PG>707-14</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:08:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gordon-1982" MODIFIED="2009-10-19 17:09:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gordon 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:09:01 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gordon DJ, Salz KM, Roggenkamp KJ, Franklin FA</AU>
<TI>Dietary determinants of plasma cholesterol change in the recruitment phase of the Lipid Research Clinics Coronary Primary Prevention Trial</TI>
<SO>Arteriosclerosis</SO>
<YR>1982</YR>
<VL>2</VL>
<PG>537-48</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grande-1970" MODIFIED="2009-10-19 17:09:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Grande 1970" YEAR="1970">
<REFERENCE MODIFIED="2009-10-19 17:09:05 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:09:05 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grande F, Anderson JT, Keys A</AU>
<TI>Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1970</YR>
<VL>23</VL>
<PG>1184-93</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grande-1972" MODIFIED="2009-10-19 17:09:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Grande 1972" YEAR="1972">
<REFERENCE MODIFIED="2009-10-19 17:09:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME" NOTES_MODIFIED="2009-10-19 17:09:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grande F, Anderson JT, Keys A</AU>
<TI>Diets of different fatty acid composition producing identical serum cholesterol levels in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1972</YR>
<VL>25</VL>
<PG>53-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gries-1990" MODIFIED="2009-10-19 17:09:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gries 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:09:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:09:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gries A, Malle E, Wurm H, Kostner GM</AU>
<TI>Influence of dietary fish oils on Lp(a) levels</TI>
<SO>Thrombosis Research</SO>
<YR>1990</YR>
<VL>58</VL>
<PG>667-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Groot-1980" MODIFIED="2009-10-19 17:09:19 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Groot 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:09:19 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Groot PH, Grose WFA, Dijkhuis-Stoffelsma R, Fernandes J, Ambagtsheer JJ</AU>
<TI>The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A)</TI>
<SO>European Journal of Pediatrics</SO>
<YR>1980</YR>
<VL>135</VL>
<PG>81-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:19 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grundy-1970" MODIFIED="2009-10-19 17:09:23 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Grundy 1970" YEAR="1970">
<REFERENCE MODIFIED="2009-10-19 17:09:23 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:09:23 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grundy SM, Ahrens EH</AU>
<TI>The effects of unsaturated dietary fats on absorption, excretion, synthesis and distribution of cholesterol in man</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1970</YR>
<VL>49</VL>
<PG>1135-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:23 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grundy-1986" MODIFIED="2009-10-19 17:09:38 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Grundy 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:09:38 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - RCT but ?FH patients" NOTES_MODIFIED="2009-10-19 17:09:38 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grundy SM</AU>
<TI>Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol</TI>
<SO>New England Journal of Medicine</SO>
<YR>1986</YR>
<VL>314</VL>
<PG>745-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grundy-1990" MODIFIED="2009-10-19 17:09:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Grundy 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:09:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:09:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grundy SM, Denke MA</AU>
<TI>Dietary influences on serum lipids and lipoproteins</TI>
<SO>Journal of Lipid Research</SO>
<YR>1990</YR>
<VL>31</VL>
<PG>1149-72</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guardamagna-2011b" MODIFIED="2012-04-20 10:47:10 +0100" MODIFIED_BY="anita  s malhotra" NAME="Guardamagna 2011b" YEAR="">
<REFERENCE MODIFIED="2012-04-20 10:47:10 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guardamagna O, Abello F, Baracco V, Federici G, Bertucci P, Mozzi A, et al</AU>
<TI>Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption</TI>
<SO>Acta Diabetologica</SO>
<YR>2011</YR>
<VL>48</VL>
<NO>2</NO>
<PG>127-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustafsson-1982" MODIFIED="2009-10-19 17:09:47 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gustafsson 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:09:47 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:09:47 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustafsson IB, Vessby B, Boberg J, Karlstrom B, Lithell H</AU>
<TI>Effects of lipid lowering diets on patients with hyperlipoproteinemia</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1982</YR>
<VL>80</VL>
<PG>426-32</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:47 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustafsson-1983" MODIFIED="2009-10-19 17:09:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gustafsson 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:09:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="3" NOTES_MODIFIED="2009-10-19 17:09:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustafsson I, Boberg J, Karlstrom B, Lithell H, Vessby B</AU>
<TI>Similar serum lipoprotein reductions by lipid-lowering diets with different polyunsaturated: saturated fat values</TI>
<SO>British Journal of Nutrition</SO>
<YR>1983</YR>
<VL>50</VL>
<PG>531-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustafsson-1985" MODIFIED="2009-10-19 17:09:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gustafsson 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:09:54 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustafsson I, Vessby B, Karlstrom B, Boberg J, Boberg M, Lithell H</AU>
<TI>Effects on the serum lipoprotein concentrations by lipid-lowering diets with different fatty acid compositions</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1985</YR>
<VL>4</VL>
<PG>241-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustafsson-1992" MODIFIED="2009-10-19 17:09:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gustafsson 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:09:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/?FH" NOTES_MODIFIED="2009-10-19 17:09:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustafsson IB, Vessby B, Nydahl M</AU>
<TI>Effects of lipid lowering diets enriched with monounsaturated and polyunsaturated fatty acids on serum lipoprotein composition in patients with hypolipoproteinemia</TI>
<SO>Atherosclerosis</SO>
<YR>1992</YR>
<VL>96</VL>
<PG>109-18</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:09:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustafsson-1994" MODIFIED="2009-10-19 17:10:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gustafsson 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:10:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="1" NOTES_MODIFIED="2009-10-19 17:10:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustafsson I, Vessby B, Ohrvall M, Nydahl M</AU>
<TI>A diet rich in monounsaturated rapeseed oil reduces the lipoprotein cholesterol concentration and increases the relative content of n-3 fatty acids in serum in hyperlipidemic subjects</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>59</VL>
<PG>667-74</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gylling-1988" MODIFIED="2009-10-19 17:10:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Gylling 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:10:05 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RB1.CLI - Not RCT/CCT - included FH patients" NOTES_MODIFIED="2009-10-19 17:10:05 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gylling H, Miettinen TA</AU>
<TI>Serum non-cholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia</TI>
<SO>Clinica Chimica Acta; International Journal of Clinical Chemistry</SO>
<YR>1988</YR>
<VL>178</VL>
<PG>41-50</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gylling-2010" MODIFIED="2012-04-20 10:47:54 +0100" MODIFIED_BY="anita  s malhotra" NAME="Gylling 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-04-20 10:47:54 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gylling H , Hallikainen M, Nissinen MJ, Simonen P, Miettinen TA</AU>
<TI>Very high plant stanol intake and serum plant stanols and non-cholesterol sterols</TI>
<SO>European Journal of Nutrition</SO>
<YR>2010</YR>
<VL>49</VL>
<NO>2</NO>
<PG>111-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gylling-2011" MODIFIED="2012-08-16 15:48:15 +0100" MODIFIED_BY="anita  s malhotra" NAME="Gylling 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-08-16 15:48:15 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gylling H, Hallikainen M, Simonen P, Miettinen HE, Nissinen MJ, Miettinen TA</AU>
<TI>Serum and lipoprotein sitostanol and non-cholesterol sterols after an acute dose of plant stanol ester on its long-term consumption</TI>
<SO>European Journal of Nutrition</SO>
<YR>2011</YR>
<VL>51</VL>
<NO>5</NO>
<PG>615-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1989" MODIFIED="2013-08-11 12:42:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hansen 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-08-11 12:42:46 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R81.JOU INCORRECT REFERENCE" NOTES_MODIFIED="2013-08-11 12:42:46 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen JB, Olsen JO, Wilsgard L, Osterud P</AU>
<TI>Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis</TI>
<SO>Journal of Internal Medicine Suppl</SO>
<YR>1989</YR>
<VL>731</VL>
<PG>133-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1983a" MODIFIED="2009-10-19 17:10:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Harris 1983a" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:10:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET - Healthy volunteers" NOTES_MODIFIED="2009-10-19 17:10:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris WS, Connor WE, McMurry MP</AU>
<TI>The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oil</TI>
<SO>Metabolism</SO>
<YR>1983</YR>
<VL>32</VL>
<PG>179-84</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1988" MODIFIED="2009-10-19 17:10:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Harris 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:10:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="19" NOTES_MODIFIED="2009-10-19 17:10:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris WS, Dujovne CA, Zucker M, Johnson B</AU>
<TI>Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1988</YR>
<VL>109</VL>
<PG>465-70</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1989" MODIFIED="2009-10-19 17:10:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Harris 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:10:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QP501.JOU - review of trials - some involving FH patients" NOTES_MODIFIED="2009-10-19 17:10:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris WS</AU>
<TI>Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review</TI>
<SO>Journal of Lipid Research</SO>
<YR>1989</YR>
<VL>30</VL>
<PG>785-807</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hashim-1960" MODIFIED="2009-10-19 17:10:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hashim 1960" YEAR="1930">
<REFERENCE MODIFIED="2009-10-19 17:10:33 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hashim SA, Arteaga A, van Itallie TB</AU>
<TI>Effect of a saturated medium-chain triglyceride on serum lipids in man</TI>
<SO>Lancet</SO>
<YR>1930</YR>
<VL>1</VL>
<PG>1105-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hay-1982" MODIFIED="2009-10-19 17:10:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hay 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:10:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT" NOTES_MODIFIED="2009-10-19 17:10:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hay CRM, Durber AP, Saynor R</AU>
<TI>Effect of fish oil on platelet kinetics in patients with ischaemic heart disease</TI>
<SO>Lancet</SO>
<YR>1982</YR>
<VL>1</VL>
<PG>1269-72</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hegsted-1965" MODIFIED="2009-10-19 17:10:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hegsted 1965" YEAR="1965">
<REFERENCE MODIFIED="2009-10-19 17:10:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT mental health patients" NOTES_MODIFIED="2009-10-19 17:10:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hegsted DM, McGandy RB, Myers ML, Stare FJ</AU>
<TI>Quantitative effects of dietary fats on serum cholesterol in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1965</YR>
<VL>17</VL>
<PG>281-90</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hegsted-1986" MODIFIED="2009-10-19 17:10:45 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hegsted 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:10:45 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hegsted DM</AU>
<TI>Serum cholesterol response to dietary cholesterol: a re-evaluation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>44</VL>
<PG>299-305</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:45 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hegsted-1993" MODIFIED="2009-10-19 17:10:48 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hegsted 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:10:48 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="REVIEW" NOTES_MODIFIED="2009-10-19 17:10:48 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hegsted DM, Ausman LM, Johnson JA, Dallal GE</AU>
<TI>Dietary fat and serum lipids: an evaluation of the experimental data</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>57</VL>
<NO>6</NO>
<PG>875-83</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:48 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heinemann-1986" MODIFIED="2009-10-19 17:10:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Heinemann 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:10:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/?FH" NOTES_MODIFIED="2009-10-19 17:10:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heinemann T, Leiss O, von Bergmann K</AU>
<TI>Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia</TI>
<SO>Atherosclerosis</SO>
<YR>1986</YR>
<VL>61</VL>
<PG>219-23</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Helms-1977" MODIFIED="2009-10-19 17:10:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Helms 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:10:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH LETTER ONLY" NOTES_MODIFIED="2009-10-19 17:10:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helms P, Gatti E, Sirtori CR</AU>
<TI>Soybean protein diet and plasma cholesterol</TI>
<SO>Lancet</SO>
<YR>1977</YR>
<VL>1</VL>
<PG>805-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hennekens-1996" MODIFIED="2009-10-19 17:10:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hennekens 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:10:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:10:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hennekens CH, Buring JE, Manson JE, Stampfer MJ, Rosner B, Cook NR, et al</AU>
<TI>Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>1996</YR>
<VL>334</VL>
<PG>1145-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:10:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herold-1986" MODIFIED="2009-10-19 17:11:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Herold 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:11:02 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Review article" NOTES_MODIFIED="2009-10-19 17:11:02 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herold PM, Kinsella JE</AU>
<TI>Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>43</VL>
<PG>566-98</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hodges-1967" MODIFIED="2009-10-19 17:11:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hodges 1967" YEAR="1967">
<REFERENCE MODIFIED="2009-10-19 17:11:05 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:11:05 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hodges RE, Krehl WA, Stone DB, Lopez A</AU>
<TI>Dietary carbohydrates and low cholesterol diets - Effects on serum lipids in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1967</YR>
<VL>20</VL>
<PG>198</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoeg-1984" MODIFIED="2009-10-19 17:11:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hoeg 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:11:09 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoeg JM, Maher MB, Bou E, Zech LA, Bailey KR, Gregg RE, et al</AU>
<TI>Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin</TI>
<SO>Circulation</SO>
<YR>1984</YR>
<VL>70</VL>
<NO>6</NO>
<PG>1004-11</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holme-1990" MODIFIED="2009-10-19 17:11:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Holme 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:11:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.CIR - Meta-analysis of RCTs" NOTES_MODIFIED="2009-10-19 17:11:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holme I</AU>
<TI>An analysis of randomised trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence</TI>
<SO>Circulation</SO>
<YR>1990</YR>
<VL>82</VL>
<PG>1916-24</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holmes-1980" MODIFIED="2013-08-11 12:53:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Holmes 1980" YEAR="1980">
<REFERENCE MODIFIED="2013-08-11 12:53:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME INCORRECT REFERENCE" NOTES_MODIFIED="2013-08-11 12:53:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holmes WL, Rubel GB, Hood SS</AU>
<TI>Comparison of the effect of dietary meat versus dietary soybean protein on plasma lipids of hyperlipidemic individuals</TI>
<SO>Atherosclerosis</SO>
<YR>1980</YR>
<VL>36</VL>
<PG>379-387</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hooper-1980" MODIFIED="2009-10-19 17:11:29 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hooper 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:11:29 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:11:29 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hooper PL, Visconti L, Garry PJ, Johnson GE</AU>
<TI>Zinc lowers high density lipoprotein cholesterol levels</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1980</YR>
<VL>244</VL>
<PG>1960-1</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hopkins-1992" MODIFIED="2009-10-19 17:11:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hopkins 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:11:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="REVIEW" NOTES_MODIFIED="2009-10-19 17:11:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hopkins PN</AU>
<TI>Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>55</VL>
<PG>1060-70</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huff-1984" MODIFIED="2009-10-19 17:11:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Huff 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:11:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - RCT - ?include FH patients" NOTES_MODIFIED="2009-10-19 17:11:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huff MW, Giovannetti PM, Wolfe BM</AU>
<TI>Turn-over of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>39</VL>
<PG>888-97</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunninghake-1993" MODIFIED="2009-10-19 17:11:40 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hunninghake 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:11:40 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/?FH" NOTES_MODIFIED="2009-10-19 17:11:40 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, et al</AU>
<TI>The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>328</VL>
<NO>17</NO>
<PG>1213-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:40 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iacono-1991" MODIFIED="2009-10-19 17:11:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Iacono 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:11:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:11:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iacono JM, Dougherty RM</AU>
<TI>Lack of effect of linoleic acid on the high-density-lipoprotein-cholesterol fraction of plasma lipoproteins</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>53</VL>
<PG>660-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Illingworth-1991" MODIFIED="2009-10-19 17:11:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Illingworth 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:11:46 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Illingworth DR, Hatcher LF, Newcomb KC, Connor WE</AU>
<TI>Response to dietary cholesterol on a monounsaturated enriched low-fat diet [abstract]</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1991</YR>
<VL>11</VL>
<PG>1602(a)</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:46 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-1984" MODIFIED="2009-10-19 17:11:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jackson 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:11:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:11:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson RL, Kashyap ML, Barnhart RL, Allen C, Hogg E, Glueck CJ</AU>
<TI>Influence of polyunsaturated and saturated fats on plasma lipids and lipoproteins in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>39</VL>
<PG>589-97</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakubowski-1978" MODIFIED="2009-10-19 17:11:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jakubowski 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:11:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:11:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakubowski JA, Ardlie NG</AU>
<TI>Modification of human platelet function by a diet enriched in saturated or polyunsaturated fat</TI>
<SO>Atherosclerosis</SO>
<YR>1978</YR>
<VL>31</VL>
<PG>335-44</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1975a" MODIFIED="2009-10-19 17:11:59 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jenkins 1975a" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:11:59 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:11:59 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Leeds AR, Newton C, Cummings JH</AU>
<TI>Effect of pectin, guar gum and wheat fibre on serum cholesterol</TI>
<SO>Lancet</SO>
<YR>1975</YR>
<VL>1</VL>
<PG>1116</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:11:59 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1975b" MODIFIED="2009-10-19 17:12:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jenkins 1975b" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:12:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:12:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Hill MS, Cummings JH</AU>
<TI>Effect of wheat fiber on blood lipids, fecal steroid excretion and serum iron</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1975</YR>
<VL>28</VL>
<PG>1408</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1980" MODIFIED="2009-10-19 17:12:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jenkins 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:12:07 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT - FH patients" NOTES_MODIFIED="2009-10-19 17:12:07 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Reynold D, Slavin B, Leeds AR, Jenkins AL, Jepson EM</AU>
<TI>Treatment of hypercholesterolemia with guar crispbread</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1980</YR>
<VL>33</VL>
<PG>575</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jialal-1992" MODIFIED="2009-10-19 17:12:20 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jialal 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:12:20 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.JOU RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:12:20 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jialal I, Grundy SM</AU>
<TI>Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low-density lipoprotein</TI>
<SO>Journal of Lipid Research</SO>
<YR>1992</YR>
<VL>33</VL>
<PG>899-906</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:20 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jialal-1993" MODIFIED="2009-10-19 17:12:26 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Jialal 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:12:26 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:12:26 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jialal I, Grundy SM</AU>
<TI>Effect of combined supplementation with alpha-tocopherol, ascorbate and beta-carotene on low-density lipoprotein oxidation</TI>
<SO>Circulation</SO>
<YR>1993</YR>
<VL>88</VL>
<PG>2780-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:26 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joyner-1955" MODIFIED="2009-10-19 17:12:31 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Joyner 1955" YEAR="1955">
<REFERENCE MODIFIED="2009-10-19 17:12:31 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="MI/JR RCT/?FH" NOTES_MODIFIED="2009-10-19 17:12:31 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joyner CP, Kuo PT</AU>
<TI>The effect of sitosterol administration upon the serum cholesterol level and lipoprotein pattern</TI>
<SO>American Journal of Medical Science</SO>
<YR>1955</YR>
<VL>230</VL>
<PG>636</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:31 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Judd-1988" MODIFIED="2009-10-19 17:12:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Judd 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:12:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:12:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Judd JT, Oh SY, Hennig B, Dupont J, Marshall MW</AU>
<TI>Effects of low fat diets differing in degree of fat unsaturation on plasma lipids, lipoproteins and apolipoproteins in adult men</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1988</YR>
<VL>7</VL>
<PG>223-34</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kane-1981" MODIFIED="2009-10-19 17:12:39 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kane 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:12:39 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, et al</AU>
<TI>Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen</TI>
<SO>New England Journal of Medicine</SO>
<YR>1981</YR>
<VL>304</VL>
<NO>5</NO>
<PG>251-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:39 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kane-1990" MODIFIED="2009-10-19 17:12:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kane 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:12:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="15" NOTES_MODIFIED="2009-10-19 17:12:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ</AU>
<TI>Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimes</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1990</YR>
<VL>264</VL>
<PG>3007-12</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kestin-1989" MODIFIED="2009-10-19 17:12:47 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kestin 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:12:47 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:12:47 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kestin M, Rouse IL, Correll RA, Nestel PJ</AU>
<TI>Cardiovascular disease risk factors in free-living men: comparison of two prudent diets, one based on lactoovovegetarianism and the other allowing lean meat</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1989</YR>
<VL>50</VL>
<PG>280-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:47 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ketom_x00e4_ki-2004b" MODIFIED="2012-08-16 15:45:58 +0100" MODIFIED_BY="anita  s malhotra" NAME="Ketomäki 2004b" YEAR="2004">
<REFERENCE MODIFIED="2012-04-20 10:52:13 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ketomaki A, Gylling H, Miettinen TA</AU>
<TI>Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject</TI>
<SO>Journal of Laboratory and Clinical Clin Med</SO>
<YR>2004</YR>
<VL>143</VL>
<NO>4</NO>
<PG>255-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keys-1957" MODIFIED="2009-10-19 17:12:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Keys 1957" YEAR="1957">
<REFERENCE MODIFIED="2009-10-19 17:12:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:12:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keys A, Anderson JT, Grande F</AU>
<TI>Essential fatty acids, degree of unsaturation and effect of corn (maize) oil on the serum cholesterol level in man</TI>
<SO>Lancet</SO>
<YR>1957</YR>
<VL>1</VL>
<PG>66</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:12:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keys-1965a" MODIFIED="2009-10-19 17:13:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Keys 1965a" YEAR="1965">
<REFERENCE MODIFIED="2009-10-19 17:13:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET - Not RCT/CCT" NOTES_MODIFIED="2009-10-19 17:13:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keys A, Anderson JT, Grande F</AU>
<TI>Serum cholesterol response to changes in the diet IV. Particular saturated fatty acids in the diet</TI>
<SO>Metabolism</SO>
<YR>1965</YR>
<VL>14</VL>
<PG>776-87</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keys-1965b" MODIFIED="2009-10-19 17:13:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Keys 1965b" YEAR="1965">
<REFERENCE MODIFIED="2009-10-19 17:13:05 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET - Not RCT/CCT" NOTES_MODIFIED="2009-10-19 17:13:05 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keys A, Anderson JT, Grande E</AU>
<TI>Serum cholesterol response to changes in the diet. I. Iodine value of dietary fat vs 2S-P</TI>
<SO>Metabolism</SO>
<YR>1965</YR>
<VL>14</VL>
<PG>747-58</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keys-1984" MODIFIED="2009-10-19 17:13:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Keys 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:13:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not a trial - healthy subjects" NOTES_MODIFIED="2009-10-19 17:13:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keys A</AU>
<TI>Serum cholesterol response to dietary cholesterol</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>40</VL>
<PG>351-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khan-1981" MODIFIED="2009-10-19 17:13:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Khan 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:13:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME RCT/HEALTHY SUBJECT" NOTES_MODIFIED="2009-10-19 17:13:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan AR, Khan GY, Mitchel A, Quadeer MA</AU>
<TI>Effect of guar gum on blood lipids</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<PG>2446</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kingsbury-1961" MODIFIED="2009-10-19 17:13:16 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kingsbury 1961" YEAR="1961">
<REFERENCE MODIFIED="2009-10-19 17:13:16 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:13:16 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kingsbury KJ, Morgan DM, Aylott C, Emmerson R</AU>
<TI>Effects of ethyl arachidonate, cod liver oil and corn oil on the plasma cholesterol level</TI>
<SO>Lancet</SO>
<YR>1961</YR>
<VL>1</VL>
<PG>739-41</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:16 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kinsell-1952" MODIFIED="2009-10-19 17:13:21 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kinsell 1952" YEAR="1952">
<REFERENCE MODIFIED="2009-10-19 17:13:21 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC648.A1.JOU - Letter, not RCT/CCT" NOTES_MODIFIED="2009-10-19 17:13:21 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kinsell LW, Partridge J, Boling L, Margen S, Michaels G</AU>
<TI>Dietary modification of serum cholesterol and phospholipid levels</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1952</YR>
<VL>12</VL>
<PG>909-13</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:21 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirby-1981" MODIFIED="2009-10-19 17:13:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kirby 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:13:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RM214.AME RCT/?FH" NOTES_MODIFIED="2009-10-19 17:13:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirby RW, Anderson JW, Sieling B, Rees ED, Chen WJ, Miller RE, et al</AU>
<TI>Oat-bran selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<NO>5</NO>
<PG>824-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kok-1987" MODIFIED="2009-10-19 17:13:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kok 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:13:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RETROSPECTIVE STUDY" NOTES_MODIFIED="2009-10-19 17:13:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, Van Laar A, de Bruin M, et al</AU>
<TI>Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1987</YR>
<VL>45</VL>
<NO>2</NO>
<PG>462-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kris_x002d_Etherton-1993" MODIFIED="2009-10-19 17:13:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kris-Etherton 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:13:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:13:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kris-Etherton PM, Derr J, Mitchell DC, Mustad VA, Russell ME, McDonnell ET, et al</AU>
<TI>The role of fatty acid saturation on plasma lipids, lipoproteins and apolipoproteins. I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter and milk chocolate on the plasma lipids of young men</TI>
<SO>Metabolism</SO>
<YR>1993</YR>
<VL>42</VL>
<NO>1</NO>
<PG>121-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kromhout-1985" MODIFIED="2009-10-19 17:13:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kromhout 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:13:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:13:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kromhout D, Bosschieter EB, Coulnader CL</AU>
<TI>The inverse relation between fish consumption and 20-year mortality from coronary heart disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>1985</YR>
<VL>312</VL>
<NO>19</NO>
<PG>1205-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kudchodkar-1976" MODIFIED="2009-10-19 17:13:40 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kudchodkar 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-10-19 17:13:40 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT" NOTES_MODIFIED="2009-10-19 17:13:40 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kudchodkar BJ, Horlick L, Sodhi HS</AU>
<TI>Effect of plant sterols on cholesterol metabolism in man</TI>
<SO>Atherosclerosis</SO>
<YR>1976</YR>
<VL>23</VL>
<PG>239-48</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:40 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuo-1979" MODIFIED="2009-10-19 17:13:45 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kuo 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:13:45 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="6" NOTES_MODIFIED="2009-10-19 17:13:45 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuo PT, Hayase K, Kostis JB, Moreyra AE</AU>
<TI>Use of combined diet and colestipol in long-term (7-7.5 years) treatment of patients with type II hyperlipoproteinemia</TI>
<SO>Circulation</SO>
<YR>1979</YR>
<VL>59</VL>
<PG>199-211</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:45 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuo-1981" MODIFIED="2009-10-19 17:13:49 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kuo 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:13:49 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/FH" NOTES_MODIFIED="2009-10-19 17:13:49 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuo PT, Kostis JB, Morayra AE, Hayes JA</AU>
<TI>Familial type II hyperlipoproteinemia with coronary heart disease. Effect of diet-cholesterol-nicotinic acid treatment</TI>
<SO>Chest</SO>
<YR>1981</YR>
<VL>79</VL>
<PG>286-91</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:13:49 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuusi-1985" MODIFIED="2009-10-19 17:14:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kuusi 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:14:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.JOU RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:14:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuusi T, Ehnholm C, Huttunen JK, Kostiainen E, Pietinen P, Leino U, et al</AU>
<TI>Concentration and composition of serum lipoproteins during a low fat diet at two levels of polyunsaturated fat</TI>
<SO>Journal of Lipid Research</SO>
<YR>1985</YR>
<VL>26</VL>
<NO>3</NO>
<PG>360-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laine-1982" MODIFIED="2009-10-28 09:22:12 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Laine 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-28 09:22:12 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-28 09:22:12 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laine DC, Snodgrass CM, Dawson EA, Ener MA, Kuba K, Frantz ID</AU>
<TI>Lightly hydrogenated soy oil versus other vegetable oils as a lipid lowering dietary constituent</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1982</YR>
<VL>35</VL>
<PG>683-90</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:06 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lambert-1996" MODIFIED="2009-10-19 17:14:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lambert 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:14:12 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lambert M, Lupien PJ, Gagne C, Levy E, Blaichman S, Langlois S, et al</AU>
<TI>Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadaian Lovastatin in Children Study Group</TI>
<SO>Pediatrics</SO>
<YR>1996</YR>
<VL>97</VL>
<PG>619-28</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leaf-1988" MODIFIED="2009-10-19 17:14:37 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Leaf 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:14:37 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:14:37 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leaf A, Weber PC</AU>
<TI>Cardiovascular effects of n-3 fatty acids</TI>
<SO>New England Journal of Medicine</SO>
<YR>1988</YR>
<VL>318</VL>
<PG>549-57</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:37 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leelarthaepin-1974" MODIFIED="2009-10-19 17:14:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Leelarthaepin 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-10-19 17:14:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT - FH" NOTES_MODIFIED="2009-10-19 17:14:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leelarthaepin B, Palmer AJ, Woodhill JM, Blacket RB</AU>
<TI>Obesity, diet and type II hyperlipidemia</TI>
<SO>Lancet</SO>
<YR>1974</YR>
<VL>2</VL>
<PG>1217-21</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lees-1977" MODIFIED="2009-10-19 17:14:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lees 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:14:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.ATH NOT RCT/CCT-FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:14:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lees AM, Mok HYI, McCluskey MA, Grundy SM</AU>
<TI>Plant sterols as cholesterol lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance</TI>
<SO>Atherosclerosis</SO>
<YR>1977</YR>
<VL>28</VL>
<PG>325-38</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leibman-1983" MODIFIED="2009-10-19 17:14:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Leibman 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:14:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - CCT not FH" NOTES_MODIFIED="2009-10-19 17:14:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leibman M, Smith MC, Iverson J, Thye FW, Hinkle DE, Herbert WG, et al</AU>
<TI>Effects of coarse wheat bran fiber and exercise on plasma lipids and lipoproteins in moderately overweight men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>37</VL>
<PG>71</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LeLorier-1977" MODIFIED="2009-10-19 17:14:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="LeLorier 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:14:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="12" NOTES_MODIFIED="2009-10-19 17:14:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LeLorier J, DuBreuil-Quidoz S, Lussier-Cacan S, Huang YS, Davignon J</AU>
<TI>Additive effects on plasma cholesterol concentrations in patients with familial type II hyperlipoproteinemia</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1977</YR>
<VL>137</VL>
<PG>1429-34</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-1981" MODIFIED="2009-10-19 17:14:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lewis 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:14:57 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lewis B, Hammett F, Katan M, Merkx I, Miller NE, Kay RM, et al</AU>
<TI>Towards an improved lipid lowering diet: additive effects of changes in nutrient intake</TI>
<SO>Lancet</SO>
<YR>1981</YR>
<VL>ii</VL>
<PG>1310</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:14:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lichtenstein-1994" MODIFIED="2009-10-19 17:15:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lichtenstein 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:15:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/?FH" NOTES_MODIFIED="2009-10-19 17:15:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ</AU>
<TI>Short term consumption of a reduced fat diet beneficially affects plasma lipid concentrations only when accompanied by weight loss</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1994</YR>
<VL>14</VL>
<PG>1751-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lifshitz-1989" MODIFIED="2009-10-19 17:15:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lifshitz 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:15:07 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT - GOOD BACKGROUNG INFO" NOTES_MODIFIED="2009-10-19 17:15:07 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lifshitz F, Moses N</AU>
<TI>Growth failure: a complication of dietary treatment of hypercholesterolemia</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1989</YR>
<VL>143</VL>
<PG>537-42</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindgard-1984" MODIFIED="2009-10-19 17:15:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lindgard 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:15:10 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/FH" NOTES_MODIFIED="2009-10-19 17:15:10 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindgard F, Larsson L</AU>
<TI>Effects of a concentrated bran fibre preparation on HDL-cholesterol in hypercholesterolaemic men</TI>
<SO>Human Nutrition Clinical Nutrition</SO>
<YR>1984</YR>
<VL>38C</VL>
<PG>39</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linnebur-2007" MODIFIED="2012-04-20 10:54:48 +0100" MODIFIED_BY="anita  s malhotra" NAME="Linnebur 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-04-20 10:54:48 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH</AU>
<TI>Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations</TI>
<SO>Journal of Clinical Lipidology</SO>
<YR>2007</YR>
<VL>1</VL>
<NO>6</NO>
<PG>626-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lithell-1984" MODIFIED="2009-10-19 17:15:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lithell 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:15:14 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lithell H, Selinus I, Vessby B</AU>
<TI>Lack of effect of a purified bran preparation in men with low HDL cholesterol</TI>
<SO>Human Nutrition Clinical Nutrition</SO>
<YR>1984</YR>
<VL>38</VL>
<PG>309-13</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lorenz-1983" MODIFIED="2009-10-19 17:15:29 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lorenz 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:15:29 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR NOT RCT/HEALTHY VOLUNTEERS" NOTES_MODIFIED="2009-10-19 17:15:29 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorenz R, Spengler U, Fischer S, Drum J, Weber PC</AU>
<TI>Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil</TI>
<SO>Circulation</SO>
<YR>1983</YR>
<VL>67</VL>
<PG>504-11</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lovati-1987" MODIFIED="2009-10-19 17:15:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Lovati 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:15:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - RCT - ?included FH patients" NOTES_MODIFIED="2009-10-19 17:15:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lovati MR, Manzoni C, Canavesi A, Sirtori M, Vaccarino V, Marchi M, et al</AU>
<TI>Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1987</YR>
<VL>80</VL>
<NO>5</NO>
<PG>1498-502</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LRCP-1984a" MODIFIED="2009-10-19 17:15:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="LRCP 1984a" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:15:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU RCT/FH - DRUG VS PLACEBO" NOTES_MODIFIED="2009-10-19 17:15:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lipid Research Clinics Program</AU>
<TI>The Lipid Research Clinics Coronary Primary Intervention Trials results II. The relationship in incidence of coronary heart disease to cholesterol lowering</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1984</YR>
<VL>251</VL>
<PG>351-74</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LRCP-1984b" MODIFIED="2009-10-19 17:15:40 +0100" MODIFIED_BY="Nikki Jahnke" NAME="LRCP 1984b" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:15:40 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU RCT/FH - DRUGS VS PLACEBO" NOTES_MODIFIED="2009-10-19 17:15:40 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lipid Research Clinics Program</AU>
<TI>The Lipid Research Clinics Coronary Prevention Trial results I. Reduction in incidence of coronary heart disease</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1984</YR>
<VL>251</VL>
<PG>351</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:40 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Macdonald-1967" MODIFIED="2009-10-19 17:15:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Macdonald 1967" YEAR="1967">
<REFERENCE MODIFIED="2009-10-19 17:15:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not RCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:15:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Macdonald I</AU>
<TI>Interrelationships between the influence of dietary carbohydrates and fats on fasting serum lipids</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1967</YR>
<VL>20</VL>
<PG>345-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mackness-1993" MODIFIED="2009-10-19 17:15:48 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mackness 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:15:48 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP501.BIO NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:15:48 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mackness MI, Abbott C, Arrol S, Durrington PN</AU>
<TI>The role of high density lipoprotein and lipid soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation</TI>
<SO>Biochemical Journal</SO>
<YR>1993</YR>
<VL>294</VL>
<PG>829-34</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:48 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malmros-1957" MODIFIED="2009-10-19 17:15:51 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Malmros 1957" YEAR="1957">
<REFERENCE MODIFIED="2009-10-19 17:15:51 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT - FH" NOTES_MODIFIED="2009-10-19 17:15:51 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malmros H, Wigand G</AU>
<TI>The effect on serum cholesterol of diets containing different fats</TI>
<SO>Lancet</SO>
<YR>1957</YR>
<VL>2</VL>
<PG>1-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:51 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mannarinno-2009" MODIFIED="2012-04-20 10:55:58 +0100" MODIFIED_BY="anita  s malhotra" NAME="Mannarinno 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-04-20 10:55:58 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mannarino E, Pirro M, Cortese C, Lupattelli G, Siepi D, Mezzetti A, et al</AU>
<TI>Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study</TI>
<SO>Nutrition, Metabolism &amp; Cardiovascular Diseases</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>2</NO>
<PG>84-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maranhao-1983" MODIFIED="2009-10-19 17:15:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Maranhao 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:15:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/?INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:15:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maranhao RC, Quintao E</AU>
<TI>Long term steroid metabolism balance studies in subjects on cholesterol-free and cholesterol-rich diets: comparison between normal and hypercholesterolemic individuals</TI>
<SO>Journal of Lipid Research</SO>
<YR>1983</YR>
<VL>24</VL>
<PG>167-73</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marshall-1986" MODIFIED="2009-10-28 09:22:30 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Marshall 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-28 09:22:30 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-28 09:22:30 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marshall MW, Judd JT, Matusik EJ, Church J, Canary JJ</AU>
<TI>Effects of low fat diets varying in P/S ratio on nutrient intakes, fecal excretion, blood chemistry profiles, and fatty acids of adult men</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1986</YR>
<VL>5</VL>
<PG>263-79</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:15:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mata-1992" MODIFIED="2009-10-19 17:16:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mata 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:16:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:16:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mata P, Garrido JA, Ordovas JM, Blazquez E, Alvarez-Sala LA, Rubio MJ, et al</AU>
<TI>Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>56</VL>
<NO>1</NO>
<PG>77-83</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathur-1968" MODIFIED="2009-10-19 17:16:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mathur 1968" YEAR="1968">
<REFERENCE MODIFIED="2009-10-19 17:16:07 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:16:07 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathur KS, Khan MA, Sharma RD</AU>
<TI>Hypocholesterolemic effect of Bengal Gram: A long term study in man</TI>
<SO>British Medical Journal</SO>
<YR>1968</YR>
<VL>1</VL>
<PG>30-1</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattson-1972" MODIFIED="2009-10-19 17:16:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mattson 1972" YEAR="1972">
<REFERENCE MODIFIED="2009-10-19 17:16:10 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Healthy prisoners" NOTES_MODIFIED="2009-10-19 17:16:10 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mattson FH, Erickson BA, Kligman AM</AU>
<TI>Effect of dietary cholesterol on serum cholesterol in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1972</YR>
<VL>25</VL>
<PG>589-94</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:10 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattson-1975" MODIFIED="2009-10-19 17:16:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mattson 1975" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:16:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RM214.AME CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:16:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mattson FH, Hollenback EJ, Kligman AM</AU>
<TI>Effect of hydrogenated fat on the plasma cholesterol and triglyceride levels of man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1975</YR>
<VL>28</VL>
<PG>726-31</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattson-1977" MODIFIED="2009-10-19 17:16:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mattson 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:16:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RM214.JOU RATS" NOTES_MODIFIED="2009-10-19 17:16:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mattson FH, Volpenhein RA, Erickson BA</AU>
<TI>Effect of plant sterol esters on the absorption of dietary cholesterol</TI>
<SO>Journal of Nutrition</SO>
<YR>1977</YR>
<VL>107</VL>
<PG>1139-46</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattson-1982" MODIFIED="2009-10-19 17:16:23 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mattson 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:16:23 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME NOT RCT" NOTES_MODIFIED="2009-10-19 17:16:23 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mattson FH, Grundy SM, Crouse JR</AU>
<TI>Optomizing the effect of plant sterols on cholesterol absorption in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1982</YR>
<VL>35</VL>
<PG>697-700</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:23 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattson-1985" MODIFIED="2009-10-19 17:16:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mattson 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:16:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QP501.JOU - RCT - ?included FH patients" NOTES_MODIFIED="2009-10-19 17:16:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Mattson FH, Grundy SM</AU>
<TI>Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man</TI>
<SO>Journal of Lipid Research</SO>
<YR>1985</YR>
<VL>26</VL>
<PG>194-202</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCombs-1994" MODIFIED="2009-10-19 17:16:47 +0100" MODIFIED_BY="Nikki Jahnke" NAME="McCombs 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:16:47 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.NEW - CCT of FH patients with healthy controls" NOTES_MODIFIED="2009-10-19 17:16:47 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCombs RJ, Marcadis DE, Ellis J, Weinberg RB</AU>
<TI>Attenuated hypercholesterolemic response to a high cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>331</VL>
<PG>706-10</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:47 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McGill-1979" MODIFIED="2009-10-19 17:16:51 +0100" MODIFIED_BY="Nikki Jahnke" NAME="McGill 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:16:51 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:16:51 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McGill HC</AU>
<TI>The relationship of dietary cholesterol to serum cholesterol concentration and to atherosclerosis in man</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<PG>2664-702</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:16:51 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mellies-1983" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mellies 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="Need to contact authors for additional data" NOTES_MODIFIED="2009-07-20 15:13:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mellies JM, Jandacek RJ, Taulbee JD, Tewksbury MB, Lamkin G, Baehler L, et al</AU>
<TI>A double-blind, placebo-controlled study of sucrose polyester in hypercholesterolemic outpatients</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>37</VL>
<PG>339-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mensink-1992" MODIFIED="2009-10-19 17:17:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mensink 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:17:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR META-ANALYSIS" NOTES_MODIFIED="2009-10-19 17:17:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Mensink RP, Katan MB</AU>
<TI>Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<PG>911-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1972" MODIFIED="2013-08-11 12:59:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1972" YEAR="1972">
<REFERENCE MODIFIED="2013-08-11 12:59:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - CCT (cross-over) but ?not FH (non-consenting mental health patients)" NOTES_MODIFIED="2013-08-11 12:59:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen M, Turpeinen O, Karvonen MJ, Elosno R, Paavilainen E</AU>
<TI>Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. A twelve-year clinical trial in men and women</TI>
<SO>Lancet</SO>
<YR>1972</YR>
<VL>2</VL>
<PG>835</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1977" MODIFIED="2009-10-19 17:17:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:17:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:17:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Miettinen TA, Tarpila S</AU>
<TI>Effects of pectin on serum cholesterol, fecal bile acids and biliary lipids in normolipidemic and hyperlipidemic individuals</TI>
<SO>Clinica Chimica Acta</SO>
<YR>1977</YR>
<VL>79</VL>
<PG>471-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1989a" MODIFIED="2009-10-19 17:17:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1989a" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:17:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R850.A1.MET NOT RCT/CCT - RANDOM SELECTION OF VOLUNTEERS" NOTES_MODIFIED="2009-10-19 17:17:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen TA, Tilvis RS, Kesaniemi YA</AU>
<TI>Serum cholesterol and plant sterol levels in relation to cholesterol metabolism in middle aged men</TI>
<SO>Metabolism</SO>
<YR>1989</YR>
<VL>38</VL>
<PG>136-40</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1989b" MODIFIED="2009-10-19 17:17:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1989b" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:17:15 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not RCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:17:15 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen TA</AU>
<TI>Serum plant sterols and their relation to cholesterol absorption</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1989</YR>
<VL>49</VL>
<PG>629-35</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1992a" MODIFIED="2013-08-11 13:08:20 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1992a" YEAR="1992">
<REFERENCE MODIFIED="2013-08-11 13:08:20 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="INCORRECT REFERENCE" NOTES_MODIFIED="2013-08-11 13:08:20 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen TA, Gylling H, Vanhanen HT, Ollus A</AU>
<TI>Cnolesterol absorption, elimination and synthesis related to LDL kinetics during varying fat intake in men with differentapoprotein E phenotypes</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<PG>1044-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:20 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1992b" MODIFIED="2009-10-19 17:17:23 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1992b" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:17:23 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR ?RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:17:23 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen TA, Gylling H, Vanhanen HT, Ollus A</AU>
<TI>Cholesterol absorption, elimination and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<NO>9</NO>
<PG>1044-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:23 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miettinen-1994" MODIFIED="2009-10-19 17:17:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miettinen 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:17:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/FH" NOTES_MODIFIED="2009-10-19 17:17:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miettinen TA, Vanhanen HT</AU>
<TI>Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes</TI>
<SO>Atherosclerosis</SO>
<YR>1994</YR>
<VL>105</VL>
<PG>217-26</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1988" MODIFIED="2009-10-19 17:17:31 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Miller 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:17:31 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RB1.CLI RCT/HYPERTRIGLYCERIDE PATIENTS" NOTES_MODIFIED="2009-10-19 17:17:31 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller JP, Heath ID, Choraria SK, Shepherd NW, Cajendragadkar RV, Harcus AW, et al</AU>
<TI>Triglyceride lowering effect of MaxEPA fish lipid concentrate: a multicentre placebo controlled double blind study</TI>
<SO>Clinica Chimica Acta</SO>
<YR>1988</YR>
<VL>178</VL>
<NO>3</NO>
<PG>251-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:31 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mokino-1990" MODIFIED="2009-10-19 17:17:35 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Mokino 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:17:35 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/FH" NOTES_MODIFIED="2009-10-19 17:17:35 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mokino H, Yamada N, Sugimoto T, et al</AU>
<TI>Cholesterol free diet with a high ratio of polyunsaturated to saturated fatty acids in heterozygous familial hypercholesterolemia: significant lowering effect on plasma cholesterol</TI>
<SO>Hormone and Metabolic Research</SO>
<YR>1990</YR>
<VL>22</VL>
<PG>246-51</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:35 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morita-1983" MODIFIED="2009-10-19 17:17:48 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Morita 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:17:48 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QP751.LIP RATS" NOTES_MODIFIED="2009-10-19 17:17:48 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morita I, Saito Y, Chang WC, Murota S</AU>
<TI>Effects of purified eicosapentaenoic acid or arachidonic acid metabolism in cultured murine aortic smooth muscle cells, vessel walls and platelets</TI>
<SO>Lipids</SO>
<YR>1983</YR>
<VL>18</VL>
<NO>1</NO>
<PG>1842-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:48 +0100" MODIFIED_BY="Nikki Jahnke">
<IDENTIFIER MODIFIED="2009-10-19 17:17:48 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="MEDLINE" VALUE="237"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MRC-1965" MODIFIED="2009-10-19 17:17:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="MRC 1965" YEAR="1965">
<REFERENCE MODIFIED="2009-10-19 17:17:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/POST MI" NOTES_MODIFIED="2009-10-19 17:17:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Research Committee to the MRC</AU>
<TI>Low fat diet in myocardial infarction: A controlled trial</TI>
<SO>Lancet</SO>
<YR>1965</YR>
<VL>2</VL>
<PG>501-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MRC-1968" MODIFIED="2009-10-19 17:17:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="MRC 1968" YEAR="1968">
<REFERENCE MODIFIED="2009-10-19 17:17:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/POST MI" NOTES_MODIFIED="2009-10-19 17:17:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Research Committee to the MRC</AU>
<TI>Controlled trial of soybean oil in myocardial infarction</TI>
<SO>Lancet</SO>
<YR>1968</YR>
<VL>2</VL>
<PG>693-700</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:17:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nagakawa-1983" MODIFIED="2009-10-19 17:18:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nagakawa 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:18:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.ATH NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:18:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nagakawa Y, Orimo H, Harasawa M, Morita I, Yashiri K, Murota S</AU>
<TI>Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man</TI>
<SO>Atherosclerosis</SO>
<YR>1983</YR>
<VL>47</VL>
<PG>71-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Napoli-1998" MODIFIED="2009-10-19 17:18:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Napoli 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-10-19 17:18:04 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Napoli C, Leccese M, Palumbo G, de Nigris F, Chiariello P, Zuliani P, et al</AU>
<TI>Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia</TI>
<SO>Coronary Artery Disease</SO>
<YR>1998</YR>
<VL>9</VL>
<PG>257-64</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NDHSRG-1968" MODIFIED="2009-10-19 17:18:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="NDHSRG 1968" YEAR="1968">
<REFERENCE MODIFIED="2009-10-19 17:18:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.CIR RCT/HEALTHY VOLUNTEERS" NOTES_MODIFIED="2009-10-19 17:18:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>National Diet-Heart Study Research Group</AU>
<TI>The National Diet-Heart Study Final Report</TI>
<SO>Circulation</SO>
<YR>1968</YR>
<VL>1 Suppl 1</VL>
<PG>1-428</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neil-1995" MODIFIED="2009-10-19 17:18:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Neil 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:18:17 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neil HA, Roe L, Godlee RL, Moore JW, Clark GM, Brown J</AU>
<TI>Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins and antioxidants</TI>
<SO>British Medical Journal</SO>
<YR>1995</YR>
<VL>310</VL>
<PG>569-73</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nenseter-1992" MODIFIED="2009-10-19 17:18:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nenseter 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:18:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:18:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nenseter MS, Rustan AC, Lund-Katz S, Maelandsmo G, Phillips MC, Drevon CA</AU>
<TI>Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<PG>369-79</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nessim-1983" MODIFIED="2009-10-19 17:18:26 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nessim 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:18:26 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nessim SA, Chin HP, Alaupovic P, Blankenhorn DH</AU>
<TI>Combined therapy of niacin, colestipol and fat controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins</TI>
<SO>Arteriosclerosis</SO>
<YR>1983</YR>
<VL>3</VL>
<PG>568-73</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:26 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1973" MODIFIED="2009-10-19 17:18:30 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1973" YEAR="1973">
<REFERENCE MODIFIED="2009-10-19 17:18:30 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:18:30 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel P, Havenstein N, Whyte HM, Scott TJ, Cook LJ</AU>
<TI>Lowering of plasma cholesterol and enhanced sterol excretion with the consumption of polyunsaturated ruminant fats</TI>
<SO>New England Journal of Medicine</SO>
<YR>1973</YR>
<VL>288</VL>
<PG>379-82</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:30 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1976" MODIFIED="2009-10-19 17:18:34 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-10-19 17:18:34 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET NOT RCT/?FH" NOTES_MODIFIED="2009-10-19 17:18:34 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel P, Poyser A</AU>
<TI>Changes in cholesterol synthesis and excretion when cholesterol intake is increased</TI>
<SO>Metabolism</SO>
<YR>1976</YR>
<VL>25</VL>
<PG>1591-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:34 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1984" MODIFIED="2009-10-19 17:18:38 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:18:38 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - Not RCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:18:38 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R</AU>
<TI>Suppression by diets rich in fish oil of very low density lipoprotein production in man</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1984</YR>
<VL>74</VL>
<PG>82-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1986" MODIFIED="2009-10-19 17:18:43 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:18:43 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:18:43 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel P</AU>
<TI>Fish oil attenuates the cholesterol rise in lipoprotein cholesterol</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>43</VL>
<PG>752-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:43 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1992a" MODIFIED="2009-10-19 17:18:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1992a" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:18:46 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/?INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:18:46 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel P, Noakes M, Belling B</AU>
<TI>Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet</TI>
<SO>Journal of Lipid Research</SO>
<YR>1992</YR>
<VL>33</VL>
<PG>1029-36</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:46 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nestel-1992b" MODIFIED="2009-10-19 17:18:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nestel 1992b" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:18:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT - NOT FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:18:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nestel PJ, Noakes M, Belling GB, MacArthur R, Clifton PM, Abbey M</AU>
<TI>Plasma cholesterol-lowering potential of edible-oil blends suitable for commercial use</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>55</VL>
<PG>46-50</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nilson-1991" MODIFIED="2009-10-19 17:18:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nilson 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:18:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/CABG PATIENTS" NOTES_MODIFIED="2009-10-19 17:18:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nilson DW, Dalaker K, Nordoy A, Osterud B, Ingedretsen OC, Lyngmo V, et al</AU>
<TI>Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery</TI>
<SO>Thrombosis and Haemostasis</SO>
<YR>1991</YR>
<VL>66</VL>
<PG>195-201</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nydahl-1994" MODIFIED="2009-10-19 17:18:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nydahl 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:18:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - ?FH patients and ?RCT (cross-over)" NOTES_MODIFIED="2009-10-19 17:18:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nydahl M, Gustafsson IB, Vessby B</AU>
<TI>Lipid-lowering diets enriched with monounsaturated and polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid concentrations in hyperlipidemic patients</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>59</VL>
<PG>115-22</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:18:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nyyssonen-1994" MODIFIED="2009-10-19 17:19:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Nyyssonen 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:19:02 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:19:02 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nyyssonen K, Porkkala E, Salonen R, Korpela H, Salonen JT</AU>
<TI>Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomised double-blind placebo controlled clinical trial</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>48</VL>
<PG>633-42</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olszewski-1993" MODIFIED="2009-10-19 17:19:07 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Olszewski 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:19:07 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olszewski AJ, McCully KS</AU>
<TI>Fish oil decreases serum homocysteine in hyperlipemic men</TI>
<SO>Coronary Artery Disease</SO>
<YR>1993</YR>
<VL>4</VL>
<PG>53-60</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:07 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Omenn-1996" MODIFIED="2009-10-19 17:19:11 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Omenn 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:19:11 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/ NOT FH" NOTES_MODIFIED="2009-10-19 17:19:11 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al</AU>
<TI>Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>1996</YR>
<VL>334</VL>
<PG>1150-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:11 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ordovas-1995" MODIFIED="2009-10-19 17:19:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ordovas 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:19:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR REVIEW" NOTES_MODIFIED="2009-10-19 17:19:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH, Schaefer EJ</AU>
<TI>Gene-diet interaction in determining plasma lipid response to dietary intervention</TI>
<SO>Atherosclerosis</SO>
<YR>1995</YR>
<VL>118 (Suppl)</VL>
<PG>S11-27</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parks-1990" MODIFIED="2009-10-19 17:19:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Parks 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:19:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR REVIEW OF ANIMAL STUDIES" NOTES_MODIFIED="2009-10-19 17:19:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parks JS, Rudel LL</AU>
<TI>Effect of fish oil on atherosclerosis and lipoprotein metabolism</TI>
<SO>Atherosclerosis</SO>
<YR>1990</YR>
<VL>84</VL>
<PG>83-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parthasarathy-1990" MODIFIED="2009-10-19 17:19:21 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Parthasarathy 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:19:21 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="Q1.PRO RABBITS" NOTES_MODIFIED="2009-10-19 17:19:21 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D</AU>
<TI>Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis</TI>
<SO>Proceedings of the National Academy of Sciences</SO>
<YR>1990</YR>
<VL>87</VL>
<PG>3894-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:21 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peto-1985" MODIFIED="2009-10-19 17:19:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Peto 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:19:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR REVIEW OF TRIALS - NO INFO" NOTES_MODIFIED="2009-10-19 17:19:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peto R, Yusuf S, Collins R</AU>
<TI>Cholesterol lowering trial results in their epidemiological context [abstract]</TI>
<SO>Circulation</SO>
<YR>1985</YR>
<VL>72 (Suppl III)</VL>
<PG>III-451</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phillipson-1985" MODIFIED="2009-10-19 17:19:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Phillipson 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:19:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - CCT/?RCT - includes some FH patients" NOTES_MODIFIED="2009-10-19 17:19:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR</AU>
<TI>Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1985</YR>
<VL>312</VL>
<PG>1210-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pirich-1999" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Pirich 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pirich C, Caszo A, Granegger S, Sinzinger H</AU>
<TI>Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients</TI>
<SO>Thrombosis Research</SO>
<YR>1999</YR>
<VL>96</VL>
<PG>219-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Princen-1995" MODIFIED="2009-10-19 17:19:52 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Princen 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-10-19 17:19:52 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR ?NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:19:52 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Princen HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Popple G, Gevers Leuven JA, et al</AU>
<TI>Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women</TI>
<SO>Arteriosclerosis, Thrombosis, and Vascular Biology</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>325-33</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:52 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quintao-1971" MODIFIED="2009-10-19 17:19:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Quintao 1971" YEAR="1971">
<REFERENCE MODIFIED="2009-10-19 17:19:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/?INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:19:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quintao E, Grundy SM, Ahrens EH</AU>
<TI>Effects of dietary cholesterol on the regulation of total body cholesterol in man</TI>
<SO>Journal of Lipid Research</SO>
<YR>1971</YR>
<VL>12</VL>
<PG>233-47</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:19:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Radack-1989" MODIFIED="2009-10-19 17:20:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Radack 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:20:00 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="14" NOTES_MODIFIED="2009-10-19 17:20:00 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Radack K, Deck C, Huster D</AU>
<TI>Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1989</YR>
<VL>111</VL>
<PG>757-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Radack-1990" MODIFIED="2009-10-19 17:20:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Radack 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:20:05 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Radack K, Deck C, Huster D</AU>
<TI>The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1990</YR>
<VL>9</VL>
<PG>352-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:05 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rapola-1996" MODIFIED="2009-10-19 17:20:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Rapola 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:20:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU RCT/?FH" NOTES_MODIFIED="2009-10-19 17:20:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rapola JM, Virtamo J, Haukka JK, Heinonen OP, Albanes D, Taylor PR, et al</AU>
<TI>Effect of vitamin E and beta-carotene on the incidence of angina pectoris: a randomised, double blind controlled trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1996</YR>
<VL>275</VL>
<PG>693-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reaven-1991" MODIFIED="2009-10-19 17:20:14 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reaven 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:20:14 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:20:14 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, et al</AU>
<TI>Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>54</VL>
<PG>701-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:14 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reaven-1993a" MODIFIED="2009-10-19 17:20:16 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reaven 1993a" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:20:16 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/?FH" NOTES_MODIFIED="2009-10-19 17:20:16 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reaven PD, Witztum JL</AU>
<TI>Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans: effects on lipid levels and lipoprotein susceptibility to oxidation</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1993</YR>
<VL>13</VL>
<PG>601-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:16 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reaven-1993b" MODIFIED="2009-10-19 17:20:22 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reaven 1993b" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:20:22 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.JOU RCT/?FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:20:22 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL</AU>
<TI>Effects of oleate-rich and linoleate-rich diets on the susceptibility of low-density lipoprotein to oxidative modification in mildly hypercholesterolaemic subjects</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1993</YR>
<VL>91</VL>
<PG>668-76</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:22 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reaven-1993c" MODIFIED="2009-10-19 17:20:26 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reaven 1993c" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:20:26 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/?NOT FH" NOTES_MODIFIED="2009-10-19 17:20:26 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL</AU>
<TI>Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1993</YR>
<VL>13</VL>
<PG>590-600</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:26 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reaven-1994" MODIFIED="2009-10-19 17:20:30 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reaven 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:20:30 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:20:30 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reaven PD, Grasse BJ, Tribble DL</AU>
<TI>Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1994</YR>
<VL>14</VL>
<PG>557-66</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:30 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reiser-1985" MODIFIED="2009-10-19 17:20:34 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reiser 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:20:34 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reiser R, Probstfield JL, Silvers A, Scott LW, Shorney ML, Wood RD, et al</AU>
<TI>Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1985</YR>
<VL>42</VL>
<PG>190-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:34 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Retzloff-1991" MODIFIED="2009-10-19 17:20:38 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Retzloff 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:20:38 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - RCT / FH" NOTES_MODIFIED="2009-10-19 17:20:38 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Retzloff BM, Dowdy AA, Walden CE, McCann BS, Gey G, Cooper M, et al</AU>
<TI>Changes in vitamin and mineral intakes and serum concentrations among free living men on cholesterol lowering diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>53</VL>
<NO>4</NO>
<PG>890-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riccardi-1987" MODIFIED="2013-08-11 13:11:30 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Riccardi 1987" YEAR="1987">
<REFERENCE MODIFIED="2013-08-11 13:11:30 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC666.EUR INCORRECT REFERENCE" NOTES_MODIFIED="2013-08-11 13:11:30 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riccardi G, Rivellese AA, Mancini M</AU>
<TI>The use of diet to lower plasma cholesterol levels</TI>
<SO>European Heart Journal</SO>
<YR>1987</YR>
<VL>8 Suppl</VL>
<PG>79-85</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:42 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rivellese-1994" MODIFIED="2009-10-19 17:20:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Rivellese 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:20:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="8" NOTES_MODIFIED="2009-10-19 17:20:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivellese AA, Auletta P, Marotta G, Saldalamacchia G, Giacco A, Mastrilli V, et al</AU>
<TI>Long term metabolic effects of two dietary methods of treating hyperlipidaemia</TI>
<SO>British Medical Journal</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>227-31</PG>
<EN>308</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberts-1994" MODIFIED="2009-10-19 17:20:59 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Roberts 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:20:59 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="EDITORIAL" NOTES_MODIFIED="2009-10-19 17:20:59 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberts WC</AU>
<TI>The ineffectiveness of a commonly recommended lipid lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels</TI>
<SO>American Journal of Cardiology</SO>
<YR>1994</YR>
<VL>73</VL>
<PG>623-4</PG>
<EN>73</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:20:59 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rona-1985" MODIFIED="2009-10-19 17:21:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Rona 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:21:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:21:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Rona RJ, Angelico F, Antonini R, Arca M, Brenci G, Ben M, et al</AU>
<TI>Plasma cholesterol response to a change in dietary fat intake</TI>
<SO>Journal of Chronic Diseases</SO>
<YR>1985</YR>
<VL>38</VL>
<NO>11</NO>
<PG>927-34</PG>
<EN>38</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rose-1976" MODIFIED="2009-10-19 17:21:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Rose 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-10-19 17:21:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - Not RCT/CCT - FH patients" NOTES_MODIFIED="2009-10-19 17:21:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rose V, Allen DM, Pearse RG, Chapell J</AU>
<TI>Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1976</YR>
<VL>115</VL>
<PG>753-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosenthal-1985" MODIFIED="2009-10-19 17:21:11 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Rosenthal 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:21:11 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.AME - Not RCT/CCT" NOTES_MODIFIED="2009-10-19 17:21:11 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosenthal MB, Barnard RJ, Rose DP, Inkeles S, Hall J, Pritikin N</AU>
<TI>Effects of a high complex carbohydrate, low fat, low cholesterol diet on levels of serum lipids and estradiol</TI>
<SO>American Journal of Medicine</SO>
<YR>1985</YR>
<VL>78</VL>
<PG>23-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:11 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacks-1986" MODIFIED="2009-10-19 17:21:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sacks 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:21:15 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:21:15 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacks FM, Handysides GH, Marais GE, Rosner B, Kass EH</AU>
<TI>Effects of a low fat diet on plasma lipoprotein levels</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1986</YR>
<VL>146</VL>
<PG>1573-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1981" MODIFIED="2009-10-19 17:21:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sanders 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:21:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="TX501.BRI HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:21:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders TA, Younger KM</AU>
<TI>The effect of dietary supplements of w-3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglycerides</TI>
<SO>British Journal of Nutrition</SO>
<YR>1981</YR>
<VL>45</VL>
<PG>613-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1983" MODIFIED="2009-10-19 17:21:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sanders 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:21:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="TX501.BRI RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:21:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders TA, Hochland MC</AU>
<TI>A comparison of the influence on plasma lipids and platelet function of supplements of w-3 and w-6 polyunsaturated fatty acids</TI>
<SO>British Journal of Nutrition</SO>
<YR>1983</YR>
<VL>50</VL>
<PG>521-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1984" MODIFIED="2009-10-19 17:21:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sanders 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:21:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R31.BRI - Can not find!" NOTES_MODIFIED="2009-10-19 17:21:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders TA, Mistry M</AU>
<TI>Controlled trials of fish oils supplements on plasma lipid concentrations</TI>
<SO>British Journal of Clinical Practice Supplement</SO>
<YR>1984</YR>
<VL>31</VL>
<PG>78-84</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saynor-1982a" MODIFIED="2009-10-19 17:21:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Saynor 1982a" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:21:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH LETTER" NOTES_MODIFIED="2009-10-19 17:21:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saynor R, Verel D</AU>
<TI>Eicosapentaenoic acid, bleeding time and serum lipids</TI>
<SO>Lancet</SO>
<YR>1982</YR>
<VL>2</VL>
<PG>272</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saynor-1984a" MODIFIED="2009-10-19 17:21:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Saynor 1984a" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:21:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH NOT RCT/CCT - INCL.FH PTS" NOTES_MODIFIED="2009-10-19 17:21:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saynor R, Verel D, Gillott T</AU>
<TI>The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina</TI>
<SO>Atherosclerosis</SO>
<YR>1984</YR>
<VL>50</VL>
<PG>3-10</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saynor-1984b" MODIFIED="2009-10-19 17:21:39 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Saynor 1984b" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:21:39 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/HYPERTRIGLYCERIDEMIA (LETTER)" NOTES_MODIFIED="2009-10-19 17:21:39 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saynor R</AU>
<TI>Effects of w-3 fatty acids on serum lipids</TI>
<SO>Lancet</SO>
<YR>1984</YR>
<VL>2</VL>
<PG>696-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:39 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schaefer-1981" MODIFIED="2009-10-19 17:21:42 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Schaefer 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:21:42 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not RCT included FH patients" NOTES_MODIFIED="2009-10-19 17:21:42 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schaefer EJ, Levy RI, Ernst ND, van Sant FD, Brewer HB Jr</AU>
<TI>The effects of low cholesterol, high polyunsaturated fat and low fat diets on plasma lipids and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<NO>9</NO>
<PG>1758-63</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:42 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schectman-1989" MODIFIED="2009-10-19 17:21:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Schectman 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:21:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.ANN CCT/HYPERTRIGLYCERIDEMIA" NOTES_MODIFIED="2009-10-19 17:21:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schectman G, Kaul S, Cherayil GD, Lee M, Kissebah A</AU>
<TI>Can the hypotriglyceridemia effect of fish oil concentrate be sustained</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1989</YR>
<VL>110</VL>
<PG>346-52</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schlierf-1982" MODIFIED="2009-10-19 17:21:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Schlierf 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:21:54 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schlierf G, Mrozik K, Heuck CC, Middlehoff G, Oster P, Riesen W, et al</AU>
<TI>"Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolaemia</TI>
<SO>Atherosclerosis</SO>
<YR>1982</YR>
<VL>41</VL>
<NO>1</NO>
<PG>133-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schonfeld-1982" MODIFIED="2009-10-19 17:21:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Schonfeld 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:21:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:21:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schonfeld G, Patsch W, Rudel LL, Nelson C, Epstein M, Olson RE</AU>
<TI>Effects of dietary cholesterol and fatty acids on plasma lipoproteins</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1982</YR>
<VL>69</VL>
<NO>5</NO>
<PG>1072-80</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:21:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwandt-1982" MODIFIED="2009-10-19 17:22:01 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Schwandt 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:22:01 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:22:01 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwandt P, Janetschek P, Weisweiler P</AU>
<TI>High density lipoproteins unaffected by dietary fat modification</TI>
<SO>Atherosclerosis</SO>
<YR>1982</YR>
<VL>44</VL>
<PG>9-17</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:01 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Segall-1970" MODIFIED="2009-07-20 15:13:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Segall 1970" YEAR="1970">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Segall MM, Fosbrooke AS, Lloyd JK, Wolff OH</AU>
<TI>Treatment of familial hypercholesterolaemia in children</TI>
<SO>Lancet</SO>
<YR>1970</YR>
<VL>1</VL>
<PG>641-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seppanen_x002d_Laakso-1992" MODIFIED="2009-10-19 17:22:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Seppanen-Laakso 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:22:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:22:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seppanen-Laakso T, Vanhanen HT, Laakso I, Kohtamaki H, Viikari J</AU>
<TI>Replacement of butter on bread by rapeseed oil and rapeseed oil containing margarine: effects on plasma fatty acid composition and serum cholesterol</TI>
<SO>British Journal of Nutrition</SO>
<YR>1992</YR>
<VL>68</VL>
<PG>677-92</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seppanen_x002d_Laakso-1993" MODIFIED="2009-10-19 17:22:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Seppanen-Laakso 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:22:13 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:22:13 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seppanen-Laakso T, Vanhanen HT, Laakso I, Kohtamaki H, Viikari J</AU>
<TI>Replacement of margarine on bread by rapeseed and olive oil effects on plasma fatty acid composition and serum cholesterol</TI>
<SO>Annals of Nutrition and Metabolism</SO>
<YR>1993</YR>
<VL>37</VL>
<PG>161-74</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:13 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shepherd-1978" MODIFIED="2009-10-19 17:22:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Shepherd 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:22:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - healthy subjects" NOTES_MODIFIED="2009-10-19 17:22:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shepherd J, Packard CJ, Patsch JR, Gotto AM Jr, Taunton OD</AU>
<TI>Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoprotein and the metabolism of apolipoprotein A-1</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1978</YR>
<VL>61</VL>
<PG>1582-92</PG>
<EN>61</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shepherd-1980" MODIFIED="2009-10-19 17:22:25 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Shepherd 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:22:25 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:22:25 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shepherd J, Packard CJ, Grundy SM, Yeshurun D, Gotto AM Jr, Taunton OD</AU>
<TI>Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man</TI>
<SO>Journal of Lipid Research</SO>
<YR>1980</YR>
<VL>21</VL>
<PG>91-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shorey-1981" MODIFIED="2009-10-19 17:22:33 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Shorey 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:22:33 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME UNCLEAR - COPY" NOTES_MODIFIED="2009-10-19 17:22:33 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Shorey RAL, Bazan B, Lo GS, Steinke FH</AU>
<TI>Determinants of hypercholesteraemic response to soy and animal protein-based diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<PG>1769-78</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:29 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siess-1980" MODIFIED="2009-10-19 17:22:49 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Siess 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:22:49 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - Healthy adults only - not RCT/CCT - not copied" NOTES_MODIFIED="2009-10-19 17:22:49 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siess W, Roth P, Scherer B, Kurzmann I, Bohlig B, Weber PC</AU>
<TI>Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet</TI>
<SO>Lancet</SO>
<YR>1980</YR>
<VL>1</VL>
<PG>441-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:49 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simons-1985a" MODIFIED="2009-10-19 17:22:56 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Simons 1985a" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:22:56 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/INCLUDES FH" NOTES_MODIFIED="2009-10-19 17:22:56 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simons LA, Hickie JB, Balasubramaniam S</AU>
<TI>On the effects of dietary n-3 fatty acids (MaxEPA) on plasma lipids and lipoproteins in patients with hyperlipidaemia</TI>
<SO>Atherosclerosis</SO>
<YR>1985</YR>
<VL>54</VL>
<PG>75-88</PG>
<EN>54</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:22:56 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simons-1985b" MODIFIED="2009-10-19 17:23:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Simons 1985b" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:23:00 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simons LA, Hickie JB</AU>
<TI>On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia</TI>
<SO>Atherosclerosis</SO>
<YR>1985</YR>
<VL>54</VL>
<PG>75-88</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singer-1983" MODIFIED="2009-10-19 17:23:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Singer 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:23:04 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH CCT/HEALTHY VOLUNTEERS" NOTES_MODIFIED="2009-10-19 17:23:04 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singer P, Jaeger W, Wirth M, Voight S, Naumann, Zimontkowski S, et al</AU>
<TI>Lipid and blood pressure-lowering effect of mackerel diet in man</TI>
<SO>Atherosclerosis</SO>
<YR>1983</YR>
<VL>49</VL>
<NO>1</NO>
<PG>99-108</PG>
<EN>49</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singer-1984" MODIFIED="2009-10-28 09:23:37 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Singer 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-28 09:23:37 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singer P, Voigt S, Wirth M, et al</AU>
<TI>Effect of eicosapentaenoic acid-rich diet on risk factors of atherosclerosis in healthy subject and patients with essential hypertension and hyperlipoproteinemia</TI>
<TO>Zur Beeinflussung von Risikofaktoren der Arteriosklerose durch eicosapentaensourereiche Diet bei klinisch Gesunden sowie Patienten mit essentieller Hypertonie und Hyperlipoproteinomie</TO>
<SO>Das Deutsche Gesundheitswesen</SO>
<YR>1984</YR>
<VL>39</VL>
<PG>219-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singer-1986" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Singer 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singer P, Wirth M, Godlicke W, Jaeger W, Voight S</AU>
<TI>Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects</TI>
<SO>Leukotrienes &amp; Medicine</SO>
<YR>1986</YR>
<VL>24</VL>
<PG>173-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirtori-1977" MODIFIED="2009-10-19 17:23:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sirtori 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-10-19 17:23:18 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - ?FH patients - ?RCT (cross-over)" NOTES_MODIFIED="2009-10-19 17:23:18 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E</AU>
<TI>Soybean protein diet in the treatment of type II hypercholesterolaemia</TI>
<SO>Lancet</SO>
<YR>1977</YR>
<VL>1</VL>
<PG>275-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:18 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirtori-1979" MODIFIED="2009-10-19 17:23:21 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sirtori 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:23:21 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Unclear - included FH patients" NOTES_MODIFIED="2009-10-19 17:23:21 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirtori CR, Gatti E, Mantero O, Conti F, Agradi E, Tremoli E, et al</AU>
<TI>Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1979</YR>
<VL>32</VL>
<NO>8</NO>
<PG>1645-58</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:21 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirtori-1981" MODIFIED="2009-10-19 17:23:24 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sirtori 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:23:24 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.ATH LETTER" NOTES_MODIFIED="2009-10-19 17:23:24 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirtori CR, Descovich GC, Noseda G</AU>
<TI>The soybean protein diet does not lower plasma cholesterol?</TI>
<SO>Atherosclerosis</SO>
<YR>1981</YR>
<VL>38</VL>
<PG>423</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:24 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirtori-1986" MODIFIED="2009-10-19 17:23:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sirtori 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:23:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - RCT / FH" NOTES_MODIFIED="2009-10-19 17:23:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Sirtori CR, Tremoli E, Gatti E, Montanari G, Sirtori M, Colli S, et al</AU>
<TI>Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>44</VL>
<NO>5</NO>
<PG>635-42</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirtori-1992" MODIFIED="2009-10-19 17:23:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sirtori 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:23:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC/AH - No FH patients included - RCT - not copied" NOTES_MODIFIED="2009-10-19 17:23:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirtori CR, Gatti E, Tremoli E, Gatti C, Gianfranceschi G, Franceschini G, et al</AU>
<TI>Olive oil, corn oil and n-3 fatty acids differently affect lipids, lipoproteins, platelets and superoxide formation in type II hypercholesterolemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>56</VL>
<NO>1</NO>
<PG>113-22</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sperling-1987" MODIFIED="2009-10-19 17:23:36 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sperling 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:23:36 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="QR180.JOU NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:23:36 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sperling RI, Robin JL, Kylander KA, Lee TH, Lewis RA, Austen KF</AU>
<TI>The effects of n-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes</TI>
<SO>Journal of Immunology</SO>
<YR>1987</YR>
<VL>139</VL>
<NO>12</NO>
<PG>4186-91</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:36 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-1975" MODIFIED="2009-10-19 17:23:40 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Stein 1975" YEAR="1975">
<REFERENCE MODIFIED="2009-10-19 17:23:40 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:23:40 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein EA, Mendelsohn D, Fleming M, Barnard CD, Carter KJ, du Toit PS, et al</AU>
<TI>Lowering of plasma cholesterol levels in free-living adolescent males: use of natural and synthetic polyunsaturated foods to provide balanced fat diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1975</YR>
<VL>28</VL>
<NO>11</NO>
<PG>1204-16</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:40 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-1982" MODIFIED="2009-10-19 17:23:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Stein 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:23:46 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="CCT/INLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:23:46 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein EA, Shapero J, McNerney C, Glueck CJ, Tracy T, Gartside P</AU>
<TI>Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated and total fat in free-living normal and hypercholesterolemic children</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1982</YR>
<VL>35</VL>
<PG>1375-90</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:46 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stephens-1996" MODIFIED="2009-10-19 17:23:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Stephens 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-10-19 17:23:50 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH RCT/?FH" NOTES_MODIFIED="2009-10-19 17:23:50 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ</AU>
<TI>Randomised controlled trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study (CHAOS)</TI>
<SO>Lancet</SO>
<YR>1996</YR>
<VL>347</VL>
<NO>9004</NO>
<PG>781-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:50 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Subbaiah-1989" MODIFIED="2009-10-19 17:23:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Subbaiah 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:23:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/INCLUDES FH" NOTES_MODIFIED="2009-10-19 17:23:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Subbaiah PV, Davidson MH, Ritter MC, Buchanan W, Bagdade JD</AU>
<TI>Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients</TI>
<SO>Atherosclerosis</SO>
<YR>1989</YR>
<VL>79</VL>
<PG>157-66</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:23:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sucic-1998" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Sucic 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sucic M, Katica D, Kovacevic V</AU>
<TI>Effect of dietary fish supplementation on lipiprotein levels in patients with hyperlipoproteinemia</TI>
<SO>Collegium Antropologicum</SO>
<YR>1998</YR>
<VL>22</VL>
<NO>1</NO>
<PG>77-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szczeklik-1985" MODIFIED="2009-10-19 17:24:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Szczeklik 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:24:00 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szczeklik A, Gryglewski RJ, Domagala B, Dworski R, Basista M</AU>
<TI>Dietary supplementation with vitamin E in hyperlipoproteinaemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability</TI>
<SO>Thrombosis and Haemostasis</SO>
<YR>1985</YR>
<VL>54</VL>
<PG>425-30</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorngren-1981" MODIFIED="2009-10-19 17:24:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Thorngren 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-10-19 17:24:04 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:24:04 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorngren M, Gustafson A</AU>
<TI>Effects of 11 week increase in dietary eicosapentaenoic acid on bleeding time, lipids and platelet aggregation</TI>
<SO>Lancet</SO>
<YR>1981</YR>
<VL>2</VL>
<PG>1190-3</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorngren-1984" MODIFIED="2009-10-19 17:24:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Thorngren 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-10-19 17:24:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC633.A1.BRI NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:24:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorngren M, Shafi M, Born GVR</AU>
<TI>Delay in primary haemostasis produced by a fish diet without change in local thromboxane A2</TI>
<SO>British Journal of Haematology</SO>
<YR>1984</YR>
<VL>58</VL>
<PG>567-78</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorngren-1986" MODIFIED="2009-10-19 17:24:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Thorngren 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:24:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:24:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorngren M, Nilsson E, Gustafson A</AU>
<TI>Plasma lipoproteins and fatty acid composition during moderate EPA diet</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1986</YR>
<VL>219</VL>
<PG>23-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tonstad-1997b" MODIFIED="2009-10-19 17:24:19 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Tonstad 1997b" YEAR="1997">
<REFERENCE MODIFIED="2009-10-19 17:24:19 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH CROSS SECTIONAL SURVEY" NOTES_MODIFIED="2009-10-19 17:24:19 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tonstad S, Aksnes L</AU>
<TI>Fat soluble vitamin levels in familial hypercholesterolemia</TI>
<SO>Journal of Pediatrics</SO>
<YR>1997</YR>
<VL>130</VL>
<PG>274-80</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:19 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ullmann-1990" MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Ullmann 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-07-20 15:13:27 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ullmann D, Connor WE, Illingworth DR, Hagemenas FC, Pappu A</AU>
<TI>Additive effects of Lovastatin and fish oil in familial hypercholesterolaemia</TI>
<SO>Arteriosclerosis</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>5</NO>
<PG>846a</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uusitupa-1991" MODIFIED="2013-08-23 11:45:06 +0100" MODIFIED_BY="[Empty name]" NAME="Uusitupa 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-08-23 11:45:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uusitupa M, Ebeling T, Happonen P, Vartilainen E, Turtola H, Parviainen M, Pyorala K</AU>
<TI>Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia</TI>
<SO>J Cardiovasc Pharmacol</SO>
<YR>1991</YR>
<VL>18</VL>
<PG>496-503</PG>
<IDENTIFIERS MODIFIED="2013-08-23 11:45:06 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-08-23 11:44:25 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
<IDENTIFIER MODIFIED="2013-08-23 11:44:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
<IDENTIFIER MODIFIED="2013-08-23 11:45:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valsta-1992" MODIFIED="2009-10-19 17:24:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Valsta 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:24:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:24:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valsta L, Jauhiainen M, Aro A, Katan MB, Mutanen M</AU>
<TI>Effects of a monounsaturated rapeseed oil and a polyunsaturated sunflower oil diet on lipoprotein levels in humans</TI>
<SO>Arteriosclerosis Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<PG>50-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Gent-1979" MODIFIED="2009-10-19 17:24:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Van Gent 1979" YEAR="1979">
<REFERENCE MODIFIED="2009-10-19 17:24:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH NOT RCT/CCT - HEALTHY SUBJECTS (LETTER)" NOTES_MODIFIED="2009-10-19 17:24:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Gent CM, Luten JB, Brongeest-Schoute HO, Ruiter A</AU>
<TI>Effect on serum lipid levels of w-3 fatty acids, of ingesting fish oil concentrate</TI>
<SO>Lancet</SO>
<YR>1979</YR>
<VL>2</VL>
<PG>1249-50</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanhanen-1991" MODIFIED="2009-10-19 17:24:42 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vanhanen 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:24:42 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RC681.A1.CIR NOT RCT/?FH" NOTES_MODIFIED="2009-10-19 17:24:42 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vanhanen HT, Miettinen TA</AU>
<TI>Effects of sitostanol ester, dissolved in dietary oil, on serum cholesterol, plant sterols and cholesterol precursors</TI>
<SO>Circulation</SO>
<YR>1991</YR>
<VL>84 (Suppl II)</VL>
<PG>601</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:42 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanhanen-1993" MODIFIED="2009-10-19 17:24:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vanhanen 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:24:55 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QP501.JOU - RCT - ?FH patients" NOTES_MODIFIED="2009-10-19 17:24:55 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vanhanen HT, Blomqvist S, Ehnholm C, Hyvonen M, Jauhiainen M, Torstila I, et al</AU>
<TI>Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment</TI>
<SO>Journal of Lipid Research</SO>
<YR>1993</YR>
<VL>34</VL>
<PG>1535-44</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:55 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanhanen-1994" MODIFIED="2009-10-19 17:24:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vanhanen 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-19 17:24:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R31.CLI - RCT - ?FH patients" NOTES_MODIFIED="2009-10-19 17:24:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vanhanen HT, Kajander J, Lehtovirta H, Miettinen TA</AU>
<TI>Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects</TI>
<SO>Clinical Science</SO>
<YR>1994</YR>
<VL>87</VL>
<PG>61-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Horn-1986" MODIFIED="2009-10-19 17:24:38 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Van Horn 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:24:38 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:24:38 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Horn LV, Liu K, Parker D, Emdiy L, Liao YL, Pan WH, et al</AU>
<TI>Serum lipid response to oat product intake with a fat modified diet</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1986</YR>
<VL>86</VL>
<NO>6</NO>
<PG>759-64</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:24:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Varady-2007" MODIFIED="2012-04-20 11:47:03 +0100" MODIFIED_BY="anita  s malhotra" NAME="Varady 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-04-20 11:47:03 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Varady KA, Houweling AH, Jones PJ</AU>
<TI>Effect of plant sterols and exercise training on cholesterol absorption and synthesis in previously sedentary hypercholesterolemic subjects</TI>
<SO>Translational Research</SO>
<YR>2007</YR>
<VL>149</VL>
<NO>1</NO>
<PG>22-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vega-1982" MODIFIED="2009-10-19 17:25:03 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vega 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:25:03 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC QP501.JOU CCT/INCLUDED ONE FH PATIENT" NOTES_MODIFIED="2009-10-19 17:25:03 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Vega GL, Groszek E, Wolfe R, Grundy SM</AU>
<TI>Influence of polyunsaturated fats on plasma lipoprotein composition and apolipoprotein</TI>
<SO>Journal of Lipid Research</SO>
<YR>1982</YR>
<VL>23</VL>
<PG>811-22</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:03 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verrillo-1985" MODIFIED="2009-10-19 17:25:06 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Verrillo 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:25:06 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR RCT/FH" NOTES_MODIFIED="2009-10-19 17:25:06 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Verrillo A, Teresa A de, Carandente Giarrusso P, La Rocca S</AU>
<TI>Soybean protein diets in the management of type II hyperlipoproteinaemia</TI>
<SO>Atherosclerosis</SO>
<YR>1985</YR>
<VL>54</VL>
<PG>321-31</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:06 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vessby-1980a" MODIFIED="2009-10-19 17:25:09 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vessby 1980a" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:25:09 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RB37.EUR NOT RCT/INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:25:09 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vessby B, Gustafsson IB, Boberg J, Karlstrom B, Lithell H, Werner I</AU>
<TI>Substituting polyunsaturated fat for saturated fat as a single change in a Swedish diet: effects on serum lipoprotein metabolism and glucose tolerance in patients with hyperlipoproteinemia</TI>
<SO>European Journal of Clinical Investigation</SO>
<YR>1980</YR>
<VL>10</VL>
<PG>193-202</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:09 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vessby-1980b" MODIFIED="2009-10-19 17:25:12 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vessby 1980b" YEAR="1980">
<REFERENCE MODIFIED="2009-10-19 17:25:12 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RC681.A1.ATH NOT CCT/RCT - FH PTS" NOTES_MODIFIED="2009-10-19 17:25:12 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vessby B, Boberg J, Gustafsson IB, Karlstrom B, Lithell H, Ostlund-Lindqvist AM</AU>
<TI>Reduction of high density lipoprotein cholesterol and apolipoprotein A-1 concentrations by a lipid-lowering diet</TI>
<SO>Atherosclerosis</SO>
<YR>1980</YR>
<VL>35</VL>
<PG>21-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:12 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vessby-1982" MODIFIED="2009-10-19 17:25:17 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Vessby 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-10-19 17:25:17 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/?FH" NOTES_MODIFIED="2009-10-19 17:25:17 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vessby B, Karlstrom B, Lithell H, Gustafsson IB, Werner I</AU>
<TI>The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy-protein in a lipid-lowering diet for hypercholesterolaemic patients</TI>
<SO>Human Nutrition Applied Nutrition</SO>
<YR>1982</YR>
<VL>36A</VL>
<PG>179-89</PG>
<EN>36A</EN>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:17 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Von-Schacky-1985" MODIFIED="2009-10-19 17:25:27 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Von Schacky 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:25:27 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R11.JOU - Not RCT/CCT - healthy subjects" NOTES_MODIFIED="2009-10-19 17:25:27 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>von Schacky C, Fischer S, Weber PC</AU>
<TI>Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1985</YR>
<VL>76</VL>
<PG>1626-31</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:27 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Von-Schacky-1987" MODIFIED="2009-10-19 17:25:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Von Schacky 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-10-19 17:25:32 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT A TRIAL" NOTES_MODIFIED="2009-10-19 17:25:32 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>von Schacky C</AU>
<TI>Prophylaxis of atherosclerosis with marine omega-3 fatty acids</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1987</YR>
<VL>107</VL>
<PG>890-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:32 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vuorio-2000" MODIFIED="2009-07-31 11:20:34 +0100" MODIFIED_BY="[Empty name]" NAME="Vuorio 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-07-31 11:20:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vuorio AF, Gylling H, Turtola H, Kontula K, Ketonen P, Miettinen TA</AU>
<TI>Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with hypercholesterolemia caused by the FH-Karelia mutation</TI>
<SO>Arteriosclerosis, Thrombosis and Vascular Biology</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>2</NO>
<PG>500-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wardlaw-1990" MODIFIED="2009-10-19 17:25:40 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wardlaw 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-19 17:25:40 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - RCT / healthy subjects" NOTES_MODIFIED="2009-10-19 17:25:40 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wardlaw GM, Snook JT</AU>
<TI>Effects of diets high in butter, corn oil or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1990</YR>
<VL>51</VL>
<PG>815-21</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:40 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weisweiler-1983" MODIFIED="2009-10-19 17:25:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Weisweiler 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:25:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="NOT RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:25:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weisweiler P, Drosner M, Janetschek P, Schwandt P</AU>
<TI>Changes in very low and low density lipoproteins with dietary fat modification</TI>
<SO>Atherosclerosis</SO>
<YR>1983</YR>
<VL>49</VL>
<PG>325-32</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weisweiler-1985" MODIFIED="2009-10-19 17:25:48 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Weisweiler 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-10-19 17:25:48 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:25:48 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weisweiler P, Janetschek P, Schwandt P</AU>
<TI>Influence of polyunsaturated fats and fat restriction on serum lipoproteins in humans</TI>
<SO>Metabolism</SO>
<YR>1985</YR>
<VL>34</VL>
<PG>83-7</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:48 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widhalm-1978" MODIFIED="2009-10-19 17:25:53 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Widhalm 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-10-19 17:25:53 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="ORDER" NOTES_MODIFIED="2009-10-19 17:25:53 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Widhalm K, Maxa E, Zyman H</AU>
<TI>Effect of diet and exercise upon the cholesterol and triglyceride content of plasma lipoproteins in overweight children</TI>
<SO>European Journal of Pediatrics</SO>
<YR>1978</YR>
<VL>127</VL>
<PG>121-6</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:53 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widhalm-1993" MODIFIED="2009-10-19 17:25:57 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Widhalm 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:25:57 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="2" NOTES_MODIFIED="2009-10-19 17:25:57 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Widhalm K, Brazada G</AU>
<TI>Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolaemia</TI>
<SO>Journal of Pediatrics</SO>
<YR>1993</YR>
<VL>123</VL>
<PG>30-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:25:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1986" MODIFIED="2009-10-19 17:26:00 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Williams 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:26:00 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.AME - Not RCT / healthy subjects" NOTES_MODIFIED="2009-10-19 17:26:00 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams PT, Krauss RM, Kindel-Joyce S, Dreon DM, Vranizan KM, Wood PD</AU>
<TI>Relationship of dietary fat, protein, cholesterol and fiber intake to atherogenic lipoproteins in men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>44</VL>
<PG>788-97</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:00 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1971" MODIFIED="2009-10-19 17:26:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wilson 1971" YEAR="1971">
<REFERENCE MODIFIED="2009-10-19 17:26:04 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC NOT RCT/INCLUDED FH PATIENTS" NOTES_MODIFIED="2009-10-19 17:26:04 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson WS, Hulley SB, Burrows M, Nichaman MZ</AU>
<TI>Serial lipid and lipoprotein responses to the American Heart Association fat controlled diet</TI>
<SO>American Journal of Medicine</SO>
<YR>1971</YR>
<VL>51</VL>
<PG>491-503</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:04 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilt-1989" MODIFIED="2009-10-19 17:26:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wilt 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-19 17:26:08 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="R11.ANN RCT/?FH" NOTES_MODIFIED="2009-10-19 17:26:08 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilt TJ, Lofgren RP, Nichol KS, Schorer AE, Crespin L, Downes D, et al</AU>
<TI>Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1989</YR>
<VL>111</VL>
<PG>900-5</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:08 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Witters-1976" MODIFIED="2009-10-19 17:26:15 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Witters 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-10-19 17:26:15 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="17" NOTES_MODIFIED="2009-10-19 17:26:15 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Witters LA, Herbert PN, Shulman RS, Krauss RM, Levy RI</AU>
<TI>Theraputic failure in familial Type II hyperlipoproteinemia</TI>
<SO>Metabolism</SO>
<YR>1976</YR>
<VL>25</VL>
<PG>1017-26</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:15 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolf-1983" MODIFIED="2009-10-19 17:26:28 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wolf 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:26:28 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC RM214.JOU - Not RCT/ ?not FH" NOTES_MODIFIED="2009-10-19 17:26:28 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolf RN, Grundy SM</AU>
<TI>Influence of exchanging carbohydrate for saturated fatty acids on plasma lipids and lipoproteins in men</TI>
<SO>Journal of Nutrition</SO>
<YR>1983</YR>
<VL>113</VL>
<PG>1521-8</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:28 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolfe-1991" MODIFIED="2009-10-19 17:26:31 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Wolfe 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-10-19 17:26:31 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="HC R850.A1.MET RCT/?FH" NOTES_MODIFIED="2009-10-19 17:26:31 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolfe BM, Giovannetti PM</AU>
<TI>Short-term effects of substituting protein for carbohydrate in the diets of moderately hypercholesterolemic human subjects</TI>
<SO>Metabolism</SO>
<YR>1991</YR>
<VL>40</VL>
<PG>338-43</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:31 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Worne-1959" MODIFIED="2009-10-19 17:26:41 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Worne 1959" YEAR="1959">
<REFERENCE MODIFIED="2009-10-19 17:26:41 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="MI/JR ?RCT/?FH" NOTES_MODIFIED="2009-10-19 17:26:41 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Worne HE, Smith LW</AU>
<TI>Effects of certain pure long chain polyunsaturated fatty acid esters on blood lipids in man</TI>
<SO>American Journal of Medical Science</SO>
<YR>1959</YR>
<VL>237</VL>
<PG>710-21</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:41 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yacowitz-1965" MODIFIED="2009-10-19 17:26:44 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Yacowitz 1965" YEAR="1965">
<REFERENCE MODIFIED="2009-10-19 17:26:44 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="AH CCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:26:44 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yacowitz H, Fleischman AI, Bierenbaum ML</AU>
<TI>Effects of oral calcium upon serum lipids in man</TI>
<SO>British Medical Journal</SO>
<YR>1965</YR>
<VL>1</VL>
<PG>1352-4</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:44 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-1993" MODIFIED="2009-10-19 17:26:47 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zhao 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-19 17:26:47 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="18" NOTES_MODIFIED="2009-10-19 17:26:47 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="OTHER">
<AU>Zhao XQ, Brown BG, Hillger L, Sacco D, Bisson B, Fisher L, et al</AU>
<TI>Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B</TI>
<SO>Circulation</SO>
<YR>1993</YR>
<VL>88</VL>
<PG>2744-53</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:47 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimmerman-1986" MODIFIED="2009-10-19 17:26:51 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zimmerman 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-10-19 17:26:51 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="JR NOT RCT/HEALTHY SUBJECTS &amp;amp; HYPERTRIGLYCERIDEMIA PATIENTS" NOTES_MODIFIED="2009-10-19 17:26:51 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmerman J, Eisenberg S, Kaufmann NA, Fainaru M, OSchry Y, Friedlander Y, et al</AU>
<TI>Effect of moderate isocaloric modification of dietary carbohydrate on high density lipoprotein composition and apolipoprotein A-1 turnover in humans</TI>
<SO>Israel Journal of Medical Sciences</SO>
<YR>1986</YR>
<VL>22</VL>
<NO>2</NO>
<PG>95-104</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:51 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zino-1987" MODIFIED="2009-10-19 17:26:54 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zino 1987" YEAR="1997">
<REFERENCE MODIFIED="2009-10-19 17:26:54 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/healthy subjects" NOTES_MODIFIED="2009-10-19 17:26:54 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zino S, Skeaff M, Williams S, Mann J</AU>
<TI>Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants</TI>
<SO>British Medical Journal</SO>
<YR>1997</YR>
<VL>314</VL>
<PG>1787-91</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:54 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zock-1992" MODIFIED="2009-10-19 17:26:58 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zock 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-19 17:26:58 +0100" MODIFIED_BY="Nikki Jahnke" NOTES="RCT/HEALTHY SUBJECTS" NOTES_MODIFIED="2009-10-19 17:26:58 +0100" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zock PL, Katan MB</AU>
<TI>Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans</TI>
<SO>Journal of Lipid Research</SO>
<YR>1992</YR>
<VL>33</VL>
<PG>399-410</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:26:58 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zucker-1983" MODIFIED="2009-10-19 17:27:02 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zucker 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-10-19 17:27:02 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zucker ML, Woodroof J, DeCoursey S, Jackson B, Dujovne CA</AU>
<TI>The effect of variable fat diets and cholesterol-lowering drugs on Antithrombin III levels in hyperlipoproteinemic and normal subjects</TI>
<SO>Thrombosis Research</SO>
<YR>1983</YR>
<VL>30</VL>
<PG>661-9</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:27:02 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zucker-1988" MODIFIED="2009-10-19 17:27:06 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Zucker 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-19 17:27:06 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zucker ML, Bilyeu DS, Helmkamp GM, Harris WS, Dujovne CA</AU>
<TI>Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects</TI>
<SO>Atherosclerosis</SO>
<YR>1988</YR>
<VL>73</VL>
<PG>13-22</PG>
<IDENTIFIERS MODIFIED="2009-10-19 17:27:06 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-09-20 11:26:06 +0100" MODIFIED_BY="Nikki Jahnke">
<STUDY DATA_SOURCE="PUB" ID="STD-Fuentes-2008" MODIFIED="2013-09-20 11:25:55 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Fuentes 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-09-20 11:25:55 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fuentes F, Lopez-Miranda J, Garcia A, Perez-Martinez P, Moreno J, Cofan M, et al</AU>
<TI>Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>62</VL>
<NO>4</NO>
<PG>495-501</PG>
<IDENTIFIERS MODIFIED="2009-10-19 15:17:38 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-2007" MODIFIED="2013-09-20 11:26:06 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Stein 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-09-20 11:26:06 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein EA, Amerena J, Ballantyne CM, Brice E, Farnier M, Guthrie RM, et al</AU>
<TI>Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia</TI>
<SO>American Journal of Cardiology</SO>
<YR>2007</YR>
<VL>100</VL>
<NO>9</NO>
<PG>1387-96</PG>
<IDENTIFIERS MODIFIED="2009-10-19 15:18:57 +0100" MODIFIED_BY="Nikki Jahnke"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2012-04-20 11:07:34 +0100" MODIFIED_BY="anita  s malhotra">
<STUDY DATA_SOURCE="PUB" ID="STD-P_x00e1_rraga-ongoing" MODIFIED="2012-04-20 11:07:34 +0100" MODIFIED_BY="anita  s malhotra" NAME="Párraga ongoing" YEAR="">
<REFERENCE MODIFIED="2012-04-20 11:07:34 +0100" MODIFIED_BY="anita  s malhotra" PRIMARY="NO" TYPE="OTHER">
<AU>Párraga I, López-Torres J, Andrés F, Navarro B, del Campo JM, García-Reyes M, et al</AU>
<TI>Effect of plant sterols on the lipid profile of patients with hypercholesterolaemia. Randomised, experimental study</TI>
<SO>www.biomedcentral.com/1472-6882/11/73 (BMC Complementary and Alternative Medicine)</SO>
<YR>(accessed 01 March 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-05-22 12:22:09 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-05-22 12:22:09 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AHA-Statement-2007" MODIFIED="2009-07-20 15:24:46 +0100" MODIFIED_BY="Nikki Jahnke" NAME="AHA Statement 2007" TYPE="JOURNAL_ARTICLE">
<AU>McCrindle BW, Urbina EM, Dennison BA, Jacobson MC, Steinberger J, Rocchin AP, et al</AU>
<TI>AHA Scientific Statement. Drug therapy of high risk lipid abnormalities in children and adolescents. A scientific statement from the American Heart Association Atherosclerosis, hypertension and obesity in Youth Committee, Council of Cardiovascular disease in the Young with the Council on Cardiovascular Nursing</TI>
<SO>Circulation</SO>
<YR>2007</YR>
<VL>115</VL>
<NO>14</NO>
<PG>1948-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Austin-2004" MODIFIED="2012-04-20 11:09:18 +0100" MODIFIED_BY="anita  s malhotra" NAME="Austin 2004" TYPE="JOURNAL_ARTICLE">
<AU>Austin MA, Hutter CM, Zimmern RL, Humphries SE</AU>
<TI>Familial hypercholesterolemia and coronary heart disease: a HuGE association review</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2004</YR>
<VL>160</VL>
<NO>5</NO>
<PG>421-9</PG>
<IDENTIFIERS MODIFIED="2012-02-05 05:40:04 +0000" MODIFIED_BY="anita  s malhotra"/>
</REFERENCE>
<REFERENCE ID="REF-Avis-2007" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Avis 2007" TYPE="JOURNAL_ARTICLE">
<AU>Avis HJ, Vissers MN, Stein EA, Wijburg FA, Frip MD, Kastelein JJ, et al</AU>
<TI>A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia</TI>
<SO>Arteriosclerosis, Thrombosis, and Vascular Biology</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>8</NO>
<PG>1803-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-1999" MODIFIED="2014-05-22 12:22:09 +0100" MODIFIED_BY="[Empty name]" NAME="Brown 1999" TYPE="JOURNAL_ARTICLE">
<AU>Brown L, Rosner B, Willett WW, Sacks FM</AU>
<TI>Cholesterol-lowering effects of dietary fiber: a meta-analysis</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<NO>1</NO>
<PG>30-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2008-11-21 14:38:05 +0000" MODIFIED_BY="Tracey Remmington" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldberg-2011" MODIFIED="2014-05-22 12:21:42 +0100" MODIFIED_BY="[Empty name]" NAME="Goldberg 2011" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al</AU>
<TI>Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients</TI>
<SO>Journal of Clinical Lipidology</SO>
<YR>2011</YR>
<VL>5</VL>
<NO>3 suppl</NO>
<PG>51-8</PG>
<IDENTIFIERS MODIFIED="2013-08-18 08:27:40 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-18 08:27:40 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE="Goldberg 2011"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goldstein-1995" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Goldstein 1995" TYPE="BOOK_SECTION">
<AU>Goldstein JL, Hobbs HH, Brown MS</AU>
<TI>Familial hypercholesterolemia</TI>
<SO>The metabolic and molecular bases of inherited disease</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>1981-2030</PG>
<EN>7th</EN>
<ED>Scriver CR, Beaudet AL, Sly WS, Valle D</ED>
<PB>McGraw-Hill</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2009-07-20 14:51:18 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hopkins-2011" MODIFIED="2014-05-22 12:19:51 +0100" MODIFIED_BY="[Empty name]" NAME="Hopkins 2011" TYPE="JOURNAL_ARTICLE">
<AU>Hopkins PN, Toth PP, Ballantyne CM, Rader DJ</AU>
<TI>Familial Hypercholesterolemias:prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia</TI>
<SO>Journal of Clinical Lipidology</SO>
<YR>2011</YR>
<VL>5</VL>
<NO>3 suppl</NO>
<PG>S9&#8211;S17</PG>
<IDENTIFIERS MODIFIED="2013-08-18 08:35:16 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-18 08:35:16 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE="Hopkins 2011"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Howell-1997" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Howell 1997" TYPE="JOURNAL_ARTICLE">
<AU>Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA</AU>
<TI>Plasma lipid and lipoprotein response to dietary fat and cholesterol: a meta-analysis</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1997</YR>
<VL>65</VL>
<PG>747-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Levantesi-2010" MODIFIED="2012-04-20 11:15:32 +0100" MODIFIED_BY="anita  s malhotra" NAME="Levantesi 2010" TYPE="JOURNAL_ARTICLE">
<AU>Levantesi G, Silletta MG, Marchioli R</AU>
<TI>Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease</TI>
<SO>Journal of Multidisciplinary Healthcare</SO>
<YR>2010</YR>
<VL>3</VL>
<PG>79&#8211;96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maclean-1994" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Maclean 1994" TYPE="BOOK_SECTION">
<AU>Maclean M</AU>
<TI>Lipid disorders</TI>
<SO>Clinical Paediatric Dietetics</SO>
<YR>1994</YR>
<PG>239-45</PG>
<ED>Shaw V &amp; Lawson M</ED>
<PB>Blackwell Science</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marais-2004" MODIFIED="2014-05-22 12:17:09 +0100" MODIFIED_BY="[Empty name]" NAME="Marais 2004" TYPE="JOURNAL_ARTICLE">
<AU>Marais AD</AU>
<TI>Familial hypercholesterolaemia</TI>
<SO>Clinical Biochemist Reviews</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>1</NO>
<PG>49-68</PG>
<IDENTIFIERS MODIFIED="2013-08-18 08:30:34 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-18 08:30:34 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE="Marais 2004"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marks-2003" MODIFIED="2014-02-27 14:42:48 +0000" MODIFIED_BY="[Empty name]" NAME="Marks 2003" TYPE="JOURNAL_ARTICLE">
<AU>Marks D, Thorogood M, Neil AW, Humphries SE</AU>
<TI>A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia</TI>
<SO>Atherosclerosis</SO>
<YR>2003</YR>
<VL>168</VL>
<NO>1</NO>
<PG>1-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marlett-1997" MODIFIED="2012-04-20 11:16:52 +0100" MODIFIED_BY="anita  s malhotra" NAME="Marlett 1997" TYPE="JOURNAL_ARTICLE">
<AU>Marlett JA</AU>
<TI>Sites and mechanism for the hypocholesterolemic actions of soluble dietary fiber sources</TI>
<SO>Advances in Experimental Medicine and Biology</SO>
<YR>1997</YR>
<VL>427</VL>
<PG>109-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Connor-1990" MODIFIED="2014-05-22 12:15:59 +0100" MODIFIED_BY="[Empty name]" NAME="O'Connor 1990" TYPE="JOURNAL_ARTICLE">
<AU>O'Connor P, Feely J, Shepherd J</AU>
<TI>Lipid lowering drugs</TI>
<SO>BMJ</SO>
<YR>1990</YR>
<VL>300</VL>
<NO>6725</NO>
<PG>667-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rader-2003" MODIFIED="2014-05-22 12:15:26 +0100" MODIFIED_BY="[Empty name]" NAME="Rader 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rader DJ, Cohen J, Hobbs HH</AU>
<TI>Monogenic hypercholesterolemia: new insights in pathogenesis and treatment</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>2003</YR>
<VL>111</VL>
<NO>12</NO>
<PG>1795-1803</PG>
<IDENTIFIERS MODIFIED="2013-08-18 08:33:16 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-18 08:33:16 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE="Rader 2003"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2013-09-20 10:48:48 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SBRG-1991" MODIFIED="2014-05-22 12:14:34 +0100" MODIFIED_BY="[Empty name]" NAME="SBRG 1991" TYPE="JOURNAL_ARTICLE">
<AU>Scientific Steering Committee on behalf of the Simon Broome Register Group</AU>
<TI>Risk of fatal coronary heart disease in familial hypercholesterolaemia</TI>
<SO>BMJ</SO>
<YR>1991</YR>
<VL>303</VL>
<NO>6807</NO>
<PG>893-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schneeman-1998" MODIFIED="2012-04-20 12:00:15 +0100" MODIFIED_BY="anita  s malhotra" NAME="Schneeman 1998" TYPE="JOURNAL_ARTICLE">
<AU>Schneeman BO</AU>
<TI>Dietary fiber and gastrointestinal function</TI>
<SO>Nutrition Research</SO>
<YR>1998</YR>
<VL>18</VL>
<PG>625-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shafiq-2007" MODIFIED="2009-10-19 17:27:32 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Shafiq 2007" TYPE="JOURNAL_ARTICLE">
<AU>Shafiq N, Bhasin B, Pattanaik S, Pandhi P, Venkateshan SP, Singh M, et al</AU>
<TI>A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia</TI>
<SO>International Journal of Clinical Pharmacology and Therapeutics</SO>
<YR>2007</YR>
<VL>45</VL>
<NO>10</NO>
<PG>548-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tonstad-1997a" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Tonstad 1997a" TYPE="JOURNAL_ARTICLE">
<AU>Tonstad S</AU>
<TI>A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits</TI>
<SO>Drug safety</SO>
<YR>1997</YR>
<VL>16</VL>
<NO>5</NO>
<PG>330-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US-FDA-2010" MODIFIED="2012-04-20 11:56:34 +0100" MODIFIED_BY="anita  s malhotra" NAME="US FDA 2010" TYPE="OTHER">
<AU>U.S. Food and Drug Administration</AU>
<TI>Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease</TI>
<SO>http://www.gpo.gov/fdsys/pkg/FR-2010-12-08/pdf/2010-30386.pdf</SO>
<YR>(accessed 01 March 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wray-1996" MODIFIED="2008-11-21 14:38:04 +0000" MODIFIED_BY="Tracey Remmington" NAME="Wray 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wray R, Neil H, Rees J</AU>
<TI>Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association</TI>
<SO>Journal of Royal College of Physicians London</SO>
<YR>1996</YR>
<VL>30</VL>
<NO>2</NO>
<PG>115-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yeste-2009" MODIFIED="2014-05-22 12:12:14 +0100" MODIFIED_BY="[Empty name]" NAME="Yeste 2009" TYPE="JOURNAL_ARTICLE">
<AU>Yeste D, Chacon P, Clemente M, Albisu MA, Gussinye M, Carracosa A</AU>
<TI>Ezetimibe as monotherapy in the treatment of hypercholesterolemia in children and adolescents</TI>
<SO>Journal of Pediatric Endocrinology and Metabolism</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>6</NO>
<PG>487-92</PG>
<IDENTIFIERS MODIFIED="2013-08-18 08:37:12 +0100" MODIFIED_BY="anita  s malhotra">
<IDENTIFIER MODIFIED="2013-08-18 08:37:12 +0100" MODIFIED_BY="anita  s malhotra" TYPE="OTHER" VALUE="Yeste 2009"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zavala-2006" MODIFIED="2012-04-20 11:58:51 +0100" MODIFIED_BY="anita  s malhotra" NAME="Zavala 2006" TYPE="OTHER">
<AU>Zavala D, Martí-Carvajal A, Peña-Martí G, Comunián G</AU>
<TI>Data extraction sheet to help manage the characteristics of included studies in Cochrane reviews. Valencia: Universidad de Carabobo, 2006.</TI>
<SO>www.cochrane.fcs.uc.edu.ve/hrs</SO>
<YR>(accessed 01 March 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-04-20 14:00:19 +0100" MODIFIED_BY="Tracey Remmington">
<REFERENCE ID="REF-Shafiq-2010" MODIFIED="2012-04-20 14:00:19 +0100" MODIFIED_BY="Tracey Remmington" NAME="Shafiq 2010" TYPE="COCHRANE_REVIEW">
<AU>Shafiq N, Singh M, Kaur S,Khosla P, Malhotra S</AU>
<TI>Dietary treatment for familial hypercholesterolaemia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD001918.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="Nikki Jahnke">
<REFERENCE ID="REF-" MODIFIED="2012-02-05 10:27:22 +0000" MODIFIED_BY="anita  s malhotra" NAME="" TYPE="JOURNAL_ARTICLE">
<AU>Párraga I, López-Torres J, Andrés F, Navarro B, del Campo JM, García-Reyes M, Galdón MP, Lloret A, Precioso JC, Rabanales J.</AU>
<TI>Effect of plant sterols on the lipid profile of patients with hypercholesterolaemia. Randomised, experimental study.</TI>
<YR>BMC Complement Altern Med 2011 Sep 12;11:73.</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aldamiz_x002d_Echevarria-2006" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Aldamiz-Echevarria 2006" TYPE="JOURNAL_ARTICLE">
<AU>Aldamiz-Echevarria L, Dalmau J, Prieto JA, Andrade F, Sanjurjo P, Elorz J, et al</AU>
<TI>[A randomized single-blind trial of the effects of vitamins C and E in familial hypercholesterolemia]</TI>
<TO>Ensayo aleatorizado ciego-sencillo sobre los efectos de las vitaminas C y E en la hipercolesterolemia</TO>
<SO>Anales de Pediatria (barc)</SO>
<YR>2006</YR>
<VL>65</VL>
<NO>2</NO>
<PG>101-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002871"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baldassarre-2006" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Baldassarre 2006" TYPE="JOURNAL_ARTICLE">
<AU>Baldassarre D, Amato M, Eligini S, Barbieri SS, Mussoni L, Frigerio B, et al</AU>
<TI>Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention</TI>
<SO>Annals of Medicine</SO>
<YR>2006</YR>
<VL>38</VL>
<NO>5</NO>
<PG>367-75</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003020"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Barter-1974" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Barter 1974" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Barter PJ, Connor WE, Spector AA, Armstrong M, Connor SL, Newman MA</AU>
<TI>Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Studies in patients with types II-A and II-B</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1974</YR>
<VL>81</VL>
<NO>5</NO>
<PG>619-24</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000039"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Briani-1975" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Briani 1975" TYPE="JOURNAL_ARTICLE">
<AU>Briani G, Fellin R, Balestrieri P, Baggio G, Baiocchi MR, Crepaldi G</AU>
<TI>Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin</TI>
<TO>Trattamento a lungo termine dell'ipercolesterolemia familiare con colestipol, una nuova resina a scambio anionico</TO>
<SO>Giornale Italiano Di Cardiologia</SO>
<YR>1975</YR>
<VL>5</VL>
<PG>390-404</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002466"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Broekhuizen-2012" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Broekhuizen 2012" TYPE="JOURNAL_ARTICLE">
<AU>Broekhuizen K, van Poppel MN, Koppes LL, Kindt I, Brug J, van Mechelen W</AU>
<TI>Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial</TI>
<SO>PloS One</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>12</NO>
<PG>e50032</PG>
<CY>United States</CY>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011563"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Castano-2005" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Castano 2005" TYPE="JOURNAL_ARTICLE">
<AU>Castano G, Fernandez L, Mas R, Illnait J, Gamez R, Mendoza S, et al</AU>
<TI>Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia</TI>
<SO>Drugs in R&amp;D</SO>
<YR>2005</YR>
<VL>6</VL>
<NO>4</NO>
<PG>207-19</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002762"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Jongh-2002" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="de Jongh 2002" TYPE="JOURNAL_ARTICLE">
<AU>de Jongh S, Ose L, Szamosi T, Gagne C, Lambert M, Scott R, et al</AU>
<TI>Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin</TI>
<SO>Circulation</SO>
<YR>2002</YR>
<VL>106</VL>
<NO>17</NO>
<PG>2231-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002253"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Jongh-2002a" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="de Jongh 2002a" TYPE="JOURNAL_ARTICLE">
<AU>de Jongh S, Stalenhoef AFH, Tuohy MB, Mercuri M, Bakker HD, Kastelein JJP</AU>
<TI>Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia: Rationale, design and baseline characteristics</TI>
<SO>Clinical Drug Investigation</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>8</NO>
<PG>533-40</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002335"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Jongh-2003" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="de Jongh 2003" TYPE="JOURNAL_ARTICLE">
<AU>de Jongh S, Stalenhoef AFH, Tuohy MB, Mercuri M, Bakker HD, Kastelein JJP</AU>
<TI>Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolemia: rationale, design, and baseline characteristics</TI>
<SO>Klinicka Biochemie a Metabolismus</SO>
<YR>2003</YR>
<VL>32</VL>
<NO>3</NO>
<PG>157-62</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002573"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ditschuneit-1980" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Ditschuneit 1980" TYPE="JOURNAL_ARTICLE">
<AU>Ditschuneit VHH, Hutt V, Klor H-U, Ditschuneit H</AU>
<TI>Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV</TI>
<TO>Die Wirkung von Etofyllinclofibrat auf die Zusammensetzung der Lipoproteine bei Hyperlipoproteinamien Typ IIb und IV</TO>
<SO>Arzneimittel-Forschung</SO>
<YR>1980</YR>
<VL>30 (II)</VL>
<PG>2063-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002478"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Engler-2003" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Engler 2003" TYPE="JOURNAL_ARTICLE">
<AU>Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, et al</AU>
<TI>Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial</TI>
<SO>Circulation</SO>
<YR>2003</YR>
<VL>108</VL>
<NO>9</NO>
<PG>1059-63</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002326"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Engler-2005" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Engler 2005" TYPE="JOURNAL_ARTICLE">
<AU>Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML</AU>
<TI>Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study)</TI>
<SO>American Journal of Cardiology</SO>
<YR>2005</YR>
<VL>95</VL>
<NO>7</NO>
<PG>869-71</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002718"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Feussner-1992" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Feussner 1992" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Feussner G, Eichinger M, Ziegler R</AU>
<TI>The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia</TI>
<SO>Clinical Investigation</SO>
<YR>1992</YR>
<VL>70</VL>
<NO>11</NO>
<PG>1027-35</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000556"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Graisely-1980" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Graisely 1980" TYPE="JOURNAL_ARTICLE">
<AU>Graisely B, Cloarec M</AU>
<TI>Cross-over study of benfluorex and a hypolipemic agent in diet-resistant types IV and II b hyperlipemia</TI>
<TO>Etude de l'efficacite du benfluorex et d'un hypolipidemiant de reference en traitement croise dans les hyperlipidemies de types IV et II b non corrigees par le regime seul</TO>
<SO>Semaine Des Hopitaux</SO>
<YR>1980</YR>
<VL>56</VL>
<NO>25-28</NO>
<PG>1221-5</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002489"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Greyling-2006" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Greyling 2006" TYPE="JOURNAL_ARTICLE">
<AU>Greyling A, De Witt C, Oosthuizen W, Jerling JC</AU>
<TI>Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects</TI>
<SO>British Journal of Nutrition</SO>
<YR>2006</YR>
<VL>95</VL>
<NO>5</NO>
<PG>968-75</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002843"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grundy-2005" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Grundy 2005" TYPE="JOURNAL_ARTICLE">
<AU>Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J</AU>
<TI>Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)</TI>
<SO>American Journal of Cardiology</SO>
<YR>2005</YR>
<VL>95</VL>
<NO>4</NO>
<PG>462-8</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002659"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hjerkinn-2005" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Hjerkinn 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, et al</AU>
<TI>Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>3</NO>
<PG>583-9</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002665"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hoeg-1986" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Hoeg 1986" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Hoeg JM, Maher MB, Zech LA, Bailey KR, Gregg RE, Lackner KJ, et al</AU>
<TI>Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia</TI>
<SO>American Journal of Cardiology</SO>
<YR>1986</YR>
<VL>57</VL>
<NO>11</NO>
<PG>933-9</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000257"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Holtz-1983" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Holtz 1983" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Holtz H, Heinrich J, Duck KD, Ruhling K, Heller R, Schauer I</AU>
<TI>Effectiveness of different intervention measures in children and adolescents with hypertension and lipid metabolism disorders</TI>
<TO>Effektivitat unterschiedlicher Interventionsmassnahmen bei Kindern und Jugendlichen mit Hypertonie und Fettstoffwechselstorungen</TO>
<SO>Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete</SO>
<YR>1983</YR>
<VL>38</VL>
<NO>23</NO>
<PG>644-9</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000193"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kiseleva-1994" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kiseleva 1994" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Kiseleva NG</AU>
<TI>Induracin, prolonged-action nicotinic acid, in the treatment of atherogenic dyslipoproteinemia</TI>
<TO>Vozmozhnosti korrektsii aterogennykh dislipoproteidemii induratsinom -- prolongirovannoi formoi nikotinovoi kisloty</TO>
<SO>Klinicheskaia Meditsina</SO>
<YR>1994</YR>
<VL>72</VL>
<NO>3</NO>
<PG>20-4</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000655"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kwiterovich-2001" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kwiterovich 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kwiterovich PO</AU>
<TI>Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin</TI>
<SO>Nutrition, Metabolism, and Cardiovascular Diseases : NMCD</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>Suppl 5</NO>
<PG>30-4</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002343"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lansberg-1994" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Lansberg 1994" NOTES="&lt;p&gt;Vanessa Jane Poustie [09/12/2003][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Lansberg PJ, Knipscheer HC, Kastelein JJ, Prins MH, van-der-Ende AE</AU>
<TI>The effect of Fiberform, a low-phytate wheat fibre, on plasma lipids and blood pressure of women with familial hypercholesterolaemia [letter]</TI>
<SO>Journal of Internal Medicine</SO>
<YR>1994</YR>
<VL>236</VL>
<NO>4</NO>
<PG>477-8</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000647"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lekakis-2004" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Lekakis 2004" TYPE="JOURNAL_ARTICLE">
<AU>Lekakis JP, Papamichael CM, Papaioannou TG, Dagre AG, Stamatelopoulos KS, Tryfonopoulos D, et al</AU>
<TI>Oral folic acid enhances endothelial function in patients with hypercholesterolaemia receiving statins</TI>
<SO>European Journal of Cardiovascular Prevention and Rehabilitation</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>5</NO>
<PG>416-20</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002676"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Levy-1973" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Levy 1973" TYPE="JOURNAL_ARTICLE">
<AU>Levy RI, Fredrickson DS, Stone NJ, Bilheimer DW, Brown WV, Glueck CJ, et al</AU>
<TI>Cholestyramine in type II hyperlipoproteinemia. A double-blind trial</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1973</YR>
<VL>79</VL>
<NO>1</NO>
<PG>51-8</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000025"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lipid-1983" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Lipid 1983" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Lipid RCP</AU>
<TI>Pre-entry characteristics of participants in the Lipid Research Clinics' Coronary Primary Prevention Trial</TI>
<SO>Journal of Chronic Diseases</SO>
<YR>1983</YR>
<VL>36</VL>
<NO>6</NO>
<PG>467-79</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000174"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mackness-1994" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Mackness 1994" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, et al</AU>
<TI>Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>48</VL>
<NO>12</NO>
<PG>859-65</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000672"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mordasini-1978" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Mordasini 1978" TYPE="JOURNAL_ARTICLE">
<AU>Mordasini R, Twelsick F, Oster P, Schellenberg B, Raetzer H, Heuck CC, et al</AU>
<TI>A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia</TI>
<TO>Eine vergleichende Untersuchung von Colestyramin und Colestipol bei Kindern und Heranwachsenden mit familiarer Hypercholesterinamie</TO>
<SO>Monatsschrift Fur Kinderheilkunde</SO>
<YR>1978</YR>
<VL>126</VL>
<NO>7</NO>
<PG>436-40</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002512"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nestel-1997" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Nestel 1997" NOTES="&lt;p&gt;Alpo Vuorio [11/03/2010][][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, et al</AU>
<TI>A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: Prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin</TI>
<SO>Atherosclerosis</SO>
<YR>1997</YR>
<VL>129</VL>
<NO>2</NO>
<PG>231-9</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003499"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nishimura-1999" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Nishimura 1999" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Nishimura S, Sekiguchi M, Kano T, Ishiwata S, Nagasaki F, Nishide T, et al</AU>
<TI>Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)</TI>
<SO>Atherosclerosis</SO>
<YR>1999</YR>
<VL>144</VL>
<NO>2</NO>
<PG>409-17</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000001724"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nordoy-2003" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Nordoy 2003" TYPE="JOURNAL_ARTICLE">
<AU>Nordoy A, Svensson B, Hansen JB</AU>
<TI>Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia</TI>
<SO>Journal of Thrombosis and Haemostasis : JTH</SO>
<YR>2003</YR>
<VL>1</VL>
<NO>4</NO>
<PG>690-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002378"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Connor-1977" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="O'Connor 1977" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>O'Connor J, Ballantyne D, Pollock JG, Cairney B, Lawrie TDV</AU>
<TI>Limb blood flow in treated hyperlipoproteinaemic patients with peripheral vascular disease. A preliminary report</TI>
<SO>Atherosclerosis</SO>
<YR>1977</YR>
<VL>27</VL>
<NO>3</NO>
<PG>325-31</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000068"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Neill-2005" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="O'Neill 2005" TYPE="JOURNAL_ARTICLE">
<AU>O'Neill FH, Sanders TA, Thompson GR</AU>
<TI>Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies</TI>
<SO>American Journal of Cardiology</SO>
<YR>2005</YR>
<VL>96</VL>
<NO>1A</NO>
<PG>29D-36D</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002726"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Paragh-2004" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Paragh 2004" TYPE="JOURNAL_ARTICLE">
<AU>Paragh G, Torocsik D, Seres I, Harangi M, Illyes L, Balogh Z, et al</AU>
<TI>Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia</TI>
<SO>Current Medical Research and Opinions</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>8</NO>
<PG>1321-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002636"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pownall-1999" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Pownall 1999" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Pownall HJ, Brauchi D, Kilinc C, Osmundsen K, Pao Q, Payton-Ross C, et al</AU>
<TI>Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins</TI>
<SO>Atherosclerosis</SO>
<YR>1999</YR>
<VL>143</VL>
<NO>2</NO>
<PG>285-97</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000897"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rodenburg-2006" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Rodenburg 2006" TYPE="JOURNAL_ARTICLE">
<AU>Rodenburg J, Vissers MN, Wiegman A, Miller ER, Ridker PM, Witztum JL, et al</AU>
<TI>Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin</TI>
<SO>Journal of the American College of Cardioliology</SO>
<YR>2006</YR>
<VL>47</VL>
<NO>9</NO>
<PG>1803-10</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002847"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sauvanet-1978" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Sauvanet 1978" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Sauvanet JP, Drouin P, Debry G, Mejean L, Lambert D</AU>
<TI>Type II hyperlipoproteinemia: treatment with colestipol and procetophen [letter]</TI>
<TO>Hyperlipoproteinemies de type II. Traitement par colestipol et procetofene</TO>
<SO>Nouvelle Presse Medicale</SO>
<YR>1978</YR>
<VL>7</VL>
<NO>21</NO>
<PG>1862</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000079"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stefanutti-1997" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Stefanutti 1997" TYPE="JOURNAL_ARTICLE">
<AU>Stefanutti C, Di Giacomo S, Vivenzio A, Bosco G, Colloridi V, Bucci A</AU>
<TI>Diet only and diet plus simvastatin in the treatment of heterozygous familial hyperchoesterolemia in childhood [abstract]</TI>
<SO>Atherosclerosis</SO>
<YR>1997</YR>
<VL>134</VL>
<NO>1-2</NO>
<PG>383</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002525"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stein-2003" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Stein 2003" TYPE="JOURNAL_ARTICLE">
<AU>Stein EA, Strutt K, Southworth H, Diggle PJ, Miller E</AU>
<TI>Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia</TI>
<SO>American Journal of Cardiology</SO>
<YR>2003</YR>
<VL>92</VL>
<NO>11</NO>
<PG>1287-93</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002452"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stein-2004" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Stein 2004" TYPE="JOURNAL_ARTICLE">
<AU>Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, et al</AU>
<TI>Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin</TI>
<SO>American Heart Journal</SO>
<YR>2004</YR>
<VL>148</VL>
<NO>3</NO>
<PG>447-55</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002638"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Uusitupa-1992" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Uusitupa 1992" NOTES="&lt;p&gt;Alpo Vuorio [07/12/2006][][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Uusitupa MI, Miettinen TA, Happonen P, Ebeling T, Turtola H, Voutilainen E, et al</AU>
<TI>Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum</TI>
<SO>Arteriosclerosis and Thrombosis</SO>
<YR>1992</YR>
<VL>12</VL>
<NO>7</NO>
<PG>807-13</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000531"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vacek-1995" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Vacek 1995" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Vacek JL, Dittmeier G, Chiarelli T, White J, Bell HH</AU>
<TI>Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia</TI>
<SO>American Journal of Cardiology</SO>
<YR>1995</YR>
<VL>76</VL>
<NO>3</NO>
<PG>182-4</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000698"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weisweiler-1976" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Weisweiler 1976" TYPE="JOURNAL_ARTICLE">
<AU>Weisweiler P, Schwandt P</AU>
<TI>Treatment of primary hyperlipoproteinemias type IV with different biguanides</TI>
<TO>Behandlung der primaren Hyperlipoproteinamie Typ IV mit verschiedenen Biguaniden</TO>
<SO>Klinische Wochenschrift</SO>
<YR>1976</YR>
<VL>54</VL>
<PG>283-5</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002536"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weisweiler-1989" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Weisweiler 1989" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Weisweiler P</AU>
<TI>Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia</TI>
<SO>Metabolism: Clinical and Experimental</SO>
<YR>1989</YR>
<VL>38</VL>
<NO>3</NO>
<PG>271-4</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000000378"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wiegman-2004" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Wiegman 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Buller HR, et al</AU>
<TI>Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>292</VL>
<NO>3</NO>
<PG>331-7</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002544"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zavoral-1983" MODIFIED="2013-09-19 15:00:47 +0100" MODIFIED_BY="[Empty name]" NAME="Zavoral 1983" NOTES="&lt;p&gt;Vanessa Jane Poustie [01/10/2002][09/12/2003][]&lt;/p&gt;" NOTES_MODIFIED="2013-09-19 15:00:47 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Zavoral JH, Hannan P, Fields DJ, Hanson MN, Frantz ID, Kuba K, et al</AU>
<TI>The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>38</VL>
<NO>2</NO>
<PG>285-94</PG>
<IDENTIFIERS MODIFIED="2013-09-19 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002132"/>
</IDENTIFIERS>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-05-22 11:56:01 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-05-22 11:56:01 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-09-19 15:57:41 +0100" MODIFIED_BY="Tracey Remmington" STUDY_ID="STD-Amundsen-2002">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-19 15:57:41 +0100" MODIFIED_BY="Tracey Remmington">
<P>41 children with confirmed or suspected FH (mean age 10.5 years +/- 1.7 years). Three dropped out (2 because of family problems and one because she found the amount of spread was too large</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-19 13:49:55 +0100" MODIFIED_BY="Tracey Remmington">
<P>Plant sterol-enriched fat spread (8 weeks) versus a control spread not enriched with plant sterols (8 weeks). 4-week washout period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Total, LDL, HDL cholesterol, triacylglycerol, apolipoprotein A1 and B, carotenoids, retinol and alpha-tocopherol concentrations, and albumin and other blood biochemistry.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>3 children were withdrawn from the trial and not followed up.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-27 13:38:16 +0100" MODIFIED_BY="Tracey Remmington" STUDY_ID="STD-Balestrieri-1996">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-27 13:38:16 +0100" MODIFIED_BY="Tracey Remmington">
<P>16 participants (7 females, 9 males) with heterozygous FH (mean age 45.2 +/- 15.0 years).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-27 13:37:34 +0100" MODIFIED_BY="Tracey Remmington">
<P>Lipid lowering diet &amp; 6 g fish oil ethylester/day for 4 weeks versus lipid lowering diet &amp; 6 g olive oil/day for 4 weeks. 4 week washout period. All patients maintained on lipid lowering medication (simvastatin, dose range 10 - 40 mg) throughout both arms of the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Total cholesterol, HDL, LDL, triglycerides, apolipoprotein A1 &amp;B and Lp(a) concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:37:28 +0100" MODIFIED_BY="Tracey Remmington">
<P>NB. short-term outcomes only will be assessed.<BR/>2 patients were withdrawn from the trial and not included in the analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-27 13:37:13 +0100" MODIFIED_BY="Tracey Remmington" STUDY_ID="STD-Chisholm-1992">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-27 13:37:07 +0100" MODIFIED_BY="Tracey Remmington">
<P>19 participants (11 females, 8 males) with FH, mean age 51 +/- 10yrs.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>3 x 8 weeks periods (high fat, low fat, high fat verses low fat, high fat, low fat). Maintained on lipid lowering medication (simvastatin) throughout all arms of trial. Low fat diet = 27% energy from total fat, 8% energy from saturated fat, high fat diet = 38% energy from total fat, 14% energy from saturated fat.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:10:57 +0100" MODIFIED_BY="Tracey Remmington">
<P>Total &amp; HDL cholesterol, triglycerides and apolipoprotein A1 &amp; B.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:37:13 +0100" MODIFIED_BY="Tracey Remmington">
<P>NB. short-term outcomes only will be assessed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-02-27 12:35:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Engler-2004">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-19 15:41:29 +0100" MODIFIED_BY="Nikki Jahnke">
<P>20 participants (9 - 19 years) with FH or familial combined hyperlipidemia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>DHA (1.2 gm/day) was combined with NCEP-II diet (6 weeks) followed by placebo after a washout period of 2 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-02-27 12:35:18 +0000" MODIFIED_BY="[Empty name]">
<P>Total, LDL, VLDL, HDL and triglyceride levels were measured.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:11:04 +0100" MODIFIED_BY="Tracey Remmington">
<P>Short-term outcomes only will be assessed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-02 01:31:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guardamagna-2011a">
<CHAR_METHODS MODIFIED="2012-04-27 13:40:10 +0100" MODIFIED_BY="anita  s malhotra">
<P>Double-blind, randomised, placebo-controlled, cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-02 01:31:03 +0100" MODIFIED_BY="[Empty name]">
<P>Children with familial hypercholesterolemia (n = 24 ) and combined familial hyperlipidemia (n = 16).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-19 13:51:16 +0100" MODIFIED_BY="anita  s malhotra">
<P>Dietary supplement containing 200 mg red yeast rice extract, corresponding to 3 mg of monacolins, and 10 mg policosanols once-daily (for 8 weeks) versus placebo (for 8 weeks). 4-week washout period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-02 01:10:20 +0100" MODIFIED_BY="[Empty name]">
<P>Total cholesterol, LDL-C, apolipoprotein B, HDL-C.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-02 01:10:20 +0100" MODIFIED_BY="[Empty name]">
<P>No subgroup analysis presented by type of hypercholesterolemia.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-27 13:38:38 +0100" MODIFIED_BY="Tracey Remmington" STUDY_ID="STD-Gylling-1995">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-27 13:38:38 +0100" MODIFIED_BY="Tracey Remmington">
<P>14 children (7 females, 7 males) with heterozygous FH, mean age 9.1 +/- 1.1 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Rapeseed oil margarine with or without sitostanol ester for 6 weeks in addition to low fat, low cholesterol diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Total, VLDL, HDL &amp; LDL cholesterol, phospholipids &amp; triglycerides &amp; apolipoprotein E.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>NB. Short-term outcomes only will be assessed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-21 23:58:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<CHAR_METHODS MODIFIED="2012-04-27 13:11:59 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, controlled, cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-21 23:58:16 +0100" MODIFIED_BY="[Empty name]">
<P>Pediatric patients with hypercholesterolaemia with a subgroup of 16 patients who had FH.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-27 13:12:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Low fat diet with plant stanol spread compared with low fat diet with sterol ester spread for 5 weeks; separated by a 5-week washout period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:12:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Total, VLDL, HDL &amp; LDL cholesterol, triglycerides, Apo-B and non-cholesterol sterols.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:12:04 +0100" MODIFIED_BY="[Empty name]">
<P>NB: Only short term outcomes were assessed, data for the 17 patients with FH not available.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-22 00:19:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<CHAR_METHODS MODIFIED="2014-05-22 00:19:07 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-09 15:04:40 +0100" MODIFIED_BY="anita  s malhotra">
<P>5 adult participants with FH.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-19 13:54:25 +0100" MODIFIED_BY="anita  s malhotra">
<P>Sterol and stanol for 4 weeks for each treatment period. No washout period described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:36:21 +0100" MODIFIED_BY="anita  s malhotra">
<P>Total, HDL &amp; LDL cholesterol, triglycerides.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-19 13:54:10 +0100" MODIFIED_BY="anita  s malhotra">
<P>Only short-term outcomes were assessed in small number of participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-22 11:56:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<CHAR_METHODS MODIFIED="2014-05-22 11:56:01 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, controlled, cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-21 23:58:38 +0100" MODIFIED_BY="[Empty name]">
<P>18 adults (6 males, 12 females) with FH on cholesterol-lowering drug therapy. Mean (SEM) age of 48 (2) years).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-19 16:19:54 +0100" MODIFIED_BY="[Empty name]">
<P>Low fat plant sterol ester spread or low fat plant stanol ester spread over over and above ongoing drug therapy.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:35:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Total, VLDL, HDL &amp; LDL cholesterol, triglycerides, Apo-B and non-cholesterol sterols.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:35:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>NB: Only short term outcomes were assessed; No treatment period involved a phase of lipid-lowering drug given alone.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-21 23:56:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laurin-1991">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-21 23:56:03 +0100" MODIFIED_BY="[Empty name]">
<P>10 children (4 females, 6 males) with heterozygous FH, aged 6 - 12 years (mean (SD) 8 (1) year).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cows milk diet + regular diet (4 weeks) followed by soy-beverage diet + regular diet (4 weeks) or vice versa. 4 week washout period on regular diet between treatment arms.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Total, HDL, VLDL, LDL cholesterol, triglycerides, phospholipids &amp; apolipoprotein A-1 &amp; B.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-21 23:56:03 +0100" MODIFIED_BY="[Empty name]">
<P>NB. 2 children were excluded from the final analysis.<BR/>Short term outcomes only will be assessed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-19 13:54:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Neil-2001">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-18 16:12:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>30 adults with heterozygous FH and 32 with type IIa primary hypercholesterolaemia (26 females), (mean age 51.6 years).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-19 13:54:47 +0100" MODIFIED_BY="Tracey Remmington">
<P>A plant sterol-enriched fat spread (8 weeks) versus a control fat spread not enriched with plant sterols (8 weeks). No washout period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:34:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Serum total, HDL, LDL cholesterol, apolipoprotein A-1 and B, liver function tests and plant sterol and cholesterol precursor sterol levels.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:34:58 +0100" MODIFIED_BY="Tracey Remmington">
<P>Due to evidence of significant carry-over effect , analysis was restricted to first treatment period only. The authors provided data for only 15 patients with FH.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-09 15:05:02 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Nigon-2001">
<CHAR_METHODS MODIFIED="2012-07-19 13:55:02 +0100" MODIFIED_BY="anita  s malhotra">
<P>Randomised, double-blind,placebo-controlled two-period cross-over trial with 2 treatments and 3 periods. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-09 15:05:02 +0100" MODIFIED_BY="anita  s malhotra">
<P>53 primary hypercholesterolaemia participants (22 men and 31 women).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-19 13:55:17 +0100" MODIFIED_BY="anita  s malhotra">
<P>Spread enriched with plant sterols was compared to non-enriched control spread.<BR/>1.6 g/day of plant sterols . The plant sterol content consisted of sitosterol esters (50%), campesterol esters (25%), stigmasterol esters (20%) and 10% of other esters. Treatment periods: 2 months each, with a washout period of 2 months between them.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:33:56 +0100" MODIFIED_BY="anita  s malhotra">
<P>Total and LDL-C concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-27 13:33:56 +0100" MODIFIED_BY="anita  s malhotra">
<P>Fibrates were used additionally in 19 participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-22 11:55:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Neill-2004">
<CHAR_METHODS MODIFIED="2014-05-22 11:55:33 +0100" MODIFIED_BY="[Empty name]">
<P>Radnomised double blind, parallel trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-22 11:55:05 +0100" MODIFIED_BY="[Empty name]">
<P>145 participants recruited, 11 excluded, 134 completed trial. 69 participants with FH (57% female, mean age 53 years), 65 unaffected (69% female, mean age 46 years).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-22 00:21:52 +0100" MODIFIED_BY="[Empty name]">
<P>3 treatment groups: STE: 1.6g + 1 placebo cereal bar daily; LSTA: 1.6g + 1 placebo cereal bar daily; HSTA: 1.6 g+ 1 g stanol ester daily. Each treatment lasted 2 months following a 1 month run-in on placebo margarine and followed by a 1-month washout on placebo margarine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-27 13:13:07 +0100" MODIFIED_BY="Tracey Remmington">
<P>Changes in serum lipids, total and LDL cholesterol, serum apoB and LDL cholesterol: apo B ratios, changes in non-cholesterol sterols (lathosterol, sitosterol, campesterol), changes in 7 alpha OH-cholestenone.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-22 00:19:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wirth-1982">
<CHAR_METHODS MODIFIED="2014-05-22 00:19:36 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-02 01:03:03 +0100" MODIFIED_BY="[Empty name]">
<P>12 adult patients with familial hypercholesterolemia, 11 out of 12 had an isolated hypercholesterolemia (type IIa).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-02 01:03:13 +0100" MODIFIED_BY="[Empty name]">
<P>Bezafibrate at a dose of 200 mg t.i.d was prescribed for 2 months during the initial period. First group was given 5.2 g guar t.i.d in a granulate form in addition to the 200 mg bezafibrate t.i.d during the second 2-month period. They were then subsequently treated in the next period of 2 month with bezafibrate alone. In the other group the sequence was reversed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-02 01:02:55 +0100" MODIFIED_BY="[Empty name]">
<P>Serum lipids and lipoprotein levels.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-02 01:02:55 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-22 11:54:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolfe-1992">
<CHAR_METHODS>
<P>Randomised controlled cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-27 13:12:50 +0100" MODIFIED_BY="Tracey Remmington">
<P>5 patients with FH (3 females, 2 males) mean (SD) age 48 (6) years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-22 11:54:13 +0100" MODIFIED_BY="[Empty name]">
<P>4 - 5 weeks of high-protein, low-fat diet versus 4 - 5 weeks of low-protein, low-fat diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Fasting blood lipoprotein levels (LDL, HDL, VLDL, triglycerides).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>NB. Short term outcomes only will be assessed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>FH: familial hypercholesterolaemia<BR/>HDL: high density lipoprotein<BR/>HSTA: high-dose stanol group<BR/>LDL: low density lipoprotein<BR/>LSTA: low-dose stanol group<BR/>SEM: standard error of the mean<BR/>STE: plant sterol ester<BR/>VLDL: very low density lipoprotein<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-09-20 11:23:27 +0100" MODIFIED_BY="Nikki Jahnke" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Abbey-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Abbey-1993a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Abbey-1993b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Abrahamson-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ahmed-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:25:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ahrens-1954">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:25:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:18 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ahrens-1957">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:18 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ahrens-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Am-Acad-Paed-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 05:30:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amundsen-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 05:30:06 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Anderson-1957">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Anderson-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:26:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Anderson-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:26:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:06 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Anderson-1984a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:06 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Anderson-1984b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Asherio-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Atkinson-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:43 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Baggio-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:43 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-23 12:46:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bartram-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-23 12:46:46 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Becker-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:27:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Becker-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:27:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beil-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beitz-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Berg-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Berge-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Berry-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Best-1954">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:28:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Best-1955">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:28:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:13 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Best-1956">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beveridge-1955">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beveridge-1957">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beveridge-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Beynen-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bierenbaum-1963">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:42 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bierenbaum-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:42 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-20 11:23:27 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Blair-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-20 11:23:27 +0100" MODIFIED_BY="anita  s malhotra">
<P>No patients with familial hypercholesterolemia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:29:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Blankenhorn-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:29:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not diet vs diet</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:01 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Blaton-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:01 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Boberg-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bonanome-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bonanome-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bowry-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Boyd-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:30:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Braden-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:30:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:31:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brensike-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:31:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:31:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brensike-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:31:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:27:03 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brinton-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:27:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:31:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Briones-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:31:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:32:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brongeest-1979a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:32:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:32:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brongeest-1979b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:32:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brongeest-1979c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bronte_x002d_Stewart-1956">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brown-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brox-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 05:51:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brox-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 05:51:29 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bruckner-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:33:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brude-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:33:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Brussaard-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Burr-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Canetti-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not diet</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carlson-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carmen_x002d_Ramon-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:34:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carranza-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:34:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:35:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carroll-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:35:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:35:28 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carroll-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:35:28 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal studies</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:33:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carroll-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:33:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:35:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Carroll-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:35:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:00 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Chait-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Chang-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Chen-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal studies</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:25 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Chenoweth-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:25 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Childs-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Clevidence-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Clifton-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:36:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Cobb-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:36:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:13 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Cole-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Colquhoun-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Connor-1961a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:28 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Connor-1961b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:28 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:29 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Connor-1964">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:29 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Connor-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:44 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Corder-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:44 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Cortese-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:37:59 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Crouse-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:37:59 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Da-Col-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:14 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dattilo-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:18 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Davidson-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:18 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:27 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Davis-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:27 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-de-Groot-1963">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-10 14:22:45 +0000" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-De-Jong-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-10 14:22:45 +0000" MODIFIED_BY="anita  s malhotra">
<P>No F H pts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Demke-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Demke-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:38:59 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Denke-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:38:59 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Descovich-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Detre-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:28 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dieber-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:28 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dreon-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:43 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dreon-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:43 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dreon-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:39:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Durrington-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:39:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Dyerberg-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-East-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Edington-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ehnholm-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:38:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ehnholm-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:38:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Elkeles-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Erickson-1964">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Eritsland-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:40:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ernst-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:40:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Failor-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:07 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Falko-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fallat-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:18 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Farquhar-1956">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:18 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Farquhar-1958">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fehily-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fernandes-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT, drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fernandes-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ferro_x002d_Luzzi-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:41:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fisher-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:41:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Flaim-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Flynn-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Follick-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Forsythe-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Review article, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Frank-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Frankel-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Frantz-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:42:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Frantz-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:42:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Friday-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not cholesterol-lowering diet</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fumagalli-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:32 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Fumagalli-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:32 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT, not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:43 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gaddi-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:43 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:46 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Galvan-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:46 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gardner-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:12:12 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Gardner-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:12:12 +0100" MODIFIED_BY="anita  s malhotra">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:59 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:59 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:43:59 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:43:59 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Glueck-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Goldberg-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Goodnight-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:29 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gordon-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:29 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 13:23:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gordon-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 13:23:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Non-interventional study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:46 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Grande-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:46 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:44:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Grande-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:44:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gries-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:14 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Groot-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Grundy-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:26 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Grundy-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:26 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Grundy-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-10 14:00:08 +0000" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Guardamagna-2011b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-10 14:00:08 +0000" MODIFIED_BY="anita  s malhotra">
<P>Natural HMGCoA inhibitor used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gustafsson-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gustafsson-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:45:59 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gustafsson-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:45:59 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gustafsson-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gustafsson-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:14 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gylling-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:13:11 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Gylling-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:13:11 +0100" MODIFIED_BY="anita  s malhotra">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:14:15 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Gylling-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:14:15 +0100" MODIFIED_BY="anita  s malhotra">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:43:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hansen-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:43:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Study in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Harris-1983a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Harris-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Harris-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:46:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hashim-1960">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:46:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:07 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hay-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hegsted-1965">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hegsted-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hegsted-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Heinemann-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Helms-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hennekens-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Herold-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hodges-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:47:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hoeg-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:47:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Holme-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 12:54:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Holmes-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 12:54:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not in patients with FH.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hooper-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hopkins-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Huff-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hunninghake-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:48:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Iacono-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:48:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Illingworth-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jackson-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jakubowski-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jenkins-1975a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jenkins-1975b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jenkins-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jialal-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:42 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Jialal-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:42 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:49:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Joyner-1955">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:49:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-07 11:28:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Judd-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-07 11:28:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Participants did not have familial hypercholesterolemia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:50:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kane-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:50:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:50:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kane-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:50:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:50:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kestin-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:50:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-16 15:37:49 +0100" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Ketom_x00e4_ki-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-16 15:37:49 +0100" MODIFIED_BY="anita  s malhotra">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:50:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Keys-1957">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:50:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:50:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Keys-1965a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:50:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-05 13:39:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Keys-1965b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-05 13:39:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-05 13:39:27 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Keys-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-05 13:39:27 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Khan-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kingsbury-1961">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kinsell-1952">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kirby-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kok-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kris_x002d_Etherton-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kromhout-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:51:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kudchodkar-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:51:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:06 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kuo-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:06 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:07 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kuo-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kuusi-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:27 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Laine-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:27 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lambert-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:44 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Leaf-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:44 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Leelarthaepin-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:52:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lees-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:52:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:53:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Leibman-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:53:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:53:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-LeLorier-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:53:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:53:13 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lewis-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:53:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-05 13:40:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lichtenstein-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-05 13:40:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:53:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lifshitz-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:53:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lindgard-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-06 05:35:44 +0000" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Linnebur-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-06 05:35:44 +0000" MODIFIED_BY="anita  s malhotra">
<P>No FH pts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:53:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lithell-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:53:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:32 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lorenz-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:32 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:25 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lovati-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:25 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:51 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-LRCP-1984a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:51 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-LRCP-1984b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:54:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Macdonald-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:54:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-05 13:40:22 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mackness-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-05 13:40:22 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT<BR/>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Malmros-1957">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-06 05:48:26 +0000" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Mannarinno-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-06 05:48:26 +0000" MODIFIED_BY="anita  s malhotra">
<P>No F H pts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Maranhao-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Marshall-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:25 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mata-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:25 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:26 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mathur-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:26 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mattson-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mattson-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:46 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mattson-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:46 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:55:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mattson-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:55:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mattson-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-McCombs-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-McGill-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mellies-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:40 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mensink-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:40 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:43 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:43 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:56:50 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1989a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:56:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1989b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 13:09:26 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1992a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 13:09:26 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Study not relevant</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:25 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1992b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:25 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miettinen-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Miller-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mokino-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:57:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Morita-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:57:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:58:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-MRC-1965">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:58:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:58:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-MRC-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:58:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:58:42 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nagakawa-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:58:42 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:58:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Napoli-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:58:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:58:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-NDHSRG-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:58:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:59:03 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Neil-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:59:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:59:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nenseter-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:59:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:59:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nessim-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:59:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH, drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 15:59:46 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 15:59:46 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:00 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:19 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1992a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:19 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nestel-1992b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nilson-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nydahl-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Nyyssonen-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:00:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Olszewski-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:00:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:00 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Omenn-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ordovas-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:14 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Parks-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Parthasarathy-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Peto-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Phillipson-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:01:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Pirich-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:01:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:02:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Princen-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:02:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT, not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:02:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Quintao-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:02:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:02:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Radack-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:02:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:01 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Radack-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:01 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:13 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Rapola-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:18 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reaven-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:18 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reaven-1993a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reaven-1993b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reaven-1993c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reaven-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:03:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Reiser-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:03:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:04:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Retzloff-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:04:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 13:12:31 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Riccardi-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 13:12:31 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:04:46 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Rivellese-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:04:46 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:04:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Roberts-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:04:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:04:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Rona-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:04:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Rose-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Rosenthal-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sacks-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:12 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sanders-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:12 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sanders-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-11 13:18:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sanders-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-11 13:18:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not in patients with FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Saynor-1982a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Saynor-1984a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:05:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Saynor-1984b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:05:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Schaefer-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:07 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Schectman-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Schlierf-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:24 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Schonfeld-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:24 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:26 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Schwandt-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:26 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Segall-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:39 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Seppanen_x002d_Laakso-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:42 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Seppanen_x002d_Laakso-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:42 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:53 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Shepherd-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:53 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Shepherd-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Shorey-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:06:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Siess-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:06:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Simons-1985a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Simons-1985b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:25 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Singer-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:25 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Singer-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Singer-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sirtori-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:42 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sirtori-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:42 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:07:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sirtori-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:07:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sirtori-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sirtori-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sperling-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:21 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Stein-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Stein-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Stephens-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:54 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Subbaiah-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Sucic-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:08:57 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Szczeklik-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:08:57 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:07 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Thorngren-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Thorngren-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:08 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Thorngren-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:08 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:20 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Tonstad-1997b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:23 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ullmann-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:23 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-23 12:47:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Uusitupa-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-23 12:47:46 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not per protocol</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:32 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Valsta-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:32 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:32 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Van-Gent-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:32 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Van-Horn-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:40 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vanhanen-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:40 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:09:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vanhanen-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:09:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:00 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vanhanen-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-06 05:58:40 +0000" MODIFIED_BY="anita  s malhotra" STUDY_ID="STD-Varady-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-06 05:58:40 +0000" MODIFIED_BY="anita  s malhotra">
<P>No FH pts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vega-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Verrillo-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:14 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vessby-1980a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:14 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:15 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vessby-1980b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:16 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Vessby-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:32 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Von-Schacky-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:32 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:34 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Von-Schacky-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:34 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-31 11:21:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vuorio-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-31 11:21:07 +0100" MODIFIED_BY="[Empty name]">
<P> Non-randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:45 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Wardlaw-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:45 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Weisweiler-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:48 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Weisweiler-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:48 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:10:58 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Widhalm-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:10:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:02 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Widhalm-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:02 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:13 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Williams-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Wilson-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:30 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Wilt-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:30 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Witters-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:35 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Wolf-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:35 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:44 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Wolfe-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:44 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:11:49 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Worne-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:11:49 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:12:03 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Yacowitz-1965">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:12:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:12:18 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zhao-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:12:18 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH, drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:12:28 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zimmerman-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:12:28 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH, not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:12:38 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zino-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:12:38 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:12:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zock-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:12:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:13:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zucker-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:13:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH, drug study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-20 16:13:09 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Zucker-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 16:13:09 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not defined FH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT=Randomised controlled trial<BR/>FH=Familial hypercholesterolaemia<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-05-22 11:55:45 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-05-22 11:55:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fuentes-2008">
<CHAR_METHODS MODIFIED="2014-05-22 11:55:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised and cross-over dietary intervention trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-02 01:30:39 +0100" MODIFIED_BY="[Empty name]">
<P>38 participants with FH were recruited, but only 30 were subjected to 4 low-fat dietary intervention periods.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-02 01:30:39 +0100" MODIFIED_BY="[Empty name]">
<P>4 low-fat dietary intervention periods, each of 4 weeks. Each intervention had a different content of cholesterol (&lt; 150 or 300 mg/day) and sitosterol (&lt; 1 or 2 g/day).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-21 23:38:38 +0100" MODIFIED_BY="[Empty name]">
<P>Plasma sitosterol/cholesterol ratio, basal sitosterol concentrations, change in LDL-C.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-02-27 11:57:01 +0000" MODIFIED_BY="[Empty name]">
<P>Duration of intervention 4 weeks.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-05-22 11:55:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stein-2007">
<CHAR_METHODS MODIFIED="2014-05-22 11:55:45 +0100" MODIFIED_BY="[Empty name]">
<P>Open-label, non-comparative, multicenter study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-22 00:22:30 +0100" MODIFIED_BY="[Empty name]">
<P>1380 individuals with severe hypercholesterolaemia, including heterozygous familial hypercholesterolaemia. Individuals were 18 years old or over with fasting LDL-C greater than or equal to 190 and less than or equal to 260  mg/dl and triglycerides under 400 mg/dl.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-10-19 16:53:21 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Rosuvastatin 40 mg for 48 weeks. An optional additional 48-week treatment period followed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-28 09:19:45 +0000" MODIFIED_BY="Nikki Jahnke">
<P>The initial period had 2 primary end points: percentage of patients achieving National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III LDL cholesterol goals at 12 weeks, and long-term safety, assessed during 48 weeks by incidence and severity of adverse events and abnormal laboratory values.</P>
<P>Safety was the primary end point in the extension period.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-21 23:38:21 +0100" MODIFIED_BY="[Empty name]">
<P>6-week dietary lead-in.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>FH: familial hypercholesterolaemia<BR/>LDL-C: low density lipoprotein cholesterol</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-05-22 00:22:50 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-05-22 00:22:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-P_x00e1_rraga-ongoing">
<CHAR_STUDY_NAME MODIFIED="2014-05-22 00:22:44 +0100" MODIFIED_BY="[Empty name]">
<P>Párraga 2011.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-22 00:22:46 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, placebo controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-05 10:40:32 +0000" MODIFIED_BY="anita  s malhotra">
<P>Adults with "limit" or "defined" hypercholesterolaemia and who have LDL cholesterol levels of 130 mg/dl or over.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-22 00:22:49 +0100" MODIFIED_BY="[Empty name]">
<P>Yoghurt containing 2 g of plant sterol ester per container versus yoghurt without sterol for 24 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-22 00:22:50 +0100" MODIFIED_BY="[Empty name]">
<P>Change in lipid profile at 1, 3, 6, 12, 18 and 24 months.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-05 10:42:11 +0000" MODIFIED_BY="anita  s malhotra">
<P>iparraga@sescam.jccm.es</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-05-22 11:54:38 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-05-22 00:22:05 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:10:21 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Amundsen-2002">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:10:46 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Balestrieri-1996">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:10:59 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Chisholm-1992">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:03 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Engler-2004">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:40:15 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Guardamagna-2011a">
<DESCRIPTION>
<P>Arbitrary allocation was done but randomisation procedure unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:50 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Gylling-1995">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:36:38 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 00:19:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<DESCRIPTION>
<P>Described as a randomised trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:35:12 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:34:47 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Laurin-1991">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:34:35 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Neil-2001">
<DESCRIPTION>
<P>Computer-generated random numbers were used to assign the participants to either test or the control group with equal probability.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-16 06:49:58 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Nigon-2001">
<DESCRIPTION>
<P>Stated randomised, method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 00:22:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Neill-2004">
<DESCRIPTION>
<P>Stated "randomised" but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-02 01:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wirth-1982">
<DESCRIPTION>
<P>Details not given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:12:16 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Wolfe-1992">
<DESCRIPTION>
<P>Stated 'randomised' but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-05-22 00:19:30 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:10:22 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Amundsen-2002">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:10:48 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Balestrieri-1996">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chisholm-1992">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:03 +0100" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Engler-2004">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:32 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Guardamagna-2011a">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:11:51 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Gylling-1995">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:36:35 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:35:36 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:35:10 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:34:47 +0100" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Laurin-1991">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 00:19:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Neil-2001">
<DESCRIPTION>
<P>Tamper proof block randomisation was used and clinic and lab staff remained unaware of the assigned treatment throughout the trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:33:51 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Nigon-2001">
<DESCRIPTION>
<P>A physician allocated each person to one of the treatments for each period such that the design was balanced, in the following order: non-enriched control spread was followed by phytosterol enriched spread or the reverse order.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:13:02 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Neill-2004">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-02 01:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wirth-1982">
<DESCRIPTION>
<P>Details not given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 13:12:15 +0100" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Wolfe-1992">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-05-02 01:02:39 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:10:23 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Amundsen-2002">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:10:49 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Balestrieri-1996">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:11:01 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Chisholm-1992">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:11:08 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Engler-2004">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:11:38 +0100" MODIFIED_BY="anita  s malhotra" RESULT="YES" STUDY_ID="STD-Guardamagna-2011a">
<DESCRIPTION>
<P>Described as double blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:11:52 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Gylling-1995">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:36:36 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:35:35 +0100" MODIFIED_BY="anita  s malhotra" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<DESCRIPTION>
<P>Double-blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:35:09 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:34:48 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Laurin-1991">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:34:33 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Neil-2001">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:33:47 +0100" MODIFIED_BY="anita  s malhotra" RESULT="YES" STUDY_ID="STD-Nigon-2001">
<DESCRIPTION>
<P>Double blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:13:01 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2004">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-05-02 01:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wirth-1982">
<DESCRIPTION>
<P>Details not given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-04-27 13:12:14 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Wolfe-1992">
<DESCRIPTION>
<P>Described as double-blind, but not stated who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-05-22 00:19:21 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-22 00:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Amundsen-2002">
<DESCRIPTION>
<P>3 participants were withdrawn from the trials and not included in the final analysis. 2 girls dropped out during the trial because of family problems not related to the project, and a third because she found that the amount of spread was too large.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-22 00:19:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Balestrieri-1996">
<DESCRIPTION>
<P>2 participants withdrew from one trial due to medical reasons (1 suffered a heart attack and one required vascular surgery) and not included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-08-05 15:40:12 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Chisholm-1992">
<DESCRIPTION>
<P>Unclear if an intention-to-treat analysis was carried out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-02 01:30:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Engler-2004">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate. No dropouts.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-27 13:11:42 +0100" MODIFIED_BY="anita  s malhotra" RESULT="UNKNOWN" STUDY_ID="STD-Guardamagna-2011a">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-27 13:11:53 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Gylling-1995">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-02 01:10:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate. No dropouts.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-27 13:35:30 +0100" MODIFIED_BY="anita  s malhotra" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<DESCRIPTION>
<P>Included all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-27 13:35:08 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-22 00:19:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Laurin-1991">
<DESCRIPTION>
<P>2 participants were withdrawn from the trial for lack of compliance and elevated serum lipid levels and not included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-22 00:09:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Neil-2001">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate. No dropouts.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-11 12:00:03 +0100" MODIFIED_BY="anita  s malhotra" RESULT="YES" STUDY_ID="STD-Nigon-2001">
<DESCRIPTION>
<P>One patient did not consume the full amount of intervention and another stopped it for 10 days. Both were included in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-11 12:05:21 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2004">
<DESCRIPTION>
<P>All patients were included in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-02 01:02:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wirth-1982">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-02-27 11:53:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wolfe-1992">
<DESCRIPTION>
<P>Intention-to-treat analysis was considered adequate.There were no dropouts.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-05-22 11:54:38 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-02 01:31:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amundsen-2002">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 07:59:26 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Balestrieri-1996">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-18 04:21:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chisholm-1992">
<DESCRIPTION>
<P>Selective reporting of outcomes was not found</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 07:59:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Engler-2004">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guardamagna-2011a">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gylling-1995">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-01 05:10:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2003">
<DESCRIPTION>
<P>No reporting bias was noted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2004a">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ketom_x00e4_ki-2005">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laurin-1991">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-15 08:00:51 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Neil-2001">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 11:54:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nigon-2001">
<DESCRIPTION>
<P>No reporting bias was observed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 00:22:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Neill-2004">
<DESCRIPTION>
<P>Reporting bias was not present.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-02 01:02:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wirth-1982">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-22 11:54:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wolfe-1992">
<DESCRIPTION>
<P>All the outcomes stated in methods were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-08-05 15:45:59 +0100" MODIFIED_BY="Nikki Jahnke" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-05-22 11:49:40 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-09-20 11:31:34 +0100" MODIFIED_BY="Nikki Jahnke" NO="1">
<NAME>Cholesterol-lowering diet compared to no dietary intervention or nutritional advice</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2013-09-20 09:58:35 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.8703737052424194" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum total cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-low diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.01" MODIFIED="2012-03-10 13:49:08 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.15489010946384107" CI_START="-0.9548901094638418" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="5.96" MEAN_2="6.36" ORDER="527" SD_1="0.75" SD_2="0.98" SE="0.2831124009628461" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2013-09-20 09:59:12 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.8703737052424194" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" MODIFIED="2012-03-10 13:49:23 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.2533893869043683" CI_START="-0.7933893869043674" EFFECT_SIZE="-0.2699999999999996" ESTIMABLE="YES" MEAN_1="3.95" MEAN_2="4.22" ORDER="528" SD_1="0.7" SD_2="0.93" SE="0.2670403084101527" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2013-09-20 11:31:34 +0100" MODIFIED_BY="Nikki Jahnke" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.55" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" MODIFIED="2013-08-15 14:28:22 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.12229805709173033" CI_START="-0.3422980570917301" EFFECT_SIZE="-0.10999999999999988" ESTIMABLE="YES" MEAN_1="1.33" MEAN_2="1.44" MODIFIED="2013-08-15 14:25:00 +0100" MODIFIED_BY="anita  s malhotra" ORDER="529" SD_1="0.35" SD_2="0.38" SE="0.11852159474565228" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2012-03-10 13:51:51 +0000" MODIFIED_BY="Nikki Jahnke" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.15" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.01" MODIFIED="2012-03-10 13:50:35 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.5496814303489477" CI_START="-0.42968143034894757" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.55" MEAN_2="1.49" ORDER="530" SD_1="0.78" SD_2="0.76" SE="0.2498420553701457" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2013-09-20 10:01:47 +0100" MODIFIED_BY="Nikki Jahnke" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="0.2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein A1 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.01" MODIFIED="2013-08-28 01:52:49 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="-0.008040537400350739" CI_START="-0.11595946259964937" EFFECT_SIZE="-0.062000000000000055" ESTIMABLE="YES" MEAN_1="1.408" MEAN_2="1.47" MODIFIED="2013-08-28 01:52:49 +0100" MODIFIED_BY="anita  s malhotra" ORDER="531" SD_1="0.0010" SD_2="0.12" SE="0.02753084394676365" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2013-09-20 10:03:17 +0100" MODIFIED_BY="Nikki Jahnke" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.17458326123997808" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein B-100 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>No diet intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.01" MODIFIED="2013-08-28 01:54:14 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.034973649619716815" CI_START="-0.05497364961971683" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.968" MEAN_2="0.978" MODIFIED="2013-08-28 01:54:14 +0100" MODIFIED_BY="anita  s malhotra" ORDER="532" SD_1="0.0020" SD_2="0.1" SE="0.022946161242993868" STUDY_ID="STD-Chisholm-1992" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-05-22 11:49:17 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>&#969;-fatty acids added to background cholesterol-lowering diet compared to cholesterol-lowering diet</NAME>
<CONT_OUTCOME CHI2="0.17293979485305339" CI_END="0.6861008601573336" CI_START="-0.7977341175142744" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.05581662867847038" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2009-07-20 14:30:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.677512518955746" P_Q="0.677512518955746" P_Z="0.882773812563677" Q="0.17293979485305339" RANDOM="NO" SCALE="2.273693756453429" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="34" UNITS="" WEIGHT="100.0" Z="0.14745383899753142">
<NAME>Fasting serum total cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours man-fat diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9439578455734139" CI_START="-0.8439578455734142" DF="0" EFFECT_SIZE="0.04999999999999982" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2009-07-20 14:10:45 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.9127084949339959" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="68.87746215339111" Z="0.10962284151569036">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.9439578455734139" CI_START="-0.8439578455734142" EFFECT_SIZE="0.04999999999999982" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="7.75" ORDER="45" SD_1="1.14" SD_2="1.27" SE="0.4561093227349275" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="68.87746215339111"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0398973074420743" CI_START="-1.6198973074420744" DF="0" EFFECT_SIZE="-0.29000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" MODIFIED="2009-07-20 14:10:45 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="1.0" P_Z="0.6690926925147433" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="31.122537846608896" Z="0.42739356816193336">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.0398973074420743" CI_START="-1.6198973074420744" EFFECT_SIZE="-0.29000000000000004" ESTIMABLE="YES" MEAN_1="7.4" MEAN_2="7.69" ORDER="572" SD_1="2.2" SD_2="2.09" SE="0.67853150258481" STUDY_ID="STD-Engler-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="31.122537846608896"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.1283897546122159" CI_END="0.6902769748443289" CI_START="-0.9285760971799901" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1191495611678306" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2009-07-20 14:30:15 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.7201075514863267" P_Q="0.7201075514863267" P_Z="0.7729552437825349" Q="0.1283897546122159" RANDOM="NO" SCALE="2.273693756453429" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="34" UNITS="" WEIGHT="99.99999999999999" Z="0.288511480996457">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours man-fat diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9543237611637359" CI_START="-0.994323761163735" DF="0" EFFECT_SIZE="-0.019999999999999574" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2009-07-20 14:11:44 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.9679079318351138" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="69.01576213505282" Z="0.04023229367205466">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.9543237611637359" CI_START="-0.994323761163735" EFFECT_SIZE="-0.019999999999999574" ESTIMABLE="YES" MEAN_1="5.87" MEAN_2="5.89" ORDER="46" SD_1="1.34" SD_2="1.29" SE="0.4971130943471803" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="69.01576213505282"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1141427054629411" CI_START="-1.7941427054629409" DF="0" EFFECT_SIZE="-0.33999999999999986" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" MODIFIED="2009-07-20 14:11:44 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="1.0" P_Z="0.6467595740762012" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="30.984237864947165" Z="0.45826847134062193">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.1141427054629411" CI_START="-1.7941427054629409" EFFECT_SIZE="-0.33999999999999986" ESTIMABLE="YES" MEAN_1="5.53" MEAN_2="5.87" ORDER="574" SD_1="2.51" SD_2="2.17" SE="0.7419231766160159" STUDY_ID="STD-Engler-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="30.984237864947165"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06196020856396311" CI_END="0.12955439930927592" CI_START="-0.09882695105490151" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.01536372412718721" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2014-03-15 07:45:02 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8034241556799807" P_Q="0.8034241556799807" P_Z="0.7920093080423352" Q="0.06196020856396311" RANDOM="NO" SCALE="0.5888218344553405" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="26" UNITS="" WEIGHT="100.0" Z="0.26370231991078774">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours man-fat diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours chol-lowdiet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3449997757719081" CI_START="-0.40499977577190815" DF="0" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2009-07-20 14:12:55 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.8754046698181662" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.272551745625611" Z="0.1567972125187772">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.3449997757719081" CI_START="-0.40499977577190815" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="1.34" MEAN_2="1.37" ORDER="47" SD_1="0.47" SD_2="0.54" SE="0.19132993194255532" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="9.272551745625611"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1398840186784306" CI_START="-0.09988401867843055" DF="0" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.02" MODIFIED="2014-03-15 07:45:02 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7436855157470575" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="12" WEIGHT="90.7274482543744" Z="0.3269766906625547">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.1398840186784306" CI_START="-0.09988401867843055" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.34" MEAN_2="1.32" MODIFIED="2014-03-15 07:45:02 +0000" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="0.27" SD_2="0.034" SE="0.06116643959994184" STUDY_ID="STD-Engler-2004" TOTAL_1="20" TOTAL_2="12" WEIGHT="90.7274482543744"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.17589382964098765" CI_END="0.43353660241439107" CI_START="-0.07334266173866541" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.18009697033786284" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2014-03-15 07:48:21 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6749260334387936" P_Q="0.6749260334387936" P_Z="0.16368880494510632" Q="0.17589382964098765" RANDOM="NO" SCALE="0.8448833969317635" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="34" UNITS="" WEIGHT="100.0" Z="1.3927718119492978">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours man-fat diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6176247333299041" CI_START="-0.13762473332990416" DF="0" EFFECT_SIZE="0.24" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2009-07-20 14:13:33 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.2128899193266799" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="45.04309205308518" Z="1.2456582283201911">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.6176247333299041" CI_START="-0.13762473332990416" EFFECT_SIZE="0.24" ESTIMABLE="YES" MEAN_1="1.26" MEAN_2="1.02" ORDER="48" SD_1="0.66" SD_2="0.29" SE="0.19266922061250097" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="45.04309205308518"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4728718833417261" CI_START="-0.21087188334172607" DF="0" EFFECT_SIZE="0.131" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.02" MODIFIED="2014-03-15 07:48:21 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.45263594267176266" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="54.95690794691482" Z="0.7510277811237882">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.47287188334172614" CI_START="-0.21087188334172613" EFFECT_SIZE="0.131" ESTIMABLE="YES" MEAN_1="1.44" MEAN_2="1.309" MODIFIED="2014-03-15 07:48:21 +0000" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="0.78" SD_2="0.01" SE="0.1744276354251241" STUDY_ID="STD-Engler-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="54.95690794691482"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2013-08-28 01:48:47 +0100" MODIFIED_BY="Nikki Jahnke" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="66.86309084220213" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein A1 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours man-fat diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.01" MODIFIED="2013-08-28 01:48:39 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.3101743683767473" CI_START="-0.3501743683767473" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="1.27" MODIFIED="2013-08-28 01:48:39 +0100" MODIFIED_BY="[Empty name]" ORDER="579" SD_1="0.42" SD_2="0.47" SE="0.16845940587741437" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2013-08-28 01:51:42 +0100" MODIFIED_BY="Nikki Jahnke" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="59.426742529519004" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein B-100 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Manipulated fat diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours man-fat diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.06.01" MODIFIED="2013-08-28 01:51:06 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="22.011641161254325" CI_START="-21.99164116125433" EFFECT_SIZE="0.009999999999999787" ESTIMABLE="YES" MEAN_1="2.05" MEAN_2="2.04" MODIFIED="2013-08-28 01:51:06 +0100" MODIFIED_BY="[Empty name]" ORDER="580" SD_1="0.42" SD_2="42.0" SE="11.225533394899326" STUDY_ID="STD-Balestrieri-1996" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-05-22 11:49:40 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Plant stanols added to cholesterol-lowering diet compared to cholesterol-lowering diet alone</NAME>
<CONT_OUTCOME CHI2="0.5230031274721716" CI_END="0.9578019464618348" CI_START="0.07127420162854659" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5145380740451907" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2014-02-27 14:37:49 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4695635068542291" P_Q="1.0" P_Z="0.022899057948100692" Q="0.0" RANDOM="NO" SCALE="2.3207454489026516" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="99.99999999999999" Z="2.2751145684511465">
<NAME>Fasting serum total cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant stanols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours stanol diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.5230031274721716" CI_END="0.9578019464618348" CI_START="0.07127420162854659" DF="1" EFFECT_SIZE="0.5145380740451907" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2012-03-10 13:01:21 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.4695635068542291" P_Z="0.022899057948100692" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="99.99999999999999" Z="2.2751145684511465">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.7252513173088078" CI_START="-0.10525131730880666" EFFECT_SIZE="0.8100000000000005" ESTIMABLE="YES" MEAN_1="7.62" MEAN_2="6.81" ORDER="581" SD_1="1.2" SD_2="1.27" SE="0.46697353855896984" STUDY_ID="STD-Gylling-1995" TOTAL_1="14" TOTAL_2="14" WEIGHT="23.455459597199553"/>
<CONT_DATA CI_END="0.9306467094034725" CI_START="-0.08264670940347174" EFFECT_SIZE="0.4240000000000004" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.526" MODIFIED="2012-03-10 13:01:21 +0000" MODIFIED_BY="anita  s malhotra" ORDER="54" SD_1="0.491" SD_2="0.305" SE="0.25849796904424605" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="76.54454040280044"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06699009769389258" CI_END="0.9907435410274412" CI_START="0.4343777456077669" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.712560643317604" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2014-02-27 12:08:01 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7957706937812213" P_Q="1.0" P_Z="5.156034405716151E-7" Q="0.0" RANDOM="NO" SCALE="3.27" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="100.0" Z="5.02041358113946">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant stanols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plant stanol</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.06699009769389258" CI_END="0.9907435410274412" CI_START="0.4343777456077669" DF="1" EFFECT_SIZE="0.712560643317604" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2012-03-11 12:01:57 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.7957706937812213" P_Z="5.156034405716151E-7" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="5.02041358113946">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.679834977791762" CI_START="-0.03983497779176326" EFFECT_SIZE="0.8199999999999994" ESTIMABLE="YES" MEAN_1="5.47" MEAN_2="4.65" ORDER="582" SD_1="1.12" SD_2="1.2" SE="0.43869937640386825" STUDY_ID="STD-Gylling-1995" TOTAL_1="14" TOTAL_2="14" WEIGHT="10.467202764670697"/>
<CONT_DATA CI_END="0.9939945976810074" CI_START="0.4060054023189912" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="4.81" MEAN_2="4.11" MODIFIED="2012-03-11 12:01:57 +0000" MODIFIED_BY="anita  s malhotra" ORDER="54" SD_1="0.33" SD_2="0.06" SE="0.15" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="89.5327972353293"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06945975744211698" CI_END="-7.401825701829484E-4" CI_START="-0.15138771158637732" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07606394707828013" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2014-02-27 12:08:10 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7921250072346026" P_Q="1.0" P_Z="0.04779080043460887" Q="0.0" RANDOM="NO" SCALE="5.16" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="100.00000000000001" Z="1.9792239244676042">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant stanols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours plant stanol</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours chol-lowdiet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.06945975744211698" CI_END="-7.401825701829484E-4" CI_START="-0.15138771158637732" DF="1" EFFECT_SIZE="-0.07606394707828013" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" MODIFIED="2012-03-11 12:03:59 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.7921250072346026" P_Z="0.04779080043460887" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.00000000000001" Z="1.9792239244676042">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.1579515586005195" CI_START="-0.25795155860051955" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.25" ORDER="583" SD_1="0.26" SD_2="0.3" SE="0.10609968358644081" STUDY_ID="STD-Gylling-1995" TOTAL_1="14" TOTAL_2="14" WEIGHT="13.120176405733186"/>
<CONT_DATA CI_END="8.113853066509663E-4" CI_START="-0.16081138530665112" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" MEAN_1="1.29" MEAN_2="1.37" MODIFIED="2012-03-11 12:03:59 +0000" MODIFIED_BY="anita  s malhotra" ORDER="55" SD_1="0.06" SD_2="0.07" SE="0.04123105625617661" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="86.87982359426682"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.4323122847301954" CI_END="0.2710655262510889" CI_START="-0.21773923463226003" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.026663145809414427" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2014-02-27 12:08:17 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5108565421774467" P_Q="1.0" P_Z="0.8306852310706665" Q="0.0" RANDOM="NO" SCALE="5.16" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="19" UNITS="" WEIGHT="100.0" Z="0.21382281713685553">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant stanols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours stanol diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.4323122847301954" CI_END="0.2710655262510889" CI_START="-0.21773923463226003" DF="1" EFFECT_SIZE="0.026663145809414427" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.01" MODIFIED="2012-03-10 13:08:09 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.5108565421774467" P_Z="0.8306852310706665" STUDIES="2" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="0.21382281713685553">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.4584895647176356" CI_START="-0.2384895647176356" EFFECT_SIZE="0.10999999999999999" ESTIMABLE="YES" MEAN_1="1.03" MEAN_2="0.92" ORDER="584" SD_1="0.49" SD_2="0.45" SE="0.17780406551675276" STUDY_ID="STD-Gylling-1995" TOTAL_1="14" TOTAL_2="14" WEIGHT="49.18484500574052"/>
<CONT_DATA CI_END="0.28885367128447115" CI_START="-0.39685367128447124" EFFECT_SIZE="-0.05400000000000005" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.454" MODIFIED="2012-03-10 13:08:09 +0000" MODIFIED_BY="anita  s malhotra" ORDER="55" SD_1="0.258" SD_2="0.294" SE="0.174928556845359" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="50.81515499425947"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-02-27 13:12:00 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Plant sterols added to cholesterol-lowering diet compared to cholesterol-lowering diet</NAME>
<CONT_OUTCOME CHI2="3.472108831100713" CI_END="0.4796708424328985" CI_START="0.11856250926148293" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2991166758471907" ESTIMABLE="YES" I2="13.597178373900427" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2014-02-27 12:08:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.32439768569657124" P_Q="1.0" P_Z="0.001166317194624849" Q="0.0" RANDOM="NO" SCALE="3.02" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="111" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="3.246991874638037">
<NAME>Fasting serum total cholesterol concentration(mmol/l)</NAME>
<GROUP_LABEL_1>Chol lowering diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant sterols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sterol diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.472108831100713" CI_END="0.4796708424328985" CI_START="0.11856250926148293" DF="3" EFFECT_SIZE="0.2991166758471907" ESTIMABLE="YES" I2="13.597178373900427" ID="CMP-004.01.01" MODIFIED="2012-03-10 13:27:46 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.32439768569657124" P_Z="0.001166317194624849" STUDIES="4" TAU2="0.0" TOTAL_1="111" TOTAL_2="111" WEIGHT="100.0" Z="3.246991874638037">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.3204202455758778" CI_START="-0.10042024557587714" EFFECT_SIZE="0.6100000000000003" ESTIMABLE="YES" MEAN_1="7.48" MEAN_2="6.87" ORDER="585" SD_1="1.7" SD_2="1.45" SE="0.36246596936453" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="6.459283866357145"/>
<CONT_DATA CI_END="0.43219161348115165" CI_START="-0.09219161348115179" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" MEAN_1="2.59" MEAN_2="2.42" MODIFIED="2012-03-10 13:17:33 +0000" MODIFIED_BY="anita  s malhotra" ORDER="56" SD_1="0.214" SD_2="0.209" SE="0.1337736894908711" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="47.421734816280406"/>
<CONT_DATA CI_END="1.538293570966879" CI_START="0.06170642903312229" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="6.98" MEAN_2="6.18" ORDER="586" SD_1="1.28" SD_2="0.7" SE="0.3766873150682583" STUDY_ID="STD-Neil-2001" TOTAL_1="15" TOTAL_2="15" WEIGHT="5.980766631492655"/>
<CONT_DATA CI_END="0.6119892570617519" CI_START="0.042010742938248025" EFFECT_SIZE="0.32699999999999996" ESTIMABLE="YES" MEAN_1="2.743" MEAN_2="2.416" MODIFIED="2012-03-10 13:27:46 +0000" MODIFIED_BY="anita  s malhotra" ORDER="57" SD_1="0.62" SD_2="0.858" SE="0.14540535403186527" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="40.1382146858698"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.384468119726586" CI_END="-0.30566364068672336" CI_START="-0.8864016057998939" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5960326232433086" ESTIMABLE="YES" I2="11.359779620487169" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2014-02-27 12:08:34 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.33605830767415634" P_Q="1.0" P_Z="5.742111441252896E-5" Q="0.0" RANDOM="YES" SCALE="4.51" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.010500564273008738" TOTALS="SUB" TOTAL_1="111" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="4.023165507838511">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Plant sterols</GROUP_LABEL_1>
<GROUP_LABEL_2>Cholesterol-lowering</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sterol diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours chol-lowdiet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.384468119726586" CI_END="-0.30566364068672336" CI_START="-0.8864016057998939" DF="3" EFFECT_SIZE="-0.5960326232433086" ESTIMABLE="YES" I2="11.359779620487169" ID="CMP-004.02.01" MODIFIED="2013-08-15 14:39:56 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.33605830767415634" P_Z="5.742111441252896E-5" STUDIES="4" TAU2="0.010500564273008738" TOTAL_1="111" TOTAL_2="111" WEIGHT="100.0" Z="4.023165507838511">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.12284588176262168" CI_START="-1.3828458817626215" EFFECT_SIZE="-0.6299999999999999" ESTIMABLE="YES" MEAN_1="5.25" MEAN_2="5.88" MODIFIED="2013-08-15 14:39:56 +0100" MODIFIED_BY="anita  s malhotra" ORDER="587" SD_1="1.55" SD_2="1.79" SE="0.3841120998655964" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="13.887686582253803"/>
<CONT_DATA CI_END="-0.38093527867898935" CI_START="-1.1990647213210108" EFFECT_SIZE="-0.79" ESTIMABLE="YES" MEAN_1="4.02" MEAN_2="4.81" MODIFIED="2012-03-11 12:19:17 +0000" MODIFIED_BY="anita  s malhotra" ORDER="56" SD_1="0.33" SD_2="0.33" SE="0.20871032557111305" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="40.599780832047905"/>
<CONT_DATA CI_END="-0.06663116740438957" CI_START="-1.533368832595611" EFFECT_SIZE="-0.8000000000000003" ESTIMABLE="YES" MEAN_1="3.89" MEAN_2="4.69" ORDER="588" SD_1="0.75" SD_2="1.24" SE="0.37417464727940436" STUDY_ID="STD-Neil-2001" TOTAL_1="15" TOTAL_2="15" WEIGHT="14.583000746460531"/>
<CONT_DATA CI_END="0.25193702694623843" CI_START="-0.7119370269462393" EFFECT_SIZE="-0.23000000000000043" ESTIMABLE="YES" MEAN_1="4.14" MEAN_2="4.37" MODIFIED="2012-03-10 13:27:11 +0000" MODIFIED_BY="anita  s malhotra" ORDER="58" SD_1="1.42" SD_2="1.09" SE="0.24589075653823061" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="30.929531839237765"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.47558760561788777" CI_END="0.02599384194627715" CI_START="-0.11187126162248501" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.04293870983810393" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2014-02-27 13:11:54 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9242210647036434" P_Q="1.0" P_Z="0.22213174998653662" Q="0.0" RANDOM="NO" SCALE="0.46219666515830915" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="111" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="1.22087928920061">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant sterols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sterol diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.47558760561788777" CI_END="0.02599384194627715" CI_START="-0.11187126162248501" DF="3" EFFECT_SIZE="-0.04293870983810393" ESTIMABLE="YES" I2="0.0" ID="CMP-004.03.01" MODIFIED="2012-03-11 12:21:58 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.9242210647036434" P_Z="0.22213174998653662" STUDIES="4" TAU2="0.0" TOTAL_1="111" TOTAL_2="111" WEIGHT="100.0" Z="1.22087928920061">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.13865563333137074" CI_START="-0.15865563333137075" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="1.26" ORDER="589" SD_1="0.31" SD_2="0.35" SE="0.07584610457332247" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="21.50235206698162"/>
<CONT_DATA CI_END="0.027652254057658116" CI_START="-0.14765225405765822" EFFECT_SIZE="-0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.29" MEAN_2="1.35" MODIFIED="2012-03-11 12:21:58 +0000" MODIFIED_BY="anita  s malhotra" ORDER="57" SD_1="0.06" SD_2="0.08" SE="0.044721359549995794" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="61.84755476108134"/>
<CONT_DATA CI_END="0.20409076707572943" CI_START="-0.3040907670757295" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.44" MEAN_2="1.49" ORDER="590" SD_1="0.35" SD_2="0.36" SE="0.12964052864234496" STUDY_ID="STD-Neil-2001" TOTAL_1="15" TOTAL_2="15" WEIGHT="7.359883549513846"/>
<CONT_DATA CI_END="0.22615781469888416" CI_START="-0.22615781469888416" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.655" MEAN_2="1.655" MODIFIED="2012-03-10 13:29:31 +0000" MODIFIED_BY="anita  s malhotra" ORDER="59" SD_1="0.594" SD_2="0.594" SE="0.11538876044804298" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="9.290209622423196"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.729345886347623" CI_END="0.0886947913540964" CI_START="-0.14897675085116424" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.030140979748533924" ESTIMABLE="YES" I2="83.07890195593662" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2014-02-27 13:12:00 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="5.001572971941037E-4" P_Q="1.0" P_Z="0.6191068293905599" Q="0.0" RANDOM="YES" SCALE="0.9703939336978975" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.009408656019224217" TOTALS="SUB" TOTAL_1="111" TOTAL_2="111" UNITS="" WEIGHT="99.99999999999999" Z="0.49711660233060967">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Plant sterols</GROUP_LABEL_1>
<GROUP_LABEL_2>Cholesterol-lowering</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sterol diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours chol-lowdiet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="17.729345886347623" CI_END="0.0886947913540964" CI_START="-0.14897675085116424" DF="3" EFFECT_SIZE="-0.030140979748533924" ESTIMABLE="YES" I2="83.07890195593662" ID="CMP-004.04.01" MODIFIED="2012-03-11 12:23:33 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="5.001572971941037E-4" P_Z="0.6191068293905599" STUDIES="4" TAU2="0.009408656019224217" TOTAL_1="111" TOTAL_2="111" WEIGHT="99.99999999999999" Z="0.49711660233060967">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.13763303305016739" CI_START="-0.17763303305016742" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="0.8" ORDER="591" SD_1="0.33" SD_2="0.37" SE="0.08042649471804413" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="23.154086005215675"/>
<CONT_DATA CI_END="0.13437540387654745" CI_START="-0.014375403876547344" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.35" MEAN_2="1.29" MODIFIED="2012-03-11 12:23:33 +0000" MODIFIED_BY="anita  s malhotra" ORDER="58" SD_1="0.06" SD_2="0.06" SE="0.03794733192202055" STUDY_ID="STD-Ketom_x00e4_ki-2004a" TOTAL_1="5" TOTAL_2="5" WEIGHT="33.88615210785116"/>
<CONT_DATA CI_END="0.39856077717358895" CI_START="-0.6585607771735887" EFFECT_SIZE="-0.1299999999999999" ESTIMABLE="YES" MEAN_1="1.37" MEAN_2="1.5" ORDER="592" SD_1="0.53" SD_2="0.9" SE="0.26967882131651844" STUDY_ID="STD-Neil-2001" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.475774806888731"/>
<CONT_DATA CI_END="-0.08049122062517478" CI_START="-0.12750877937482497" EFFECT_SIZE="-0.10399999999999987" ESTIMABLE="YES" MEAN_1="1.07" MEAN_2="1.174" MODIFIED="2012-03-10 13:31:59 +0000" MODIFIED_BY="anita  s malhotra" ORDER="60" SD_1="0.067" SD_2="0.056" SE="0.01199449559290852" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="38.48398708004442"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.333454909744775E-5" CI_END="0.14035585365411518" CI_START="-0.08036748103986016" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.029994186307127503" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2014-02-27 12:08:55 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9931673517065913" P_Q="1.0" P_Z="0.594254663947833" Q="0.0" RANDOM="NO" SCALE="1.59" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="91" TOTAL_2="91" UNITS="" WEIGHT="100.00000000000001" Z="0.532680651903534">
<NAME>Fasting serum apolipoprotein A1concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant sterols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sterols</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.333454909744775E-5" CI_END="0.14035585365411518" CI_START="-0.08036748103986016" DF="1" EFFECT_SIZE="0.029994186307127503" ESTIMABLE="YES" I2="0.0" ID="CMP-004.05.01" MODIFIED="2013-08-28 01:56:14 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.9931673517065913" P_Z="0.594254663947833" STUDIES="2" TAU2="0.0" TOTAL_1="91" TOTAL_2="91" WEIGHT="100.00000000000001" Z="0.532680651903534">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.1403696883318254" CI_START="-0.08036968833182535" EFFECT_SIZE="0.030000000000000027" ESTIMABLE="YES" MEAN_1="1.35" MEAN_2="1.32" MODIFIED="2013-08-28 01:55:59 +0100" MODIFIED_BY="[Empty name]" ORDER="593" SD_1="0.23" SD_2="0.26" SE="0.05631210022347726" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="99.9854657678187"/>
<CONT_DATA CI_END="9.14423814628161" CI_START="-9.16423814628161" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.67" MEAN_2="1.68" MODIFIED="2013-08-28 01:56:14 +0100" MODIFIED_BY="anita  s malhotra" ORDER="61" SD_1="0.42" SD_2="34.0" SE="4.670615490125876" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="0.014534232181319804"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.078624428591565E-4" CI_END="0.13247108932314716" CI_START="-0.0924424984885706" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.020014295417288285" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2014-02-27 12:09:00 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9803302559137287" P_Q="1.0" P_Z="0.7272236514361005" Q="0.0" RANDOM="NO" SCALE="1.4" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="91" TOTAL_2="91" UNITS="" WEIGHT="100.0" Z="0.3488210612394703">
<NAME>Fasting serum apolipoprotein B-100 concentratiom (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Plant sterols</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sterols</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.078624428591565E-4" CI_END="0.13247108932314716" CI_START="-0.0924424984885706" DF="1" EFFECT_SIZE="0.020014295417288285" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.01" MODIFIED="2013-08-28 01:59:43 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.9803302559137287" P_Z="0.7272236514361005" STUDIES="2" TAU2="0.0" TOTAL_1="91" TOTAL_2="91" WEIGHT="100.0" Z="0.3488210612394703">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="11.288875837252023" CI_START="-10.968875837252023" EFFECT_SIZE="0.15999999999999992" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="1.32" MODIFIED="2013-08-28 01:59:43 +0100" MODIFIED_BY="[Empty name]" ORDER="594" SD_1="0.39" SD_2="35.0" SE="5.678102212609606" STUDY_ID="STD-Amundsen-2002" TOTAL_1="38" TOTAL_2="38" WEIGHT="0.010211012348760392"/>
<CONT_DATA CI_END="0.13246253583415077" CI_START="-0.09246253583415073" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.23" MEAN_2="1.21" MODIFIED="2013-08-28 01:59:31 +0100" MODIFIED_BY="anita  s malhotra" ORDER="62" SD_1="0.28" SD_2="0.31" SE="0.05737989918245482" STUDY_ID="STD-Nigon-2001" TOTAL_1="53" TOTAL_2="53" WEIGHT="99.98978898765124"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-09-20 10:24:39 +0100" MODIFIED_BY="Nikki Jahnke" NO="5">
<NAME>Soy protein in addition to cholesterol-lowering diet compared to cholesterol-lowering diet</NAME>
<CONT_OUTCOME CHI2="0.06994718987164703" CI_END="0.8082328574329432" CI_START="-0.6465149544496955" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.08085895149162386" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2013-09-20 10:21:44 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.7914136922527564" P_Q="0.7914136922527565" P_Z="0.8275221756024755" Q="0.069947189871647" RANDOM="NO" SCALE="10.944737015892745" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="100.0" Z="0.21788055834386702">
<NAME>Fasting serum total cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9424146005577809" CI_START="-0.9424146005577809" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.01.01" MODIFIED="2009-07-20 14:19:51 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="59.57052425418809" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.9424146005577809" CI_START="-0.9424146005577809" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="7.89" MEAN_2="7.89" ORDER="49" SD_1="1.02" SD_2="1.02" SE="0.4808326112068523" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="59.57052425418809"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.2614101384221633E-33" CI_END="1.3439542656320058" CI_START="-0.9439542656320055" DF="0" EFFECT_SIZE="0.20000000000000015" ESTIMABLE="YES" I2="100.0" ID="CMP-005.01.02" MODIFIED="2009-07-20 14:19:51 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Z="0.7318506885529598" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="40.42947574581191" Z="0.3426647451604589">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.3439542656320058" CI_START="-0.9439542656320055" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="7.1" ORDER="596" SD_1="0.67" SD_2="1.12" SE="0.5836608604318094" STUDY_ID="STD-Wolfe-1992" TOTAL_1="5" TOTAL_2="5" WEIGHT="40.42947574581191"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.1504780814044624" CI_END="0.6928856027910583" CI_START="-0.4562546398358357" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.11831548147761127" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2013-09-20 10:21:53 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.6980790625803304" P_Q="0.6980790625803304" P_Z="0.6865099824143355" Q="0.1504780814044624" RANDOM="NO" SCALE="3.3987572838589424" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="100.00000000000001" Z="0.40359579084887376">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9448697133252025" CI_START="-1.0248697133252027" DF="0" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.01" MODIFIED="2009-07-20 14:20:32 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.9365530288494504" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="34.03521605099536" Z="0.07960297521679921">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.9448697133252025" CI_START="-1.0248697133252027" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="6.29" MEAN_2="6.33" ORDER="50" SD_1="1.11" SD_2="1.02" SE="0.5024937810560445" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="34.03521605099536"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9074356897697705" CI_START="-0.5074356897697702" DF="0" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.02" MODIFIED="2009-07-20 14:20:32 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="1.0" P_Z="0.5795078189901891" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="65.96478394900466" Z="0.5541037900357874">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.9074356897697705" CI_START="-0.5074356897697702" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="5.3" ORDER="598" SD_1="0.45" SD_2="0.67" SE="0.3609432088293115" STUDY_ID="STD-Wolfe-1992" TOTAL_1="5" TOTAL_2="5" WEIGHT="65.96478394900466"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.32129580456718054" CI_END="0.08417773410416378" CI_START="-0.23383254026454625" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07482740308019124" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2013-09-20 10:21:58 +0100" MODIFIED_BY="Nikki Jahnke" NO="3" P_CHI2="0.570830082643855" P_Q="0.570830082643855" P_Z="0.35634399647046944" Q="0.32129580456718054" RANDOM="NO" SCALE="1.5104986960189022" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="100.0" Z="0.9223539420855049">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours chol-lowdiet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13069975090159935" CI_START="-0.23069975090159944" DF="0" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.01" MODIFIED="2009-07-20 14:21:01 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.5875938503168161" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="77.42963356346257" Z="0.542326144546641">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.13069975090159935" CI_START="-0.23069975090159944" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.15" MEAN_2="1.2" ORDER="51" SD_1="0.18" SD_2="0.21" SE="0.09219544457292887" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="77.42963356346257"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1746893174444632" CI_START="-0.4946893174444635" DF="0" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.02" MODIFIED="2009-07-20 14:21:01 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="1.0" P_Z="0.34877340504006715" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="22.570366436537434" Z="0.9369711585684094">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="0.17468931744446314" CI_START="-0.49468931744446343" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" MEAN_1="0.95" MEAN_2="1.11" ORDER="600" SD_1="0.27" SD_2="0.27" SE="0.17076299364909248" STUDY_ID="STD-Wolfe-1992" TOTAL_1="5" TOTAL_2="5" WEIGHT="22.570366436537434"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.3958396445521567" CI_END="0.4999821808157475" CI_START="-0.007674799214212574" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.24615369080076746" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2013-09-20 10:22:30 +0100" MODIFIED_BY="Nikki Jahnke" NO="4" P_CHI2="0.5292460944560657" P_Q="0.5292460944560657" P_Z="0.05734103063085624" Q="0.3958396445521567" RANDOM="NO" SCALE="2.4174770325600794" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" UNITS="" WEIGHT="100.0" Z="1.900702196993884">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4865839233390516" CI_START="-0.04658392333905165" DF="0" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-005.04.01" MODIFIED="2009-07-20 14:21:39 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="1.0" P_Z="0.10577639857529149" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="90.65939614258306" Z="1.6174721686063767">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="0.4865839233390516" CI_START="-0.04658392333905165" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.02" MEAN_2="0.8" ORDER="52" SD_1="0.33" SD_2="0.24" SE="0.13601470508735444" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="90.65939614258306"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.3305253432881128" CI_START="-0.33052534328811245" DF="0" EFFECT_SIZE="0.5000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-005.04.02" MODIFIED="2009-07-20 14:21:39 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="1.0" P_Z="0.2380183921621729" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="9.340603857416944" Z="1.1799543508090973">
<NAME>Over one month and up to two months</NAME>
<CONT_DATA CI_END="1.3305253432881128" CI_START="-0.33052534328811245" EFFECT_SIZE="0.5000000000000002" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="1.7" ORDER="602" SD_1="0.67" SD_2="0.67" SE="0.42374520646256286" STUDY_ID="STD-Wolfe-1992" TOTAL_1="5" TOTAL_2="5" WEIGHT="9.340603857416944"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2013-09-20 10:23:03 +0100" MODIFIED_BY="Nikki Jahnke" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="28.990636753888776" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein A1 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.01" MODIFIED="2013-08-28 02:01:16 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="5.920708548576342" CI_START="-5.840708548576342" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.59" MEAN_2="1.55" MODIFIED="2013-08-28 02:01:16 +0100" MODIFIED_BY="[Empty name]" ORDER="603" SD_1="0.15" SD_2="9.0" SE="3.0004166377354995" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2013-08-28 02:02:48 +0100" MODIFIED_BY="Nikki Jahnke" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="29.242806556518914" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein B-100 concentration (g/l)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.01" MODIFIED="2013-08-28 02:02:16 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="3.921691539951989" CI_START="-3.921691539951989" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.44" MEAN_2="1.44" MODIFIED="2013-08-28 02:02:16 +0100" MODIFIED_BY="[Empty name]" ORDER="604" SD_1="0.18" SD_2="6.0" SE="2.0008997975910736" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.07" MODIFIED="2013-09-20 10:24:39 +0100" MODIFIED_BY="Nikki Jahnke" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.57551175729543" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Weight (kg)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.07.01" MODIFIED="2013-08-11 10:41:08 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="7.576274239778239" CI_START="-7.576274239778239" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="28.75" MEAN_2="28.75" MODIFIED="2013-08-11 10:41:08 +0100" MODIFIED_BY="anita  s malhotra" ORDER="605" SD_1="8.2" SD_2="8.2" SE="3.8655170704864594" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.08" MODIFIED="2013-08-11 10:47:13 +0100" MODIFIED_BY="Nikki Jahnke" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="12.534892259530926" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Height (cm)</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.08.01" MODIFIED="2013-08-11 10:47:13 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="7.630449104860283" CI_START="-7.630449104860283" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="130.25" MEAN_2="130.25" MODIFIED="2013-08-11 10:47:13 +0100" MODIFIED_BY="anita  s malhotra" ORDER="606" SD_1="8.01" SD_2="8.5" SE="3.893157815678396" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.09" MODIFIED="2013-08-11 10:49:12 +0100" MODIFIED_BY="Nikki Jahnke" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.670142727875054" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Body mass index</NAME>
<GROUP_LABEL_1>Cholesterol-lowering</GROUP_LABEL_1>
<GROUP_LABEL_2>Other diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chol-lowdiet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours other diet</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.09.01" MODIFIED="2013-08-11 10:49:12 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Up to one month</NAME>
<CONT_DATA CI_END="2.9450216792092982" CI_START="-2.7650216792092985" EFFECT_SIZE="0.08999999999999986" ESTIMABLE="YES" MEAN_1="16.75" MEAN_2="16.66" MODIFIED="2013-08-11 10:49:12 +0100" MODIFIED_BY="anita  s malhotra" ORDER="607" SD_1="3.07" SD_2="3.11" SE="1.4566704805442063" STUDY_ID="STD-Laurin-1991" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2014-05-02 01:30:00 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Dietary fibers as a form of dietary intervention compared to another form of dietary intervention or drug or no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2014-05-02 01:26:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.21" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum total cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez &amp; guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9406245729090024" CI_START="-2.080624572909003" EFFECT_SIZE="-0.5700000000000003" ESTIMABLE="YES" MEAN_1="8.52" MEAN_2="9.09" MODIFIED="2014-03-13 10:37:23 +0000" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="1.78" SD_2="1.99" SE="0.7707409854592311" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2014-05-02 01:26:52 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.06" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum LDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.34117974091759873" CI_START="-3.3188202590824014" EFFECT_SIZE="-1.83" ESTIMABLE="YES" MEAN_1="6.08" MEAN_2="7.91" MODIFIED="2014-03-13 10:40:24 +0000" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="1.91" SD_2="1.81" SE="0.7596161311258909" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2014-05-02 01:27:33 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.87" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum HDL cholesterol concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.10475742882931993" CI_START="-0.4647574288293198" EFFECT_SIZE="-0.17999999999999994" ESTIMABLE="YES" MEAN_1="1.24" MEAN_2="1.42" MODIFIED="2014-03-13 10:43:33 +0000" MODIFIED_BY="[Empty name]" ORDER="60" SD_1="0.33" SD_2="0.38" SE="0.1452870721479834" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2014-05-02 01:27:58 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.87" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum triglyceride concentration (mmol/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9359743904446827" CI_START="-0.11597439044468238" EFFECT_SIZE="0.41000000000000014" ESTIMABLE="YES" MEAN_1="1.87" MEAN_2="1.46" MODIFIED="2014-03-13 10:45:11 +0000" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="0.49" SD_2="0.79" SE="0.26835921200261914" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.05" MODIFIED="2014-05-02 01:28:34 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="28.74" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein A1 concentration (g/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.829750147392275" CI_START="-6.749750147392275" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.21" MEAN_2="1.17" MODIFIED="2014-03-13 11:32:01 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="0.1" SD_2="12.0" SE="3.464221894355691" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.06" MODIFIED="2014-05-02 01:29:24 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.52" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Fasting serum apolipoprotein B-100 concentration (g/l)</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.3471311853498039" CI_START="-0.6528688146501956" EFFECT_SIZE="-0.4999999999999998" ESTIMABLE="YES" MEAN_1="1.55" MEAN_2="2.05" MODIFIED="2014-03-13 11:33:22 +0000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="0.17" SD_2="0.21" SE="0.0779957263786506" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.07" MODIFIED="2014-05-02 01:30:00 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="15.82" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Weight</NAME>
<GROUP_LABEL_1>Bezafibrate with guar gum</GROUP_LABEL_1>
<GROUP_LABEL_2>Bezafibrate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bez with guar gum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bezafibrate</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.88819081026944" CI_START="-5.088190810269428" EFFECT_SIZE="0.4000000000000057" ESTIMABLE="YES" MEAN_1="72.0" MEAN_2="71.6" MODIFIED="2014-03-13 11:56:24 +0000" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="7.2" SD_2="6.5" SE="2.8001488055696853" STUDY_ID="STD-Wirth-1982" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-05-22 11:54:39 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-05-22 11:54:39 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-08-29 15:02:43 +0100" MODIFIED_BY="anita  s malhotra">
<APPENDIX ID="APP-01" MODIFIED="2013-08-29 15:02:43 +0100" MODIFIED_BY="anita  s malhotra" NO="1">
<TITLE MODIFIED="2012-02-05 06:38:32 +0000" MODIFIED_BY="anita  s malhotra">Search strategy for CENTRAL, The Cochrane Library</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-29 15:02:43 +0100" MODIFIED_BY="anita  s malhotra">
<P>#1 MeSH descriptor Dietary fiber explode all trees</P>
<P>#2 diet*</P>
<P>#3 MeSH descriptor Plant sterols explode all trees</P>
<P>#4 plant next sterol</P>
<P>#5 MeSH descriptor Plant stanol ester explode all trees</P>
<P>#6 stanol*</P>
<P>#7 MeSH descriptor Soy protein explode all trees</P>
<P>#8 Barley</P>
<P>#9 Guar gum</P>
<P>#10 Rice bran</P>
<P># 11oat bran</P>
<P># 12 rice bran </P>
<P>#13 flax seeds</P>
<P>#14 psyllium</P>
<P>#15 MeSH descriptor Omega 3 fatty acids explode all trees</P>
<P>#16 (#1 OR #2 OR #3 OR #4 OR #5 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15)</P>
<P>#17 MeSH descriptor familial hypercholesterolemia explode all trees</P>
<P>#18 MeSH descriptor familial hyperlipoproteinemia explode all trees</P>
<P>#19 (#17 OR #18)</P>
<P>#20 (#16 AND #19)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>